Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,wide pore channel activity (GO:0022829),0.8912145721226372,1.9192487609066344,0.0,0.02278056274256145,0.017,2/23,0.29%,GJC1;GJD3
prerank,gap junction channel activity (GO:0005243),0.8959305464451965,1.9060789086467027,0.0,0.013371199870633895,0.02,2/22,0.29%,GJC1;GJD3
prerank,fibroblast growth factor receptor binding (GO:0005104),0.8817264639549823,1.9038289771902712,0.0,0.008914133247089263,0.02,3/21,2.34%,FGF22;FGF18;FGF1
prerank,chemokine receptor binding (GO:0042379),0.7882742827468265,1.8056533069421912,0.0,0.08072242884864164,0.237,2/35,1.82%,CXCL12;CX3CL1
prerank,cytokine activity (GO:0005125),0.7248377090630087,1.8022155584626658,0.0,0.0701245148771022,0.251,13/131,8.68%,CXCL12;BMP5;WNT4;FAM3C;WNT2B;CX3CL1;IL16;TGFB2;KITLG;IL1A;CCL25;SLURP1;IL18
prerank,chemokine activity (GO:0008009),0.7955457941205488,1.7903904330030544,0.0012033694344163659,0.07758597455799915,0.312,2/31,1.82%,CXCL12;CX3CL1
prerank,CXCR chemokine receptor binding (GO:0045236),0.9512542941771771,1.7834785115778218,0.0,0.07937823415265201,0.354,1/11,0.05%,CXCL12
prerank,growth factor activity (GO:0008083),0.7355871677010163,1.7783999302552418,0.0,0.0772558214747736,0.386,8/74,8.15%,FGF22;FGF18;FGF1;VEGFC;AREG;PDGFB;NRG3;ARTN
prerank,polynucleotide adenylyltransferase activity (GO:0004652),-0.734552086796432,-1.7357267798073932,0.00558659217877095,0.6574573592719744,0.431,6/12,13.98%,TENT2;TENT4B;MTPAP;TENT5A;TENT4A;PAPOLG
prerank,metallocarboxypeptidase activity (GO:0004181),0.7932075082259472,1.7292784889390334,0.0012345679012345679,0.1755313892482392,0.697,5/26,5.39%,ACE2;VASH2;CPD;CPE;FOLH1
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),0.857489180826139,1.6965958818674853,0.004273504273504274,0.2632640685640362,0.854,1/13,0.10%,BMP5
prerank,triglyceride lipase activity (GO:0004806),0.7856379202510054,1.6918663976781438,0.006510416666666667,0.2554484446665883,0.864,3/20,6.94%,LCAT;LIPE;CEL
prerank,O-acyltransferase activity (GO:0008374),0.7391955106772966,1.669311523103687,0.008393285371702638,0.3220643326865028,0.933,5/30,8.02%,LCAT;MOGAT3;SOAT1;GPAM;PLA2G4A
prerank,BMP receptor binding (GO:0070700),0.8574892399396794,1.6614098180376962,0.010159651669085631,0.32989911931535476,0.953,1/12,0.10%,BMP5
prerank,carbohydrate:cation symporter activity (GO:0005402),-0.7010341510985167,-1.6596127325936851,0.011940298507462687,0.7599585853631955,0.733,3/11,15.96%,SLC17A5;SLC2A9;SLC5A3
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.6880638642322277,1.6365654793290927,0.003264417845484222,0.41231403622250967,0.983,8/60,6.15%,MUSK;ROR2;DDR1;DDR2;EPHB2;NRP1;CRIM1;AXL
prerank,carboxypeptidase activity (GO:0004180),0.7168970788338388,1.6341999780703174,0.011614401858304297,0.39585354678740836,0.983,8/35,11.60%,ACE2;VASH2;CPD;CPE;FOLH1;AGBL3;CTSZ;MINDY2
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),0.7938501613818365,1.6249160134133598,0.01991465149359886,0.412402470084088,0.987,4/15,6.67%,ALDH1A2;ALDH1L1;ALDH1A1;ALDH7A1
prerank,intracellular calcium activated chloride channel activity (GO:0005229),-0.6164249900857164,-1.6222634159362275,0.011111111111111112,0.5534030843005832,0.842,5/16,10.85%,ANO6;TTYH2;ANO3;ANO10;TTYH3
prerank,intracellular chloride channel activity (GO:0061778),-0.6164249900857164,-1.6222634159362275,0.011111111111111112,0.5534030843005832,0.842,5/16,10.85%,ANO6;TTYH2;ANO3;ANO10;TTYH3
prerank,frizzled binding (GO:0005109),0.70566460596383,1.6083024163195905,0.01927710843373494,0.461728797275702,1.0,4/34,6.24%,WNT4;WNT2B;DVL1;SDCBP
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.7123549839165993,1.603803044298954,0.025059665871121718,0.45627156101768007,1.0,8/27,10.15%,POLR2D;POLR1C;POLR1D;POLR3H;POLR2A;POLR1A;CRCP;POLR3A
prerank,tropomyosin binding (GO:0005523),0.7891199432620657,1.6013051685645394,0.022130013831258646,0.44231824913188533,1.0,4/16,4.80%,NEBL;TMOD1;S100A6;TMOD3
prerank,receptor ligand activity (GO:0048018),0.6427040477229972,1.5967103831682747,0.0,0.4392686772315654,1.0,23/245,8.68%,FGF22;FGF18;BMP5;WNT4;FAM3C;WNT2B;CX3CL1;DAND5;FGF1;IL16;VEGFC;TGFB2;GAS6;AREG;PDGFB;KITLG;SEMA6D;IL1A;NRG3;CCL25;ARTN;SLURP1;IL18
prerank,death receptor activity (GO:0005035),0.8117376111223027,1.5908394916473834,0.027777777777777776,0.4430654376886589,1.0,2/11,3.43%,TNFRSF11A;TNFRSF25
prerank,DNA polymerase activity (GO:0034061),0.7386912890481586,1.5908173376828652,0.022397891963109356,0.42301614136187227,1.0,6/22,6.74%,POLG;POLE4;POLE2;POLA1;POLD3;POLB
prerank,solute:anion antiporter activity (GO:0140323),0.7876282881677751,1.58966787280353,0.028985507246376812,0.4094041776815344,1.0,3/14,6.52%,SLC4A3;SLC7A11;SLC26A11
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.7416044610968419,1.5880166655549757,0.021248339973439574,0.39956776897369556,1.0,6/21,6.74%,POLG;POLE4;POLE2;POLA1;POLD3;POLB
prerank,sodium channel regulator activity (GO:0017080),0.6900640219437266,1.5875264299836214,0.018626309662398137,0.3857640685640363,1.0,6/37,9.16%,SGK3;SGK2;NEDD4;GPD1L;CAMK2D;PTPN3
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),0.7934056339870343,1.585597306991651,0.020437956204379562,0.3774411632998308,1.0,4/13,6.67%,ALDH1A2;ALDH1L1;ALDH1A1;ALDH7A1
prerank,serine-type peptidase activity (GO:0008236),0.6474486273259576,1.5846155347261672,0.0062176165803108805,0.36749706530592685,1.0,3/96,1.02%,GZMK;TYSND1;CD5L
prerank,voltage-gated anion channel activity (GO:0008308),-0.6036812219935281,-1.5805326403500262,0.02027027027027027,0.6466895537027956,0.927,9/15,15.86%,ANO6;VDAC2;VDAC1;CLCN4;CLCN6;VDAC3;CLCN3;GPR89B;GPR89A
prerank,transmembrane receptor protein kinase activity (GO:0019199),0.6679569675773532,1.5787805515323734,0.0065005417118093175,0.3748180789133247,1.0,7/60,6.38%,MUSK;ROR2;DDR1;DDR2;EPHB2;AXL;ACVR1
prerank,cytochrome-c oxidase activity (GO:0004129),-0.6131127080732027,-1.575257386792782,0.0299625468164794,0.5661725973153144,0.937,10/15,29.66%,CYB5A;COX10;COX7A2L;COX6B1;COX8A;NDUFA4;COX4I1;COX6A1;COX5A;COX15
prerank,poly(A)-specific ribonuclease activity (GO:0004535),-0.6618289201374761,-1.5711579931848725,0.00949367088607595,0.5074772102726983,0.944,7/12,21.72%,CNOT2;CNOT1;CNOT7;PAN2;CNOT6L;CNOT8;NOCT
prerank,growth factor receptor binding (GO:0070851),0.6396286624888019,1.5700930532843378,0.004140786749482402,0.39044586697595574,1.0,18/95,12.68%,FGF22;FGF18;GLMN;FGF1;GRB2;VEGFC;AREG;PDGFB;PTPRJ;SDCBP;IL1RAP;CNOT9;ATXN2;SNX1;FRS2;ERN1;ERAP1;TGFA
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),-0.4729235901201251,-1.568443565993912,0.017341040462427744,0.4525843278295461,0.946,17/33,20.12%,PRKN;TCERG1;ARIH2;DCUN1D1;SIAH1;RNF19A;RNF14;RNF185;RNF217;ANKIB1;TRAF6;DCUN1D3;RNF180;RNF144A;AUP1;RPS3;TOLLIP
prerank,phosphatidate phosphatase activity (GO:0008195),-0.6390872113250882,-1.566034758559606,0.026578073089700997,0.41092522962720773,0.947,7/13,17.69%,PLPPR1;LPIN2;LPIN1;PLPPR4;PLPP3;PLPPR5;PLPP4
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",0.7450219022405036,1.559959092990089,0.02482758620689655,0.41414402759810265,1.0,5/18,6.50%,ALDH1A2;ALDH6A1;AKR1B1;FAR1;ALDH1A1
prerank,retinoid binding (GO:0005501),0.7265826102052002,1.558128578525186,0.029601029601029602,0.40730240370571297,1.0,1/22,0.31%,ALDH1A2
prerank,bHLH transcription factor binding (GO:0043425),0.7278716994731538,1.551050634053365,0.04025974025974026,0.42069756630012933,1.0,4/19,5.09%,ISL1;SP1;PSMD9;SMAD3
prerank,G protein-coupled receptor binding (GO:0001664),0.6160202919499813,1.5445528568960754,0.0010141987829614604,0.432500539025442,1.0,21/132,13.76%,CXCL12;WNT4;S1PR1;WNT2B;DVL1;HOMER2;FLNA;ARHGEF12;REEP2;ARRB2;SDCBP;PSMC5;USP33;CCL25;USP20;GNAQ;TULP3;GNAI3;LRP6;PDCD6IP;BICD1
prerank,5'-3' RNA polymerase activity (GO:0034062),0.6952384115644346,1.5372940844095777,0.03663003663003663,0.44526969503842934,1.0,8/27,10.15%,POLR2D;POLR1C;POLR1D;POLR3H;POLR2A;POLR1A;CRCP;POLR3A
prerank,metal ion transmembrane transporter activity (GO:0046873),-0.48953803425886516,-1.5293110770053393,0.02358490566037736,0.5007029589668138,0.976,10/27,19.55%,ITPR2;SLC11A1;ITPR1;TMEM165;MAGT1;SLC11A2;ZDHHC13;MRS2;ATP2B4;SLC12A2
prerank,cytokine receptor binding (GO:0005126),0.612934403269458,1.5179399039077006,0.014705882352941176,0.5059265847347996,1.0,16/83,13.57%,CXCL12;VEGFC;TGFB2;LIFR;SMAD3;KITLG;SPRED2;SDCBP;CCL25;IL1RAP;IL18;PXDN;ERAP1;SH2B3;SYK;SPRED1
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.6624074530357461,1.5102038878544166,0.04220398593200469,0.5258238105505247,1.0,4/38,10.43%,TFPI2;SERPINI1;ANXA2;FURIN
prerank,monovalent cation:proton antiporter activity (GO:0005451),0.7780989969096446,1.5020364219326812,0.04747774480712166,0.5474830425509598,1.0,5/12,8.80%,SLC9A9;SLC9A1;LETM1;SLC9A7;SLC9A6
prerank,potassium channel regulator activity (GO:0015459),0.6271652799379613,1.4888976814000985,0.039908779931584946,0.5929462492340165,1.0,6/49,7.48%,SGK3;SGK2;AKAP9;FLNA;YWHAE;DLG1
prerank,translation elongation factor activity (GO:0003746),-0.5842681464919104,-1.488633603546164,0.050746268656716415,0.6247021465265703,0.994,11/14,33.11%,EEFSEC;EEF1A1;GFM2;GTPBP2;EEF2;GTPBP1;GFM1;EEF1B2;EIF5A;EIF5AL1;TSFM
prerank,syntaxin-1 binding (GO:0017075),0.6889140188558649,1.4851075927037714,0.05297157622739018,0.5957993332669917,1.0,6/22,10.33%,STXBP2;LRRK2;VAMP3;DAPK1;VAMP2;STXBP5
prerank,transcription corepressor binding (GO:0001222),0.6498560411277282,1.4828649311443576,0.05962732919254658,0.591601309831824,1.0,10/27,9.64%,RORA;EHMT1;USP11;THAP7;ZBTB7A;ESR1;EHMT2;WIZ;EZH2;CTBP1
prerank,bicarbonate transmembrane transporter activity (GO:0015106),0.7256588165266241,1.4795432998171998,0.05917159763313609,0.593091830214874,1.0,1/15,0.61%,SLC4A3
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.7169547029225115,1.4728560322900053,0.08286516853932584,0.6096512505390255,1.0,3/14,6.57%,PYCR2;ALDH1L1;MTHFR
prerank,metalloexopeptidase activity (GO:0008235),0.6188544782824614,1.4707268345855449,0.04851157662624035,0.6047329567676524,1.0,10/51,12.65%,ACE2;VASH2;CPD;METAP1;CPE;FOLH1;LNPEP;AGBL3;XPNPEP1;ERAP1
prerank,lipase activity (GO:0016298),0.6298609500674434,1.4661879270228027,0.05399325084364454,0.6116536075502764,1.0,7/43,10.19%,LCAT;SMPD3;LIPE;LIPA;CEL;ABHD6;ABHD16A
prerank,ubiquitin conjugating enzyme binding (GO:0031624),-0.465565968431765,-1.4592590260625353,0.05365853658536585,0.7093119357709844,0.997,14/27,20.12%,PRKN;ARIH2;DCUN1D1;SIAH1;RNF19A;RNF14;RNF217;ANKIB1;TRAF6;DCUN1D3;RNF180;RNF144A;AUP1;TOLLIP
prerank,chloride channel regulator activity (GO:0017081),0.704450379199366,1.4549200233170003,0.07204610951008646,0.6482445738105506,1.0,2/14,4.75%,SGK3;STX7
prerank,MHC class I protein binding (GO:0042288),0.7578882306787179,1.4510729508024038,0.06461086637298091,0.6510547028798019,1.0,4/13,11.74%,TUBB4B;ATP5F1A;TAP1;DERL1
prerank,syntaxin binding (GO:0019905),0.5978388176094918,1.4500540751056459,0.05144694533762058,0.641817593790427,1.0,19/61,13.23%,STXBP2;VAMP1;LRRK2;NAPG;VAMP3;STX7;TMED9;SNAP47;SYT12;STX16;DAPK1;VAMP2;CACNA1A;STXBP5;ABL1;STXBP5L;VPS11;ABCA1;NAPA
prerank,ribosomal large subunit binding (GO:0043023),0.7592249688415793,1.445130531735011,0.07335329341317365,0.652011070235015,1.0,4/11,5.00%,EIF6;NMD3;MALSU1;RBM3
prerank,acetyltransferase activity (GO:0016407),0.6314681176464602,1.4434166456320443,0.05199516324062878,0.6458804980595084,1.0,9/31,13.16%,LCAT;ACAT1;ELP3;EP300;NAA16;GTF2B;KAT2B;ESCO1;NAA15
prerank,metalloendopeptidase inhibitor activity (GO:0008191),-0.5682876277122494,-1.442303824721291,0.07766990291262135,0.7333576455695141,0.998,6/14,24.66%,TIMP2;SPOCK1;SPOCK2;BST2;TIMP3;RECK
prerank,MHC protein binding (GO:0042287),0.7003944606742849,1.4417221243387621,0.07397260273972603,0.6407875161707633,1.0,7/20,16.95%,TUBB4B;ATP5F1A;TAP1;DERL1;ATP5F1B;CD81;TAPBP
prerank,neurexin family protein binding (GO:0042043),0.7834559096568947,1.4399350322892936,0.06901840490797546,0.6358165759835629,1.0,3/10,6.94%,SYTL2;CPE;CEL
prerank,carboxylic ester hydrolase activity (GO:0052689),0.5818327464210815,1.4387278334936813,0.03115264797507788,0.628579724972634,1.0,13/85,10.21%,LCAT;PLA2G7;NDST3;LIPE;PLA2G6;TARS2;LIPA;CEL;ABHD6;PLA2G4A;AARS1;ABHD16A;PNPLA6
prerank,insulin-like growth factor I binding (GO:0031994),0.7212801910295538,1.4382519449082527,0.07225433526011561,0.6190370310478656,1.0,5/13,13.60%,IGFBP3;IGFBP2;ITGA6;IGF1R;INSR
prerank,transcription coregulator binding (GO:0001221),0.594030772900202,1.431627622329493,0.058426966292134834,0.6357831291025825,1.0,22/50,16.07%,RORA;EHMT1;USP11;THAP7;RELA;AR;ZBTB7A;SMAD3;ESR1;EHMT2;WIZ;CDK9;EZH2;CTBP1;UBE2I;LCOR;PPARD;CHD6;CTCF;SMAD4;NEK6;LMO2
prerank,rRNA binding (GO:0019843),0.617112346963003,1.4315440801931412,0.06321839080459771,0.6247096612960132,1.0,6/42,5.41%,ANG;CAVIN1;SBDS;GTF3A;EMG1;RPLP0
prerank,R-SMAD binding (GO:0070412),0.6794770225575226,1.429671840879061,0.08366533864541832,0.6221499029754204,1.0,10/18,16.48%,RGCC;SMAD6;PMEPA1;JUN;SMAD3;LDLRAD4;PPM1A;DDX5;SMAD4;DROSHA
prerank,potassium:proton antiporter activity (GO:0015386),0.7607812561457696,1.4241123705525005,0.07332293291731669,0.6357010735117224,1.0,4/10,8.80%,SLC9A9;SLC9A1;SLC9A7;SLC9A6
prerank,pyridoxal phosphate binding (GO:0030170),0.6640696244048144,1.4172319898522485,0.07772020725388601,0.6551375630102154,1.0,4/20,10.40%,CBS;PDXK;PSAT1;SRR
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),-0.6184211868631222,-1.4147425658528903,0.08785529715762273,0.8157204356321571,1.0,4/10,7.61%,NCF2;NCF1;CYBA;CYBB
prerank,sodium:proton antiporter activity (GO:0015385),0.7450041319637837,1.4142103914442588,0.0680786686838124,0.6575810045607033,1.0,4/11,8.80%,SLC9A9;SLC9A1;SLC9A7;SLC9A6
prerank,metal ion:proton antiporter activity (GO:0051139),0.716160746975718,1.4085735715116292,0.0920863309352518,0.6722081851013367,1.0,5/13,8.80%,SLC9A9;SLC9A1;LETM1;SLC9A7;SLC9A6
prerank,potassium ion antiporter activity (GO:0022821),0.7057221659861874,1.4075867723395021,0.08757062146892655,0.6658484083727441,1.0,5/15,8.80%,SLC24A5;SLC9A9;SLC9A1;SLC9A7;SLC9A6
prerank,Hsp70 protein binding (GO:0030544),0.6155772576097288,1.4075519018936726,0.08971291866028708,0.6552367191086257,1.0,6/31,4.00%,DNAJB1;SACS;PPID;DNAJC18;DNAJC8;HIKESHI
prerank,C2H2 zinc finger domain binding (GO:0070742),0.7391285625303364,1.4064104760275347,0.0778816199376947,0.6502443582003737,1.0,4/11,13.67%,THAP7;EHMT2;ZXDC;SRRM2
prerank,myosin II binding (GO:0045159),0.7465836767803973,1.4050676620956157,0.08957654723127036,0.6457175270860285,1.0,4/10,11.92%,LLGL2;LLGL1;STXBP5;STXBP5L
prerank,peptidoglycan binding (GO:0042834),-0.62443709737304,-1.404306390019329,0.07967032967032966,0.8153851742865966,1.0,5/10,20.04%,NLRP3;HK1;RNASE7;TLR2;NOD1
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),0.7258944112331309,1.399513100345282,0.0943952802359882,0.6592039630809036,1.0,3/11,4.81%,ROR2;SASH1;MAP3K11
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),0.7291245207192585,1.3972469293124012,0.10618066561014262,0.6587304358265711,1.0,4/10,8.35%,EHMT1;SUV39H1;EHMT2;ASH1L
prerank,exopeptidase activity (GO:0008238),0.582165082482687,1.3948861180416783,0.08008898776418243,0.6587588818520592,1.0,9/50,12.65%,ACE2;METAP1;CPE;FOLH1;DPP3;LNPEP;CTSZ;XPNPEP1;ERAP1
prerank,MAP kinase phosphatase activity (GO:0033549),0.7208666201190927,1.3937141463876184,0.10058309037900874,0.6538196294041548,1.0,3/12,8.29%,DUSP3;DUSP16;DUSP10
prerank,BMP binding (GO:0036122),-0.6050019353672089,-1.3902964775861892,0.09939759036144578,0.8296516538608252,1.0,3/11,27.27%,BMPR2;ENG;GREM2
prerank,nuclease activity (GO:0004518),0.5812957136392762,1.3885047985881491,0.06759656652360516,0.6664929481410652,1.0,9/52,7.41%,ANG;DFFB;RNASE6;RNASEH2A;WRN;ISG20L2;REXO5;RNASE4;MRE11
prerank,insulin-like growth factor binding (GO:0005520),0.6812144356167377,1.3884796363211387,0.09887005649717515,0.6570423673997413,1.0,5/15,13.60%,IGFBP3;IGFBP2;ITGA6;IGF1R;INSR
prerank,phosphatase inhibitor activity (GO:0019212),0.6481816960749265,1.3872419739965847,0.1103448275862069,0.6528102964488093,1.0,8/20,15.82%,URI1;CABIN1;STYX;BOD1L1;SET;ENSA;PPME1;PPP1R9B
prerank,ribonuclease activity (GO:0004540),0.5776691191495106,1.3827155564712412,0.08043478260869565,0.6625346997628287,1.0,14/56,12.18%,ANG;RNASE6;ZC3H12D;RNASEH2A;SMG6;EXOSC5;PPP1R8;EXOSC7;RNASE4;AGO2;ZC3H12B;CPSF3;RNASE3;ERN1
prerank,sterol transfer activity (GO:0120015),0.6609029369826959,1.3796544187960849,0.12027972027972028,0.6674338549327473,1.0,6/17,16.25%,OSBP;STARD5;ABCG1;ABCA1;GRAMD1B;OSBPL2
prerank,clathrin adaptor activity (GO:0035615),0.6749262577886253,1.3747793333259133,0.11604584527220631,0.6787992006398378,1.0,5/15,8.83%,AP1M1;LDLRAP1;STON2;AP2A1;DAB2
prerank,DNA polymerase binding (GO:0070182),0.6553970352341362,1.3700334745157698,0.11819389110225764,0.6901652112979733,1.0,6/18,12.01%,SMARCA4;SMG6;CDK2AP1;POLG2;HSP90AA1;HMGB1
prerank,anion:anion antiporter activity (GO:0015301),0.6588920901189304,1.363494978455189,0.11586206896551725,0.7093643081466603,1.0,2/17,6.52%,SLC4A3;SLC26A11
prerank,transcription coactivator binding (GO:0001223),0.6390927201134515,1.3629050161526295,0.12172774869109948,0.7030974361989886,1.0,6/20,8.29%,RORA;RELA;AR;SMAD3;ESR1;CDK9
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),-0.43033413414398236,-1.360724521932865,0.07281553398058252,0.9264088829908291,1.0,12/28,29.90%,GRIK1;GABRA2;GABRA3;GRIK4;GRIK2;GABRA5;GABRA4;CHRNA7;GABRG1;GRIK5;GRIK3;GABRA1
prerank,FAD binding (GO:0071949),0.6289991055194984,1.360522962552295,0.10349127182044887,0.7037085986997048,1.0,6/24,12.19%,NQO2;KDM1B;QSOX1;MTHFR;MICAL2;AIFM1
prerank,galactosyltransferase activity (GO:0008378),0.6990180050581962,1.3600871492214248,0.12556053811659193,0.6966564388294824,1.0,3/11,9.77%,B4GALT3;B4GALT5;B4GALT1
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.6586360204550775,1.3570283768029008,0.12722298221614228,0.700341354705692,1.0,2/17,1.44%,AK4;AK3
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),-0.5283105949103428,-1.352224242865653,0.1296928327645051,0.9161262783136251,1.0,5/15,16.91%,SLC1A2;SLC25A13;SLC38A7;SLC17A6;SLC1A1
prerank,exonuclease activity (GO:0004527),0.5734872566474499,1.3482056261731372,0.10437710437710437,0.7282076505677734,1.0,14/46,13.93%,POLG;RAD50;REXO2;EXOSC5;WRN;ISG20L2;REXO5;EXOSC7;MRE11;EXD2;XRN2;CPSF3;REV3L;APEX2
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),-0.4262492453808068,-1.3463677877266682,0.09574468085106383,0.8961909432728462,1.0,19/29,48.60%,SLC25A13;SLC38A7;SLC1A1;SLC25A30;SLC26A2;SLC1A5;SLC25A11;SLC25A14;SLC25A12;SLC25A22;SLC25A21;SLC1A4;SLC13A3;SLC26A8;SLC26A6;SLC25A10;SLC46A1;SLC1A6;SLC19A1
prerank,hyaluronic acid binding (GO:0005540),0.6973040210805749,1.3349495478774,0.1600633914421553,0.7774259595967564,1.0,2/10,9.66%,CHODL;CD44
prerank,phosphate ion binding (GO:0042301),0.7123238501079341,1.3324888757725142,0.15445859872611464,0.7789425002727599,1.0,2/10,2.57%,RELA;ADSS1
prerank,acid-thiol ligase activity (GO:0016878),-0.5290453576921657,-1.33209542026496,0.15584415584415584,0.9188872541005941,1.0,6/13,35.32%,ACSS1;ACSL1;ACSS2;AASDH;ACSS3;AACS
prerank,phospholipase C activity (GO:0004629),-0.44357589200569586,-1.3300548945511146,0.10267857142857142,0.8838080706643727,1.0,6/25,14.73%,PLCG2;PLCL1;CHRM3;PLCB2;PLCE1;PLCG1
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.6680252513858712,1.325465309556139,0.14877300613496933,0.8021422892410522,1.0,1/12,0.90%,NQO2
prerank,protein tyrosine kinase activity (GO:0004713),0.5393955004300135,1.3252606409510688,0.062118126272912425,0.7937190853055324,1.0,19/108,13.79%,MUSK;ROR2;DDR1;DDR2;DYRK2;EPHB2;BTK;YES1;AXL;LYN;EPHA5;IGF1R;ABL1;HIPK2;SYK;CLK1;INSR;CAMKK2;FYN
prerank,nuclear import signal receptor activity (GO:0061608),0.6481234301269423,1.321565535912329,0.1514726507713885,0.8014427705406298,1.0,6/15,9.84%,KPNB1;HIKESHI;RANBP6;IPO9;KPNA6;IPO5
prerank,potassium ion leak channel activity (GO:0022841),0.6388182031675883,1.3173020340579087,0.17456021650879566,0.8103550504825207,1.0,4/15,12.84%,TMEM175;KCNK2;KCNK13;KCNK10
prerank,GABA receptor binding (GO:0050811),-0.5657788117442153,-1.3168492439633566,0.15223880597014924,0.9054274971391205,1.0,10/11,41.42%,PLCL2;TRAK2;TRAK1;GABARAP;GABARAPL2;JAKMIP1;GABARAPL1;LHFPL4;AKAP5;SHISA7
prerank,protein tyrosine kinase activator activity (GO:0030296),0.6301709968673693,1.3160487531419494,0.15027322404371585,0.8064139127366812,1.0,4/19,8.02%,GAS6;ABI1;NRG3;PAK2
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),-0.5554871228714439,-1.3122963933329819,0.15873015873015872,0.8856430048830417,1.0,8/11,25.71%,CASP4;PYCARD;CASP7;CASP8;CASP9;CASP2;CASP1;CASP3
prerank,dynactin binding (GO:0034452),0.6691872456598872,1.3100968391499686,0.1566265060240964,0.8243403146212771,1.0,5/12,13.76%,SNX5;BBS4;BICDL1;MAPT;BICD1
prerank,basic amino acid transmembrane transporter activity (GO:0015174),0.6591369151424284,1.3091872538869662,0.15384615384615385,0.8192198505102775,1.0,3/13,6.84%,SLC66A1;SLC7A2;SLC7A7
prerank,1-phosphatidylinositol binding (GO:0005545),0.647285002573038,1.3047364360086886,0.15774647887323945,0.8295368320230869,1.0,5/15,8.37%,ZFYVE9;EEA1;SNX10;EPB41;WDFY1
prerank,double-stranded RNA binding (GO:0003725),0.5420838545287896,1.3044698500523602,0.11670235546038545,0.8216397769137747,1.0,18/70,12.21%,TUBB4B;EIF2AK2;ILF3;ZNF346;DDX60;TLR7;EIF4B;MSN;MBNL1;RFTN1;SIDT1;RC3H2;TLR3;AGO2;MTDH;ADAR;PRKRA;ZFR
prerank,four-way junction DNA binding (GO:0000400),0.6129180403291974,1.3036128716488045,0.1539509536784741,0.816404674219978,1.0,5/17,12.01%,BLM;WRN;RAD51B;ABL1;HMGB1
prerank,acetylation-dependent protein binding (GO:0140033),0.618145251910947,1.3018162397039625,0.1562913907284768,0.8072555661469327,1.0,8/20,15.29%,THAP7;SMARCA4;ZMYND8;DPF2;BRD2;BRD7;BRD3;PHIP
prerank,lysine-acetylated histone binding (GO:0070577),0.618145251910947,1.3018162397039625,0.1562913907284768,0.8072555661469327,1.0,8/20,15.29%,THAP7;SMARCA4;ZMYND8;DPF2;BRD2;BRD7;BRD3;PHIP
prerank,endopeptidase inhibitor activity (GO:0004866),0.5293437049870109,1.3003248004416308,0.10810810810810811,0.8046243329560154,1.0,8/82,11.35%,TFPI2;UBE2Z;UCHL5;SERPINI1;BIRC6;ANXA2;FURIN;PRNP
prerank,copper ion binding (GO:0005507),0.5595366299481715,1.2988695595570479,0.13489409141583056,0.8028744365239194,1.0,8/42,12.92%,ANG;COX17;ATP7A;IL1A;LACC1;LOXL3;PRNP;TP53
prerank,heme binding (GO:0020037),0.5434112102350444,1.2981045880618531,0.13141025641025642,0.7976127910737386,1.0,4/65,4.82%,FLVCR2;CBS;EIF2AK1;HMOX2
prerank,gated channel activity (GO:0022836),0.6448692905175961,1.2942944156870928,0.17087667161961367,0.8052633792648345,1.0,4/14,8.52%,TMEM266;TMC7;TMEM63B;PIEZO2
prerank,cGMP binding (GO:0030553),-0.5592801754807959,-1.290275740849556,0.16417910447761194,0.9497325304706374,1.0,2/11,9.11%,PDE10A;PDE11A
prerank,ion gated channel activity (GO:0022839),-0.42487688876998086,-1.289883718745829,0.1346153846153846,0.9133998147239932,1.0,7/24,10.85%,ANO6;KCNT2;TTYH2;ANO3;TMEM63A;ANO10;TTYH3
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),-0.4704675027749998,-1.2898798941607088,0.13740458015267176,0.8782690526192243,1.0,11/19,29.90%,GRIK1;GABRA2;GABRA3;GRIK4;GRIK2;GABRA5;GABRA4;GABRG1;GRIK5;GRIK3;GABRA1
prerank,carboxylic acid binding (GO:0031406),-0.3701593197607181,-1.2893786470459745,0.08450704225352113,0.8473894852838779,1.0,14/38,23.84%,UBR1;SESN1;GRIN2B;GLUD1;GRIN3A;SESN3;GCLC;GLRA1;UBR2;CASTOR2;EPDR1;PHYH;GLRA2;GRIN1
prerank,nuclear receptor binding (GO:0016922),0.5213650005489672,1.2885582178740578,0.09016393442622951,0.8219821313065977,1.0,32/111,13.71%,ISL1;ZNHIT3;SMARCA4;BRD8;PPID;RERG;ZBTB7A;WBP2;PADI2;PRKCB;EP300;SMAD3;BUD31;TACC2;HMGN3;ESR1;KDM3A;NCOA1;PRPF6;JMJD1C;NCOR1;NCOA3;ACTN4;GTF2B;NCOR2;KDM4C;TCF7L2;LCOR;RXRA;PPARGC1B;GTF2H1;DDX5
prerank,DNA secondary structure binding (GO:0000217),0.5686391033518079,1.288360251850315,0.15579710144927536,0.8146478295953787,1.0,8/31,12.01%,BLM;RAD18;WRN;RBBP8;MAPT;RAD51B;ABL1;HMGB1
prerank,transforming growth factor beta binding (GO:0050431),0.5871719566902264,1.2877534596891689,0.1875,0.8092926004489764,1.0,5/23,12.97%,CD36;THBS1;ACVR1;TGFBR2;TGFBR1
prerank,GDP-dissociation inhibitor activity (GO:0005092),0.6541898524120131,1.2862938928733354,0.1891891891891892,0.8081858994084327,1.0,4/13,7.50%,ITGB1BP1;GDI1;GDI2;RGS14
prerank,estrogen receptor binding (GO:0030331),0.5691518176637023,1.2825963857147904,0.15890083632019117,0.8168146006443427,1.0,7/32,7.95%,ISL1;PPID;RERG;WBP2;PADI2;ESR1;NCOA1
prerank,peptidase inhibitor activity (GO:0030414),-0.3868617206370767,-1.2761645848627248,0.09615384615384616,0.8715562406096983,1.0,5/33,6.28%,CST3;TIMP2;RENBP;CAST;SIMC1
prerank,phospholipase A2 activity (GO:0004623),0.5720382822217424,1.2739383249844005,0.1929611650485437,0.8466351336783096,1.0,3/26,8.02%,PLA2G7;PLA2G6;PLA2G4A
prerank,leucine zipper domain binding (GO:0043522),0.6793812675274108,1.2716614951078522,0.18944099378881987,0.8483283473479949,1.0,1/10,0.63%,PMF1
prerank,fatty acid synthase activity (GO:0004312),-0.567604462276194,-1.2689531757092118,0.17117117117117117,0.8724564479244765,1.0,8/10,40.71%,ELOVL6;ELOVL7;ELOVL5;ELOVL4;CBR4;ELOVL1;OXSM;MCAT
prerank,metallopeptidase activity (GO:0008237),0.5126616143681565,1.2658114499633755,0.10164271047227925,0.8655410480468138,1.0,11/113,9.26%,ACE2;ADAMTS12;NLN;ADAMTS2;ADAM15;METAP1;ADAM12;ADAMTSL3;NRDC;LNPEP;ADAMTS10
prerank,GABA receptor activity (GO:0016917),-0.42886674482688747,-1.2642386960523604,0.17937219730941703,0.8626323724411022,1.0,9/21,29.90%,GABRB1;GABRA2;GABRA3;GABBR1;GABRA5;GABRA4;GABRB3;GABRG1;GABRA1
prerank,3'-5' exonuclease activity (GO:0008408),0.5385697368641964,1.2627388160528206,0.18242491657397109,0.8713565249029754,1.0,11/45,12.46%,POLG;RAD50;REXO2;EXOSC5;WRN;EXOSC7;ERI3;MRE11;EXD2;XRN2;REV3L
prerank,SH2 domain binding (GO:0042169),-0.3831627702642647,-1.2627080236340493,0.13414634146341464,0.8406503293307387,1.0,11/31,14.23%,ARHGAP5;PAG1;PTK2;JAK2;NLK;SH3PXD2B;LAT2;INPPL1;CCDC88A;RACK1;LILRB1
prerank,death receptor binding (GO:0005123),-0.485605587853454,-1.262604135271598,0.18115942028985507,0.8148329791292028,1.0,9/15,33.38%,MADD;RIPK1;FEM1B;EDA;TMBIM1;BID;DAB2IP;BDNF;MYD88
prerank,protein kinase C binding (GO:0005080),0.5459588901011595,1.2623082550410594,0.17494356659142213,0.865079830162479,1.0,14/43,16.76%,IRS1;NELL1;HDAC9;PRKCB;SQSTM1;HDAC5;TWF2;GRK5;ABL1;PRKCSH;NELL2;PRKD2;PKN1;TOP2B
prerank,actinin binding (GO:0042805),0.5894053448971324,1.2615845701405954,0.18725617685305593,0.8604479668940374,1.0,7/21,16.88%,RELA;CACNA1D;PPARG;PKD2;CACNA1C;DAG1;KCNA5
prerank,filamin binding (GO:0031005),0.6485432929012155,1.2607921538123155,0.21483771251931993,0.8560780217474914,1.0,3/11,13.07%,TMEM67;NEBL;FBLIM1
prerank,mRNA 3'-UTR binding (GO:0003730),0.5152090414307365,1.2601403872870784,0.144912641315519,0.8510963272153944,1.0,24/79,16.53%,ELAVL4;SECISBP2L;ELAVL2;RPL41;ILF3;CARHSP1;TARDBP;RBMS3;RNPS1;PUM2;HNRNPA2B1;LARP4B;PABPC4;FXR2;PUM1;ZFP36L1;TP53;RNF20;DDX5;RBMS1;HNRNPC;SERBP1;CELF2;CPEB2
prerank,adenyl nucleotide binding (GO:0030554),0.6616669138609014,1.2596070801345787,0.22356495468277945,0.8386757137831642,1.0,3/11,5.38%,BAG3;HSPH1;SIL1
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),0.6616669138609014,1.2596070801345787,0.22356495468277945,0.8386757137831642,1.0,3/11,5.38%,BAG3;HSPH1;SIL1
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",-0.5062981458165392,-1.2593596412305406,0.21656050955414013,0.8028792089606214,1.0,7/13,31.26%,DNA2;DNASE1L1;FAN1;ZGRF1;ENDOV;DICER1;SLX4
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),-0.4783988302570211,-1.2585753815996208,0.2226027397260274,0.7822494045844592,1.0,11/16,40.65%,SLC25A13;SLC38A7;SLC1A1;SLC25A30;SLC1A5;SLC25A11;SLC25A14;SLC25A12;SLC25A22;SLC1A4;SLC13A3
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),0.6747402586780156,1.257618710077125,0.22170542635658916,0.8402625639799763,1.0,2/10,3.36%,SLCO4C1;SLCO1B1
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),-0.43106342259939234,-1.2531842943091254,0.19591836734693877,0.7807842312991896,1.0,9/20,12.60%,USP9X;OTUD5;USP47;COPS2;UFSP2;SENP2;SENP3;COPS5;USP50
prerank,endopeptidase activator activity (GO:0061133),-0.5561696734643773,-1.2496395503426654,0.20810810810810812,0.7712038096622044,1.0,9/10,40.25%,PSMD14;VSIR;PSME1;PSME2;APH1A;PSENEN;NLRC4;APH1B;PSME3
prerank,myosin V binding (GO:0031489),-0.4754959461106857,-1.2466798237896872,0.20075757575757575,0.7616095742628357,1.0,6/15,10.31%,RAB10;RAB6B;RAB11A;RAB11B;RAB14;RAB27B
prerank,cyclic nucleotide binding (GO:0030551),-0.43854086345210125,-1.246243643987682,0.19617224880382775,0.742956787096071,1.0,7/21,20.92%,PDE4D;PDE10A;PDE4B;PDE11A;PDE4A;KCNH1;CNBD2
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.5142061704582505,1.245891686104479,0.1670235546038544,0.8820210387206138,1.0,18/69,14.15%,MOGAT3;SOAT1;ELP3;CERS6;EP300;ZDHHC5;PLA2G4A;ZDHHC1;CERS4;NMT1;NAA16;GTF2B;KAT2B;ESCO1;ZDHHC6;NAA15;CERS5;ZDHHC20
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.4931411988321954,1.2403799786812197,0.10130391173520562,0.8977116296812286,1.0,48/181,15.59%,ISL1;CDK5RAP3;PARP9;DMAP1;RELA;SMARCA4;SP1;BBS4;NFATC1;JUN;AR;EP300;SMAD3;SPEN;BUD31;TACC2;HDAC5;MEF2A;RBBP8;NCOA1;PTPRT;TAF4;NCOR1;NCOA3;FAF1;PPARG;MTDH;TAL1;ACTN4;COMMD7;NCOR2;TCF7L2;MIER3;MAPK14;HIPK2;TP53;CTDP1;RXRA;CREB1;RBPJ;PPARD;NCOA2;LDB2;LDB1;ARNT;NPM1;PIAS1;HDAC2
prerank,deoxyribonuclease activity (GO:0004536),0.6237347953116124,1.2399247128167217,0.2383638928067701,0.8920848225053171,1.0,3/14,7.85%,DFFB;MRE11;ERCC4
prerank,telomeric DNA binding (GO:0042162),0.556439497496165,1.2397852804166878,0.19494584837545126,0.8852957822844533,1.0,13/32,18.05%,BLM;RAD50;SMG6;WRN;TERF2;HNRNPA2B1;HMBOX1;TERF1;CTC1;HNRNPD;PURA;SMG7;NCL
prerank,NF-kappaB binding (GO:0051059),0.5685115425132349,1.238521039094704,0.20539152759948653,0.8835061583656748,1.0,8/24,15.59%,CDK5RAP3;RELA;EP300;FAF1;MTDH;COMMD7;NPM1;HDAC2
prerank,phosphoric ester hydrolase activity (GO:0042578),0.5188307604368471,1.2366010215893661,0.19553072625698323,0.8842918408476153,1.0,8/49,8.29%,SMPDL3A;DUSP3;PLCXD3;SMPD1;PLCXD2;PTPRJ;DUSP16;DUSP10
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),-0.4238119426522412,-1.2360443182792298,0.19047619047619047,0.7574630880172812,1.0,7/23,23.34%,PLCG2;CHRM3;PLCB2;PLCE1;PLCG1;PLCB3;PLCH1
prerank,actin binding (GO:0003779),0.49577154491765424,1.235618375213147,0.09437751004016064,0.8811271618454817,1.0,41/170,15.73%,ANG;SYNE2;VCL;VASH2;LRRK2;TLN2;VPS16;BCL7B;ADCY8;MAP1A;TMOD1;PDLIM2;IQGAP2;ALDOA;TPM1;CAPZB;PARVB;EZR;GIPC1;MAPT;ARPC1A;EPS8L1;SSH2;PHACTR2;TWF2;ADD1;MICAL2;ACTN4;EPS8;DBNL;TMSB4X;ABL1;MYO9B;FMN2;LIMA1;FLNB;DAG1;ABLIM1;MICAL3;MACF1;CAPZA1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.6477333382381962,1.2330496705012643,0.2336448598130841,0.8852048362414413,1.0,1/11,4.60%,PADI2
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),-0.36084590810146394,-1.222322577970522,0.14788732394366197,0.7862568797340744,1.0,8/35,4.90%,HCK;DYRK1A;PTK2;PTK2B;FGR;SLA;FES;CSK
prerank,GABA-A receptor activity (GO:0004890),-0.4490607641959833,-1.2218758323456171,0.21115537848605578,0.7683172712060616,1.0,8/18,29.90%,GABRB1;GABRA2;GABRA3;GABRA5;GABRA4;GABRB3;GABRG1;GABRA1
prerank,disordered domain specific binding (GO:0097718),0.5613172872615915,1.221759377187734,0.23477157360406092,0.9270379073989067,1.0,10/23,16.61%,DFFB;HSP90AA1;NCOA3;TP53;FN1;FYN;CALM1;CLTC;RB1;KCNA1
prerank,glucose transmembrane transporter activity (GO:0005355),0.5869953623944735,1.2208939376762455,0.2430939226519337,0.9232585705045279,1.0,1/17,1.39%,SLC2A3
prerank,ligand-gated ion channel activity (GO:0015276),-0.3812923179116018,-1.2207617855982684,0.16847826086956522,0.7533273131605648,1.0,7/30,17.04%,GABRB1;GRIK1;GRIN2B;GRIN3A;GRIK4;GRIK2;ANXA6
prerank,mannose binding (GO:0005537),0.6272771693034217,1.2188917784625617,0.2536873156342183,0.924428633031479,1.0,1/12,0.77%,LMAN1
prerank,semaphorin receptor activity (GO:0017154),0.6258529900467578,1.218051417342211,0.25577812018489987,0.9208229454217641,1.0,4/11,13.83%,PLXNA1;NRP1;PLXNC1;NRP2
prerank,ubiquitin-dependent protein binding (GO:0140036),-0.5332559930756955,-1.2173750633787577,0.23268698060941828,0.7467877677282653,1.0,9/10,35.85%,LAPTM5;IDE;DNAJC2;FAN1;DNAJB2;FAAP20;USP15;ANKRD13D;ANKRD13B
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.5613060939184982,1.2170005024299828,0.2572178477690289,0.9182950077821799,1.0,7/24,15.18%,CAMKK1;CAMK1D;CAMK2D;DAPK1;MAPKAPK2;CAMK2G;MKNK1
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.5487126535821801,1.216744142173231,0.23588456712672523,0.9122052909734548,1.0,6/29,10.43%,GBA2;CTBS;PARG;ACER3;GANAB;GALC
prerank,anion transmembrane transporter activity (GO:0008509),0.6228339400629871,1.216313153490225,0.26666666666666666,0.9070397241019007,1.0,4/12,15.52%,ABCC5;SLC26A11;SLCO2B1;ABCG2
prerank,calcium channel regulator activity (GO:0005246),0.5283287496169324,1.2142503483854326,0.2336018411967779,0.9083267395297394,1.0,3/37,4.70%,SGK3;CACNG7;YWHAE
prerank,mechanosensitive ion channel activity (GO:0008381),0.6123941119694246,1.2130323270664445,0.2503725782414307,0.9064277865165236,1.0,3/12,8.52%,TMC7;TMEM63B;PIEZO2
prerank,ligand-gated channel activity (GO:0022834),-0.3813030126909099,-1.2114916582755968,0.1746031746031746,0.7484519050237539,1.0,7/29,17.04%,GABRB1;GRIK1;GRIN2B;GRIN3A;GRIK4;GRIK2;ANXA6
prerank,endonuclease activity (GO:0004519),0.5137634962726416,1.2087771728241543,0.21729490022172948,0.9176716654183973,1.0,9/49,12.18%,ANG;ZC3H12D;SMG6;MRE11;ERCC4;AGO2;ZC3H12B;CPSF3;ERN1
prerank,lysine N-methyltransferase activity (GO:0016278),0.5775078249684044,1.2081433939791972,0.24904701397712833,0.9135508280878918,1.0,4/20,7.97%,EHMT1;EHMT2;SETD2;SETD3
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),-0.52796839584145,-1.2051898383181912,0.25824175824175827,0.751146470976453,1.0,8/10,35.85%,LAPTM5;IDE;PML;FAN1;DNAJB2;FAAP20;ANKRD13D;ANKRD13B
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.5610766493965921,1.2040343170139893,0.23694267515923567,0.9235262146039961,1.0,3/22,4.11%,ELAVL4;ILF3;RBMS3
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),-0.528388212738105,-1.202093523838644,0.26098191214470284,0.7437753658727282,1.0,7/10,25.71%,CASP4;CASP7;CASP8;CASP9;CASP2;CASP1;CASP3
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",-0.5090630868873997,-1.1996598830728307,0.2682119205298013,0.7348454545349142,1.0,10/12,42.64%,XDH;CISD2;SDHB;CIAPIN1;ISCA1;ISCU;CISD1;FXN;ISCA2;FDX1
prerank,hexose transmembrane transporter activity (GO:0015149),0.6122443225932932,1.1982143255902176,0.26626323751891073,0.9411183569077696,1.0,1/12,1.39%,SLC2A3
prerank,ionotropic glutamate receptor activity (GO:0004970),-0.4508907995894682,-1.1975667782240498,0.21052631578947367,0.72501498555937,1.0,6/17,13.22%,GRIK1;GRIN2B;PTK2B;GRIN3A;GRIK4;GRIK2
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),-0.33157714146541667,-1.1975472539574679,0.17355371900826447,0.7102398912810178,1.0,11/42,19.68%,CCNT2;CCNT1;CCNY;CCNH;CCNL1;CCNC;CCNYL1;CDKN1B;CCNG2;CCNK;CNPPD1
prerank,endopeptidase regulator activity (GO:0061135),-0.34277241485786547,-1.1947044440644747,0.1773049645390071,0.7048564110947633,1.0,16/40,35.05%,PSMD14;CST3;RENBP;CAST;VSIR;ABCA2;TFPI;PSMF1;RECK;PSME1;PSME2;APH1A;CST7;PSENEN;NLRC4;PCSK1N
prerank,protein kinase A regulatory subunit binding (GO:0034237),0.5432153616501887,1.1922714123820763,0.2616822429906542,0.9583741536907112,1.0,9/21,15.39%,WASF1;AKAP9;AKAP1;PRKACA;ARFGEF1;EZR;WASF2;PRRC1;AKAP8L
prerank,histone methyltransferase binding (GO:1990226),0.6276422910320094,1.1913407858115082,0.2874251497005988,0.9551831104580308,1.0,5/11,13.20%,PRDM4;WIZ;CBX1;NOP56;LCOR
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.5304038797768637,1.189482188488521,0.2459396751740139,0.956092451394641,1.0,8/34,8.54%,EHMT1;SUV39H1;EHMT2;KMT2E;SETD2;KMT5B;SETD3;EZH2
prerank,5'-3' exonuclease activity (GO:0008409),0.5876986568252726,1.1885403914810573,0.28364688856729375,0.953048188874515,1.0,5/14,11.07%,DCLRE1A;XRN1;MRE11;XRN2;CPSF3
prerank,ephrin receptor binding (GO:0046875),0.5670194870783325,1.1880159125868832,0.258732212160414,0.948403366500601,1.0,8/21,13.79%,GRB2;PTPN1;LYN;ANKS1A;CBL;ABL1;ANKS1B;FYN
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",-0.4148167541415356,-1.1874159744469739,0.2361111111111111,0.7116212077986882,1.0,10/21,17.85%,PDE4D;PDE10A;PDE8A;PDE4B;PDE8B;PDE1B;PDE11A;PDE1A;PDE4A;PDE3A
prerank,DNA-binding transcription factor binding (GO:0140297),0.4730404280194985,1.1859889844359448,0.1533066132264529,0.9503456500646832,1.0,50/189,16.27%,ISL1;DMAP1;RELA;SP1;BBS4;ZMYND8;HCFC1;PSMD9;NFATC1;JUN;AR;TLE2;ZBTB7A;HDAC9;EP300;SMAD3;SPEN;HDAC5;PSMC5;CRTC1;TLE1;MEF2A;RBBP8;NBN;NCOR1;PPARG;MTDH;CTBP1;TAL1;TXLNG;TCF12;NOC2L;HMGB1;TCF7L2;MIER3;HIPK2;TP53;BCL2;CREB1;RBPJ;PPARD;LDB2;LDB1;NPM1;PIAS1;NEK6;HDAC2;LMO2;TLE4;MEF2C
prerank,general transcription initiation factor binding (GO:0140296),0.5362585315952715,1.1846860661041236,0.27939317319848295,0.9493448013823174,1.0,7/25,12.00%,THAP7;RELA;AR;ESR1;PSMC5;GTF2B;YEATS2
prerank,cholesterol transfer activity (GO:0120020),0.5741003565313425,1.1836148031238654,0.27926657263751764,0.9473192468017824,1.0,5/16,16.25%,STARD5;ABCG1;ABCA1;GRAMD1B;OSBPL2
prerank,small GTPase binding (GO:0031267),0.4719411304288235,1.1832568717716587,0.16666666666666666,0.9423502531560868,1.0,59/170,17.12%,LRRK2;FGD6;FGD3;UNC13D;FGD1;RAB3GAP1;EHD1;BRAF;RIN3;AP3M1;WASF1;FLNA;IQGAP2;RUSC2;MYO5A;STK19;EXOC5;EVI5;BICDL1;IFT20;USP33;RANBP9;PAK2;MAPKAP1;RAPGEF4;ARHGAP1;EPS8;AKAP13;HPS4;CYRIB;EXOC4;KIF3A;OCRL;RAF1;CDKL5;SORL1;ANKFY1;RABGAP1;MYO9B;ABCA1;BICD1;PEX5L;NDRG1;TRIP11;GGA1;OPTN;ARHGDIB;PDE6D;GOLGA5;IQGAP1;GGA3;GOLGA4;PKN1;PAK1;DNM1L;CYFIP1;HACE1;GCC2;RALBP1
prerank,vitamin D receptor binding (GO:0042809),-0.45758277689551935,-1.1821161053177145,0.254601226993865,0.7125905945180099,1.0,10/14,33.90%,MED13;MED17;SNW1;MED12;THRAP3;MED4;MED30;TAF11;TAF7;MED24
prerank,phosphoric diester hydrolase activity (GO:0008081),0.5146481333585199,1.1774541465768782,0.27705112960760997,0.9594633023356784,1.0,10/35,13.93%,SMPDL3A;PLCXD3;TDP2;SMPD3;SMPD1;PLCXD2;PLD4;PLCB4;GPCPD1;APEX2
prerank,GABA-gated chloride ion channel activity (GO:0022851),-0.4917548441785923,-1.1771682383355118,0.2926829268292683,0.7124684994802608,1.0,8/12,29.90%,GABRB1;GABRA2;GABRA3;GABRA5;GABRA4;GABRB3;GABRG1;GABRA1
prerank,cell adhesion mediator activity (GO:0098631),-0.39719317802570264,-1.1766635363885523,0.24431818181818182,0.7005592590574335,1.0,9/24,17.91%,CNTN6;DSCAML1;NTNG1;JAM3;LRRC4C;SIRPA;CNTN2;EMB;BSG
prerank,peptide hormone receptor binding (GO:0051428),0.6113224560675086,1.1733325650601614,0.2974963181148748,0.9694507330746012,1.0,1/11,6.95%,PSMC5
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.5383494425475137,1.1732743330927118,0.273989898989899,0.9631680819726582,1.0,2/24,1.44%,AK4;AK3
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.48036444403867584,1.172616026405966,0.21480709071949947,0.9593894071733073,1.0,17/91,10.70%,WDR45;SVIL;LDLRAP1;SYTL2;SLC9A1;WDR45B;SDCBP;GSDMD;MAPT;MAPKAP1;SNX3;TWF2;MYO1G;KIF16B;SNX20;ANXA2;TULP3
prerank,leak channel activity (GO:0022840),0.554688192735805,1.1679010870503024,0.3,0.972591364812419,1.0,4/18,12.84%,TMEM175;KCNK2;KCNK13;KCNK10
prerank,tau-protein kinase activity (GO:0050321),-0.40916682026186046,-1.1650636323336743,0.24583333333333332,0.7191463432758185,1.0,9/20,16.72%,SIK3;DYRK1A;GSK3B;TAOK2;PRKAA1;MARK1;MARK4;PHKG2;MARK3
prerank,glycerophospholipid flippase activity (GO:0140333),-0.5093272713674839,-1.1617976099059293,0.30319148936170215,0.7154193621211767,1.0,7/11,15.69%,ATP8A2;ABCA3;ATP11A;ATP10A;ABCB4;ATP8B1;ATP8A1
prerank,single-stranded telomeric DNA binding (GO:0043047),0.608741176204632,1.1614352504724814,0.3140376266280753,0.9916530482424201,1.0,5/11,15.15%,RAD50;TERF2;HNRNPA2B1;TERF1;CTC1
prerank,GTPase binding (GO:0051020),0.462618504480726,1.1609715941515457,0.18674698795180722,0.9869861261234427,1.0,67/195,17.12%,LRRK2;FGD6;FGD3;UNC13D;FGD1;RAB3GAP1;EHD1;BRAF;RIN3;AP3M1;WASF1;FLNA;IQGAP2;RUSC2;MYO5A;FNBP1L;STK19;AMBRA1;EXOC5;EVI5;BICDL1;IFT20;HSP90AA1;USP33;RANBP9;PAK2;MAPKAP1;SPTBN1;RAPGEF4;ARHGAP1;ENO1;EPS8;AKAP13;HPS4;BNIP3;CYRIB;EXOC4;KIF3A;OCRL;RAF1;CDKL5;SORL1;ANKFY1;RABGAP1;MYO9B;ABCA1;BICD1;PEX5L;NDRG1;TRIP11;GGA1;OPTN;GNB1;ARHGDIB;BECN1;PDE6D;GOLGA5;IQGAP1;GGA3;GOLGA4;PKN1;PAK1;DNM1L;CYFIP1;HACE1;GCC2;RALBP1
prerank,low-density lipoprotein particle binding (GO:0030169),0.5689102433362376,1.159544739707611,0.3076923076923077,0.9863161521615976,1.0,4/16,12.31%,CD36;THBS1;COLEC12;SORL1
prerank,protein phosphatase regulator activity (GO:0019888),0.4799641981632705,1.1573232628277137,0.27991218441273324,0.9891343496413031,1.0,18/53,15.88%,EIF2AK2;IGBP1;CABIN1;PPP2R2A;BOD1L1;SET;PPP4R1;RCAN2;RCAN3;PPP1R16B;PPP2R3A;SHOC2;PPP2R5C;CALM1;ENSA;PPME1;PPP1R9B;PPP2R2D
prerank,MAP kinase kinase activity (GO:0004708),0.5660729134123019,1.1562000250544338,0.2918454935622318,0.9873920210324248,1.0,8/15,16.92%,LRRK2;MAP2K6;MAP3K9;MAP2K5;MAPK14;MAP2K2;MAP2K1;MAP2K4
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.5436851472488717,1.1546814673673955,0.3038961038961039,0.9872212098218728,1.0,6/20,11.65%,AK4;AK3;MPP1;DLG1;AK2;MAGI3
prerank,alpha-actinin binding (GO:0051393),0.5297803071146583,1.1539950778660295,0.29620253164556964,0.9835891215052611,1.0,8/24,16.88%,CACNA1D;PDLIM2;PPARG;PALLD;PKD2;CACNA1C;DAG1;KCNA5
prerank,death domain binding (GO:0070513),-0.49869034649211147,-1.1519618164285994,0.3089171974522293,0.7319310482625833,1.0,7/11,24.71%,BCL2L1;MCL1;RIPK1;RACK1;IRGM;BAX;DAP
prerank,acylglycerol O-acyltransferase activity (GO:0016411),0.5396415659184808,1.1517047484280862,0.2994722955145119,0.9863595006304551,1.0,4/20,13.00%,MOGAT3;LCLAT1;AGPAT4;AGPAT5
prerank,retinoic acid receptor binding (GO:0042974),-0.42561387362456105,-1.1513281418663548,0.28294573643410853,0.7210074054030693,1.0,4/17,4.84%,NSD1;CNOT1;TACC1;ASXL1
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.5106068091858392,1.1509222556696852,0.30151338766006985,0.983040149259196,1.0,14/34,16.37%,UBE2Z;UFC1;AKTIP;UBE2A;UBE2J2;BIRC6;UBE2Q2;UBE2I;UBE2W;UBE2F;UBE2H;UBE2D3;UBE2G1;UBE2E3
prerank,glutathione transferase activity (GO:0004364),0.5286917301126242,1.1506602797576684,0.3127413127413127,0.9778432749838293,1.0,1/23,0.99%,MGST3
prerank,chemoattractant activity (GO:0042056),0.5150645688635139,1.1500556985611952,0.3167701863354037,0.974162811462962,1.0,3/26,5.17%,CX3CL1;VEGFC;PDGFB
prerank,transcription cis-regulatory region binding (GO:0000976),0.454671093097695,1.148728898706206,0.119,0.9730711872933734,1.0,82/406,16.97%,ISL1;BRCA1;RORA;ZBTB8A;RELA;IRF1;SP1;SMAD6;SUV39H1;ZFP90;CASZ1;TFAP4;SOX13;ZBTB5;BBX;RUNX1;MAX;JUN;AR;KDM5A;ELK3;TRPS1;SMAD3;ARID5B;TEAD1;RBAK;HDAC5;NR3C1;JUND;MEF2A;TFCP2;CUX1;DRGX;AGO2;TAF4;NCOR1;PPARG;SETX;TAL1;ENO1;CDC5L;DEAF1;ACTN4;ZBTB46;TCF12;ZNF568;FOXN3;ARID4B;XRN2;NR5A1;PSPC1;CREB3L2;NR2C2;SOX11;HMGB1;ZFP69;TCF7L2;ATF6;SOX6;BRD7;TP53;RXRA;NFX1;RREB1;RFX3;TBL1XR1;CTCF;ARNT;SNAPC3;NPAS3;SMAD4;NPM1;SMARCA2;CIC;FOXK1;HNRNPL;MEF2C;RB1;TFDP2;STAT6;TBL1X;NFYA
prerank,ubiquitin binding (GO:0043130),0.4713330740969666,1.1472375257576957,0.27388535031847133,0.9726674418050937,1.0,16/73,10.09%,TSG101;UCHL3;FBXW7;UBXN1;RNF31;ILRUN;SMAD3;SQSTM1;UBXN7;BUB3;USP33;NEDD4;FAF1;USP5;ASCC2;PLAA
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),-0.5055204508834727,-1.1460536931849905,0.3270440251572327,0.721772886343422,1.0,4/10,9.29%,PIK3CG;PIK3CA;PIK3C3;PIK3C2B
prerank,transition metal ion binding (GO:0046914),0.4551437946312601,1.145491274539954,0.118,0.9734825365617015,1.0,75/397,13.40%,ACE2;ANG;SMPDL3A;FNTB;NQO2;BLM;PDXK;KDM1B;UBA5;KPNB1;COX17;TARS1;TDP2;DYRK2;ZMYND8;SMPD1;ENPP5;RASSF1;EEA1;KDM5A;GALNT1;WRN;ATP7A;SMAD3;RBAK;NFU1;TRAF7;ACER3;CHORDC1;DPP3;IL1A;KDM3A;MNAT1;USP33;GALNT3;LACC1;KDM5B;LNPEP;WDFY1;PTPN1;ALOX5;RCHY1;LIMS1;TAB3;EXD2;PPARG;B4GALT1;RNF11;LOXL3;MT1G;MT1X;MT1B;MT1F;MT1E;MT1M;MT1H;MT1A;GTF2B;SEC24B;CZIB;GDA;SEC24D;PTGR2;PRNP;ZMYND11;ABL1;KDM4C;ESCO1;XPNPEP1;ERAP1;CYLD;TP53;DUSP12;RXRA;S100B
prerank,histone deacetylase binding (GO:0042826),0.4667002883408699,1.1449800802846584,0.23863636363636365,0.9694675163667725,1.0,27/88,16.76%,THAP7;RELA;SP1;TFAP4;YWHAE;HDAC9;HDAC5;HSP90AA1;MEF2A;MAPK8;PKN2;NACC1;NCOR1;PHF6;TAL1;KAT2B;PRDM1;NCOR2;MIER3;TP53;LCOR;AKAP8L;HDAC2;PKN1;MEF2C;YWHAB;TOP2B
prerank,protein serine/threonine kinase activity (GO:0004674),0.4538989449491277,1.1434267102538385,0.154,0.9697491047631664,1.0,75/335,13.98%,SGK3;SGK2;PLK1;CAMKK1;LRRK2;PRKCZ;RPS6KB2;RIOK3;IRAK4;MINK1;EIF2AK2;DYRK2;NEK3;CAMK1D;BRAF;BMPR1A;PIK3R4;MAP3K11;CDK7;PRKCB;PRKCA;PRKACA;CDK2;PRKDC;SQSTM1;STK19;MAPK1;MAP3K20;CDK6;ACVR1;STK11;IKBKB;CDC42BPB;MAPK8;PKN2;PAK2;RPS6KA5;CDK9;RPS6KC1;CAMK2D;MAP3K9;CSNK1G1;MAST2;IRAK2;GRK5;DAPK1;CHEK2;BRD2;KALRN;NEK7;CDK5;MAST3;TAOK1;TGFBR2;ULK2;BMP2K;MTOR;RAF1;ERN1;CDKL5;MAPK14;SRPK2;HIPK2;MAPKAPK2;TGFBR1;NRBP1;MAST4;ACVR1B;CDK8;SYK;CAMK2G;CLK1;PRKD2;CSNK1A1;MAP3K8
prerank,endodeoxyribonuclease activity (GO:0004520),0.5307426987388133,1.142809322750651,0.311787072243346,0.9662196870812063,1.0,4/20,7.85%,RAD50;RBBP8;MRE11;ERCC4
prerank,N-acyltransferase activity (GO:0016410),0.5060184896811482,1.1420931243377384,0.31560283687943264,0.9631685599935317,1.0,8/32,13.35%,SIRT7;CERS6;EP300;CERS4;NMT1;NMT2;ESCO1;CERS5
prerank,active ion transmembrane transporter activity (GO:0022853),0.5028646351750345,1.1409468091389512,0.309048178613396,0.961618717323576,1.0,4/37,3.36%,SLCO4C1;UQCRH;UQCRC1;SLCO1B1
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),-0.3842821672825195,-1.140490243720612,0.25252525252525254,0.7244282782046392,1.0,8/23,11.08%,PDE4D;PDE10A;PDE8A;PDE4B;PDE8B;PDE1B;PDE11A;PDE1A
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.44990666086051334,1.1391643926098884,0.21385542168674698,0.9626331709915532,1.0,40/188,16.27%,BRCA1;RELA;IRF1;SP1;SMAD6;SUV39H1;TFAP4;SOX13;RUNX1;JUN;AR;KDM5A;SMAD3;ARID5B;HDAC5;JUND;NCOR1;PPARG;TAL1;TCF12;ZNF568;ARID4B;PSPC1;CREB3L2;SOX11;HMGB1;TCF7L2;ATF6;SOX6;BRD7;TP53;RXRA;RFX3;TBL1XR1;CTCF;SMAD4;SMARCA2;FOXK1;HNRNPL;MEF2C
prerank,lipoprotein particle binding (GO:0071813),0.5383289051316136,1.138827199539911,0.337612323491656,0.9582895966198377,1.0,5/20,12.31%,CD36;THBS1;MAPT;COLEC12;SORL1
prerank,organic anion transmembrane transporter activity (GO:0008514),0.4540548111770788,1.1344712013492182,0.2722672064777328,0.9697114317894642,1.0,22/134,16.20%,SLC4A3;SLC25A24;SLC66A1;SLCO4C1;SLC35D1;CD36;SFXN5;SLCO1B1;SLC7A2;SLC38A2;ABCC5;SLC7A8;SLC25A2;SLC25A32;SLC38A9;SLC27A1;SLCO2B1;SLC15A4;SLC38A6;ABCG2;SLC25A1;SLC35A3
prerank,histone deacetylase activity (GO:0004407),0.5418476684184286,1.1335037777600177,0.33378016085790885,0.9678676184671987,1.0,4/19,6.16%,SIRT7;HDAC9;HDAC11;HDAC5
prerank,ferrous iron binding (GO:0008198),0.5281561088679478,1.1316956264176803,0.3206806282722513,0.9688740687870812,1.0,9/21,17.72%,FECH;FTO;EGLN3;EGLN2;EGLN1;TET2;ALKBH1;FTH1;FTL
prerank,sodium ion transmembrane transporter activity (GO:0015081),0.5118629536310491,1.1279898957494048,0.32727272727272727,0.9774304657179819,1.0,4/27,8.80%,SLC9A9;SLC9A1;SLC9A7;SLC9A6
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.4490134503529652,1.127777590368103,0.104,0.9726816316667647,1.0,75/597,13.22%,POU2F3;ISL1;GLIS1;BRCA1;ZIC4;SP8;RELA;IRF1;SP1;SMAD6;SUV39H1;TFAP4;SOX13;TGIF1;CLOCK;BBX;RUNX1;MAX;NFATC1;JUN;AR;ZBTB7A;ORC4;KDM5A;ELK3;IRF3;BCL6;POLA1;SMAD3;ARID5B;TEAD1;ESR1;HDAC5;NR3C1;JUND;PRDM4;TFCP2;CUX1;DRGX;KDM5B;LIN28B;MAFG;NCOR1;ORC2;PPARG;NR6A1;MBNL2;TAL1;HMBOX1;HIVEP1;HOXC4;TCF12;ZNF568;ARID4B;ZSCAN29;NR5A1;PSPC1;CREB3L2;NR2C2;SOX11;PRDM1;GMEB2;ABL1;HMGB1;BACH2;TCF7L2;ATF6;SOX6;MLH3;BRD7;TP53;MAF;NR1D2;KLF13;RXRA
prerank,E-box binding (GO:0070888),0.4960149166920575,1.1248025310282752,0.3132387706855792,0.9785905261253754,1.0,5/34,9.73%,TFAP4;CLOCK;MAX;PPARG;TAL1
prerank,RNA polymerase core enzyme binding (GO:0043175),0.49627523455461564,1.1242368026390537,0.3282710280373832,0.9752907557742344,1.0,11/33,14.60%,URI1;RPRD1B;CTR9;SPTY2D1;RPRD2;RPRD1A;AGO2;NCOA3;GTF2B;UVSSA;RECQL5
prerank,single-stranded RNA binding (GO:0003727),0.48546418767481186,1.123721150420944,0.3299319727891156,0.9717954561058634,1.0,9/43,12.21%,POLR2D;ILF3;DDX60;TLR7;EIF4B;AGO2;U2AF2;RBM7;ZFR
prerank,nucleoside-diphosphatase activity (GO:0017110),0.580116520466318,1.1230401556312752,0.3490427098674521,0.968966283958603,1.0,3/12,10.09%,NUDT5;ENTPD1;CANT1
prerank,zinc ion binding (GO:0008270),0.44433407952164045,1.1229236222986494,0.209,0.9640725397211124,1.0,59/293,14.33%,ACE2;SMPDL3A;FNTB;NQO2;BLM;PDXK;KDM1B;UBA5;KPNB1;TARS1;ZMYND8;SMPD1;ENPP5;RASSF1;EEA1;KDM5A;SMAD3;RBAK;TRAF7;ACER3;CHORDC1;DPP3;MNAT1;USP33;KDM5B;LNPEP;WDFY1;PTPN1;RCHY1;LIMS1;TAB3;PPARG;RNF11;MT1G;MT1X;MT1B;MT1F;MT1E;MT1M;MT1H;MT1A;GTF2B;SEC24B;CZIB;GDA;SEC24D;PTGR2;ZMYND11;KDM4C;ESCO1;ERAP1;CYLD;TP53;DUSP12;RXRA;S100B;ZDHHC20;TET2;GRIN2A
prerank,amino acid transmembrane transporter activity (GO:0015171),0.4724210403899866,1.1227414244037022,0.31038374717832956,0.959357740819982,1.0,7/47,12.24%,SLC66A1;SLC7A2;SLC38A2;SLC7A11;SLC7A7;SLC7A8;SLC38A9
prerank,receptor tyrosine kinase binding (GO:0030971),0.46958129112756186,1.1225760537487321,0.3114224137931034,0.9547594179232146,1.0,15/56,15.70%,DUSP3;GAS6;IRS1;SQSTM1;PITPNM1;NRG3;PTPN1;NCK1;SOCS5;CBL;FRS2;SH2B3;TP53;SH2B2;PIK3R1
prerank,hydro-lyase activity (GO:0016836),0.47901729488427014,1.1222331753681867,0.3237657864523536,0.9508570284816356,1.0,7/41,14.15%,CBS;HACD1;PCBD2;ECHS1;ENO1;HSD17B4;HACD4
prerank,serotonin receptor activity (GO:0099589),-0.37752001285327275,-1.1217072424907488,0.2747747747747748,0.7395799545546153,1.0,8/22,38.03%,CHRM3;HTR4;HTR1F;HTR7;HTR2B;HRH2;HRH1;HTR2A
prerank,G protein-coupled serotonin receptor activity (GO:0004993),-0.37752001285327275,-1.1217072424907488,0.2747747747747748,0.7395799545546153,1.0,8/22,38.03%,CHRM3;HTR4;HTR1F;HTR7;HTR2B;HRH2;HRH1;HTR2A
prerank,G protein-coupled amine receptor activity (GO:0008227),-0.37752001285327275,-1.1217072424907488,0.2747747747747748,0.7395799545546153,1.0,8/22,38.03%,CHRM3;HTR4;HTR1F;HTR7;HTR2B;HRH2;HRH1;HTR2A
prerank,microtubule binding (GO:0008017),0.44892071895870633,1.1198310975152397,0.24,0.9544921943288697,1.0,56/222,16.87%,TOGARAM2;PLK1;MID1;VASH2;LRRK2;SBDS;EML3;ALMS1;NDEL1;MDM1;MAP1A;CCDC61;MAPRE1;KIF13A;MTUS1;REEP2;TUBGCP6;KIF20B;CAMSAP3;POLB;EZR;DCTN1;CCDC66;RGS14;MAPT;TUBGCP2;MAST2;KIF26B;KIF16B;APC;CDK5;FBXW11;PRNP;KIF3A;EML4;EML1;STARD9;EML2;TERF1;NDRG1;MAP6;RMDN1;KIF21A;CLASP1;PEX14;MACF1;MAP4K4;KIF1B;CLIP1;VAPB;LRPPRC;CEP290;DNM1L;CEP295;KIF2A;HOOK2
prerank,pseudouridine synthase activity (GO:0009982),-0.45136282682868895,-1.1168172131751521,0.31333333333333335,0.741127867691134,1.0,7/13,35.41%,PUS7;TRUB2;TRUB1;DKC1;PUS1;RPUSD4;PUS3
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),-0.41400511660038924,-1.116567050221871,0.31906614785992216,0.7192969419551077,1.0,5/16,9.40%,PTPRC;PTPRK;PTPRZ1;PTPN6;PTPRG
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),-0.41400511660038924,-1.116567050221871,0.31906614785992216,0.7192969419551077,1.0,5/16,9.40%,PTPRC;PTPRK;PTPRZ1;PTPN6;PTPRG
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",0.5780396123102721,1.1146238836082532,0.35064935064935066,0.9678916889232009,1.0,3/14,5.56%,NUBPL;NDUFS1;NFU1
prerank,sterol binding (GO:0032934),0.46357602633670697,1.113822901247167,0.3333333333333333,0.9657295478758362,1.0,15/56,16.25%,RORA;INSIG1;OSBP;INSIG2;SOAT1;SIDT1;STARD5;ABCG1;ABCA1;OSBPL1A;SCARB2;GRAMD1B;ERLIN1;CD81;OSBPL2
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.4661251138219938,1.113497272330458,0.3613636363636364,0.9616674422325289,1.0,11/46,17.14%,MGAT3;PIGP;B3GALNT1;B3GNT2;MGAT4B;EXT1;PIGQ;MGAT4A;LARGE1;B3GALT1;EXT2
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.4599775852158312,1.1125932423208094,0.3230932203389831,0.9597026076853049,1.0,12/72,10.70%,SVIL;LDLRAP1;SYTL2;SLC9A1;SDCBP;GSDMD;MAPKAP1;TWF2;MYO1G;SNX20;ANXA2;TULP3
prerank,protein phosphatase inhibitor activity (GO:0004864),0.4987818500179818,1.1106828471722172,0.36704119850187267,0.9616316725675768,1.0,7/26,15.82%,CABIN1;PPP1R8;BOD1L1;SET;ENSA;PPME1;PPP1R9B
prerank,water transmembrane transporter activity (GO:0005372),-0.46727368337831715,-1.1085869485756454,0.3395061728395062,0.7291603125454955,1.0,1/11,9.55%,AQP4
prerank,DNA binding (GO:0003677),0.4412269917658288,1.1068591109173778,0.143,0.9702870691465223,1.0,120/694,15.41%,POU2F3;POLR2D;ANG;POLG;BRCA1;C1D;RORA;MPG;BANF1;ZIC4;BLM;TSG101;RELA;IRF1;SMARCA4;SP1;RAD50;ILF3;PSIP1;HLX;NUPR1;TIGD2;TFAP4;TDP2;SOX13;CLOCK;DDX60;ZEB2;SSBP1;MAX;XRCC4;TARDBP;POLR2A;RAD18;JUN;ZBTB7A;KDM5A;IRF3;BCL6;POLA1;WRN;DCLRE1A;EP300;SMAD3;ARID5B;TEAD1;PRKDC;LIN9;RC3H2;SPTY2D1;RBM5;IKZF1;POLG2;BRCA2;BCLAF3;XRN1;MEF2A;RBBP8;MRE11;HP1BP3;MAPT;MECP2;ERCC4;TFCP2;CUX1;RTF2;NBN;KDM5B;CDK9;ZDHHC1;TAF4;PPARG;NR6A1;GLYR1;SETX;HMBOX1;RNF11;CDC5L;PARP4;RAD51B;CHD8;NR5A1;RBM6;ZNF711;NR2C2;ZMYND11;TSHZ2;HIVEP2;DNMT3A;ABL1;HMGB1;AIFM1;MAU2;TCF7L2;ZMYM6;ATF6;SOX6;RNF138;TP53;BCL2;RXRA;FUBP3;TERF1;SP4;COLEC11;CARF;RFX3;RBPJ;PPARD;RBMS1;RAD23B;CTCF;ARNT;SNAPC3;CTC1;SMAD4;ZBTB18;TRIM26;SMARCA2;CRLF3
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.49567457340042326,1.1059666526007934,0.34244946492271106,0.9683338344585489,1.0,11/33,14.60%,URI1;RPRD1B;CTR9;AR;RPRD2;RPRD1A;AGO2;NCOA3;GTF2B;UVSSA;RECQL5
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),0.5558470144245178,1.1032462292510987,0.3656821378340366,0.9731595702431144,1.0,3/15,10.11%,SOCS4;SOCS7;SOCS5
prerank,kinesin binding (GO:0019894),-0.3639847316673523,-1.1020623498564968,0.3064516129032258,0.7352925149134364,1.0,18/27,37.99%,SPAG9;MAPK8IP3;SNCA;AP1AR;IFT88;AP1G1;ARHGEF10;TOR1B;TTBK2;NEFH;KLC2;KIFAP3;TOR1A;CROCC;MAPK8IP1;ATCAY;PLEKHM2;RAB29
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),0.5610330758071302,1.1019924946852824,0.37622377622377623,0.9724931357610596,1.0,2/14,4.09%,MTMR11;MTMR1
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.4694623791951727,1.1015923192049148,0.35180995475113125,0.9691110433874018,1.0,11/44,9.33%,EHMT1;SUV39H1;SETD1A;EHMT2;KMT2E;SETD2;KMT5B;SETD3;ASH1L;EZH2;KMT5C
prerank,mitogen-activated protein kinase binding (GO:0051019),0.4992349603290111,1.1009841628325174,0.358560794044665,0.9664203994178525,1.0,8/29,12.92%,CDK5RAP3;NFATC1;PTPRJ;DUSP16;DUSP10;ABL1;MAPK14;MAPKAPK2
prerank,alkali metal ion binding (GO:0031420),0.5587765727582068,1.1004877815055605,0.37822349570200575,0.9631989956068059,1.0,2/13,3.78%,PDXK;ACAT1
prerank,RNA binding (GO:0003723),0.4357559751004149,1.1004120098894759,0.07,0.9586244887425353,1.0,271/1321,13.88%,TUBB4B;POLR2D;ANG;WDR6;COL14A1;SNRPD2;SNRPD1;BRCA1;CAVIN1;C1D;HABP4;RPL18;NSUN6;ATP5F1A;BOP1;UTP3;DENR;PELP1;SBDS;SECISBP2L;EIF4A3;ELAVL2;MRPS31;BICC1;MRPS30;SART1;RPS23;CCDC9;TBCA;ZC3H12D;EIF2AK2;HNRNPUL2;EIF3C;HNRNPM;MRPL37;EIF1AX;RPL41;ILF3;RPL31;PSIP1;LSM7;ZNF346;KPNB1;ATXN2L;DDX42;PDAP1;UTP18;EMG1;EIF4ENIF1;SMG6;NOA1;FAM98A;PPHLN1;PEF1;NMD3;RPS17;GRB2;FARSA;EIF3E;DDX49;TCP1;TFB2M;SYNCRIP;TUT4;PRPF38A;ALDH6A1;DDX60;CSTF3;DHX38;CSDE1;TLR7;SLIRP;DHX57;SAP18;SSBP1;ANKHD1;UBFD1;RPL4;TARDBP;MAPRE1;SARNP;EIF4B;CSTF2;MSN;POLR2A;FAM120C;RBMS3;MBNL1;RFTN1;SIDT1;JUN;SCG3;ZRANB2;MRPS21;UTP20;FRG1;FLNA;RNPS1;PYM1;YWHAE;ALDOA;RBM3;MSI1;PRPF3;RBM15;SPEN;AKAP1;CTNNA1;MYO5A;PRPF40A;RPLP0;PRKDC;DCP1B;ETF1;NOC3L;U2AF1;PUM2;GDI2;TNRC6B;R3HDM1;CS;NOL7;PTCD1;MAP3K20;RPS15A;RPL38;RC3H2;RBM5;ISG20L2;PRPF40B;METTL3;NUDT5;PPP1R8;EXOSC7;G3BP2;PDIA4;SUGP2;ERI3;HSP90AA1;LUC7L;EZR;NCOA5;MEX3C;API5;HNRNPA2B1;XRN1;MRPS35;MRPS28;PTBP3;MRPL1;SUMO2;RRP36;RRP1B;THOC5;HNRNPA3;UCHL5;POP1;HSPA9;MAPT;NUP98;GLRX3;GPKOW;TRNAU1AP;MECP2;LARP4B;TLR3;PABPC4;SRSF5;PKN2;AGO2;SPTBN1;PRPF6;FCF1;AARS1;PTPN1;LIN28B;TWF2;YTHDF1;TRA2A;UBTF;ADD1;ACIN1;SNRNP70;FXR2;PHF6;PUM1;GANAB;SNRPD3;DDX10;MTDH;MBNL2;SETX;RBFOX3;PRRC2C;IPO5;SCAF11;ENO1;FUS;APOBEC1;CDC5L;ZC3H12B;GTF2E2;SREK1;ANXA2;DDX23;ZC3H7A;DHX16;ACTN4;U2AF2;AFF2;ADAR;EIF1;YTHDC2;UBE2I;UTP6;NOC2L;ATXN2;XRN2;ARF1;DIAPH1;PRKRA;DCP1A;CPSF3;SF1;RBM7;RCAN3;RBM6;ZC3H13;PSPC1;QKI;SCAF4;SF3B2;LSM14A;SUCLG1;SNTB2;TMSB4X;HEATR1;TASOR;HMGB1;EIF3A;ZFP36L1;NOP56;SRSF9;ZFR;RPL21;RPS6;SRPRA;SRSF11;NOL8;SRPK2;DHX8;SAMD4A;EIF2S1;MSI2;RBM27;CCT3;NAA15;HNRNPH3;FUBP3;RTN4;PPARGC1B;NFX1;RPGR;DHX32;HNRNPH1;TRIM56;SRRM2;DDX5;MYEF2;FLNB;PCBP3
prerank,transmitter-gated ion channel activity (GO:0022824),-0.35294071673371075,-1.0993763290788043,0.2552083333333333,0.7321987744616058,1.0,14/29,29.90%,GABRB1;GRIK1;GABRA2;GABRA3;GRIK4;GRIK2;GABRA5;GLRA2;GABRA4;GABRB3;GABRG1;GRIK5;GRIK3;GABRA1
prerank,double-stranded DNA binding (GO:0003690),0.4379049685729074,1.0970969301156661,0.198,0.9654737952375071,1.0,63/531,13.42%,POU2F3;ISL1;GLIS1;ZIC4;SP8;SP1;RAD50;PSIP1;TFAP4;TGIF1;CLOCK;DDX60;BBX;MAX;TARDBP;NFATC1;JUN;ZBTB7A;ELK3;IRF3;BCL6;TERF2;TEAD1;PRKDC;ESR1;NR3C1;JUND;POLG2;PRDM4;RBBP8;MRE11;MAPT;MECP2;TFCP2;CUX1;DRGX;KDM5B;LIN28B;MAFG;PPARG;NR6A1;MBNL2;HMBOX1;HIVEP1;HOXC4;TCF12;RAD51B;ZSCAN29;NR5A1;NR2C2;ZMYND11;PRDM1;GMEB2;ABL1;HMGB1;BACH2;MAU2;ATF6;MAF;NR1D2;KLF13;RXRA;TERF1
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),0.5605492175466583,1.096652072690465,0.3518248175182482,0.9622559225420441,1.0,5/12,13.30%,CDK7;MAPK1;CDK6;CDK9;CDK8
prerank,RNA methyltransferase activity (GO:0008173),0.5087591134839446,1.0965923294014048,0.36435124508519,0.9576755412780857,1.0,3/19,6.37%,METTL8;TGS1;METTL3
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),0.53415714808699,1.0952141083021292,0.3736111111111111,0.9574700920932974,1.0,1/15,5.58%,CMKLR1
prerank,kinase activator activity (GO:0019209),0.4836808281386563,1.093895272508223,0.3701923076923077,0.9573252163536602,1.0,2/30,6.79%,RGCC;STK11
prerank,damaged DNA binding (GO:0003684),0.47003819213372533,1.0933996336291423,0.3646659116647792,0.9543511837949928,1.0,7/44,8.15%,MPG;RAD18;DCLRE1A;EP300;RBBP8;ERCC4;NBN
prerank,acylglycerol lipase activity (GO:0047372),0.568014271082528,1.0931489488512454,0.39209726443769,0.9505799782286309,1.0,3/11,10.19%,LIPE;ABHD6;ABHD16A
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),0.5439531565925976,1.0915860278286023,0.38274932614555257,0.9512736046044286,1.0,2/16,4.09%,MTMR11;MTMR1
prerank,deubiquitinase activity (GO:0101005),0.44001781122653466,1.0904094625853928,0.35073068893528186,0.9505633597065203,1.0,26/88,15.42%,USP11;UCHL3;USP32;USP24;DESI2;USP19;MINDY3;USP34;USP29;MINDY4;USP33;USP1;UCHL5;USP48;USP20;USP5;USP46;TANK;MINDY2;USP3;CYLD;USP37;ATXN3;USP45;OTUD7A;VCPIP1
prerank,calcium channel inhibitor activity (GO:0019855),-0.45528159277483093,-1.0903038621314631,0.38484848484848483,0.7445316331535067,1.0,4/11,21.07%,CALM2;ITPR1;FKBP1A;MCUB
prerank,histone acetyltransferase activity (GO:0004402),0.48408765133509574,1.0890338616871094,0.36771844660194175,0.9504932665874714,1.0,9/30,13.25%,SRCAP;CLOCK;EP300;BRCA2;TADA2A;NCOA3;EPC2;KAT2B;EPC1
prerank,NADP binding (GO:0050661),-0.34191669285624493,-1.0886687629485452,0.3170731707317073,0.7377346746272414,1.0,11/32,21.78%,DPYD;KCNAB1;PGD;ME3;ME1;CAT;QDPR;HMGCR;CRYZL1;LBR;DUS2
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.43354534433633235,1.0859779067235222,0.30430430430430433,0.9558216101747372,1.0,24/254,11.42%,POU2F3;RELA;IRF1;SP1;CASZ1;TFAP4;CLOCK;RUNX1;NFATC1;JUN;AR;ELK3;IRF3;SMAD3;ESR1;NR3C1;PRDM4;MEF2A;TFCP2;CDC5L;HOXC4;TCF12;NR2C2;SOX11
prerank,adrenergic receptor binding (GO:0031690),-0.418594194087613,-1.0847283298157422,0.35231316725978645,0.7368641733117784,1.0,6/16,14.68%,PDE4D;GRK2;ARRDC3;SAV1;APLP1;DLG4
prerank,voltage-gated ion channel activity (GO:0005244),-0.42268170352470014,-1.0845457019315523,0.36271186440677966,0.7272949180478389,1.0,7/14,15.86%,ANO6;CACNA1E;VDAC2;VDAC1;VDAC3;GPR89B;GPR89A
prerank,voltage-gated chloride channel activity (GO:0005247),-0.47669306286467317,-1.083731815320692,0.38028169014084506,0.7193694430084817,1.0,4/10,14.89%,ANO6;CLCN4;CLCN6;CLCN3
prerank,O-methyltransferase activity (GO:0008171),-0.48357940669916877,-1.083426819974864,0.39452054794520547,0.7105923382921912,1.0,7/10,43.73%,COQ3;CMTR1;MEPCE;FTSJ3;CMTR2;BCDIN3D;ASMT
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",0.5023952487012532,1.0829062795026814,0.38161209068010077,0.9620660845191892,1.0,7/23,15.24%,WDR45;WDR45B;MAPKAP1;SNX3;KIF16B;SNX14;HIP1
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),0.5758396962467249,1.0826397004558748,0.4012158054711246,0.9538543052368864,1.0,2/10,8.29%,DUSP16;DUSP10
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),0.5758396962467249,1.0826397004558748,0.4012158054711246,0.9538543052368864,1.0,2/10,8.29%,DUSP16;DUSP10
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),0.491199843427044,1.082626872081407,0.37791411042944784,0.9494365665749565,1.0,5/24,8.17%,OSBP;GOLPH3;GSDMD;PLA2G4A;SNX3
prerank,magnesium ion binding (GO:0000287),0.43237169647416795,1.0818704551890101,0.35121457489878544,0.9475501482571848,1.0,22/135,12.74%,PLK1;LRRK2;PDXK;EYA2;TDP2;DYRK2;WRN;NT5C3A;MAP3K20;NUDT5;STK11;HPRT1;CDC42BPB;MAST2;PI4K2A;EXD2;SRR;TKT;IDH2;ABL1;ERN1;SRPK2
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.537929275779825,1.0814301722716897,0.3971631205673759,0.9446309305334095,1.0,1/14,1.44%,AK4
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),-0.4326850939730162,-1.0806635648147442,0.3720136518771331,0.7079314478774998,1.0,2/14,8.31%,KCNJ2;KCND3
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.43193959299919993,1.0792693070834778,0.304,0.9471908539360836,1.0,52/269,13.32%,CBS;BRCA1;MID1;WFS1;VCL;CDK5RAP3;PARP9;TSG101;RELA;FBXW7;SMAD6;GLMN;UBXN1;UQCRC1;RNF31;TCP1;PRKAR2A;POLR2A;RAD18;JUN;YWHAE;SMAD3;PRKACA;SQSTM1;AMBRA1;ARRB2;UBE2A;UBE2J2;UBXN7;CKB;HSP90AA1;RNF34;SUMO3;SUMO2;HSPA9;SLF1;SYT11;CHEK2;FAF1;APC;HGS;TANK;TRAF2;DERL1;CUL4A;CAMLG;UBE2W;TP53;RNF20;BCL2;ACVR1B;RTN4
prerank,thyroid hormone receptor binding (GO:0046966),0.48924543461005027,1.0783658901126012,0.3848964677222899,0.945893147769478,1.0,9/28,15.07%,ZNHIT3;BRD8;HMGN3;JMJD1C;NCOR1;NCOA3;GTF2B;GTF2H1;TRIP12
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.4689246959804589,1.0750517640736659,0.3791907514450867,0.9525401079435536,1.0,7/37,8.31%,NARS2;TARS1;FARSA;WARS2;HARS1;TARS2;AARS1
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",0.5421414391483252,1.0724537077997103,0.4099099099099099,0.9569961995014384,1.0,4/12,18.89%,B3GALNT1;B3GNT2;B3GALT1;B3GALT5
prerank,cAMP binding (GO:0030552),-0.46637111954964794,-1.0692577328848871,0.3895705521472393,0.7255360300970894,1.0,3/11,4.82%,PDE4D;PDE10A;PDE4B
prerank,endopeptidase activity (GO:0004175),0.42615001069021163,1.0690303934723129,0.3263263263263263,0.9641715607726685,1.0,33/257,13.81%,ACE2;TYSND1;ADAMTS12;NLN;CD5L;USP11;ADAMTS2;CTSC;USP24;USP34;PSMB8;ADAMTSL3;USP29;NRDC;USP33;USP1;USP48;TPP2;USP20;ADAMTS10;USP5;USP46;PROC;F3;CTSZ;FURIN;PARL;ADAM10;PSMA2;NAPSA;PCSK6;USP37;HTRA2
prerank,retinoid X receptor binding (GO:0046965),-0.45547578685455614,-1.0681431520350009,0.3649851632047478,0.7187165095453472,1.0,2/11,2.44%,NSD1;TACC1
prerank,thiol-dependent deubiquitinase (GO:0004843),0.4330053299518012,1.0678254020315467,0.37157894736842106,0.9635913618855843,1.0,24/83,15.42%,USP11;UCHL3;USP32;USP24;DESI2;USP19;MINDY3;USP34;USP29;USP33;USP1;UCHL5;USP48;USP20;USP5;USP46;TANK;USP3;CYLD;USP37;ATXN3;USP45;OTUD7A;VCPIP1
prerank,solute:proton symporter activity (GO:0015295),-0.400996473421183,-1.066496580103893,0.36823104693140796,0.713314695367203,1.0,7/16,17.83%,SLC36A1;SLC17A5;SLC2A13;SLC2A9;SLC11A2;CTNS;SLC15A2
prerank,protein kinase C activity (GO:0004697),0.5333417308023778,1.0657009936984665,0.4186046511627907,0.9661037674964744,1.0,3/14,5.26%,PRKCZ;PRKCB;PRKCA
prerank,omega peptidase activity (GO:0008242),0.43052013358609426,1.064041149619636,0.3883089770354906,0.9676209471571363,1.0,25/89,15.42%,USP11;UCHL3;USP32;USP24;DESI2;USP19;MINDY3;USP34;USP29;USP33;ASRGL1;USP1;UCHL5;USP48;USP20;USP5;USP46;TANK;USP3;CYLD;USP37;ATXN3;USP45;OTUD7A;VCPIP1
prerank,LRR domain binding (GO:0030275),0.5302816355010176,1.0639495779589316,0.40953716690042075,0.9636151509945019,1.0,2/14,9.12%,PMF1;ZXDC
prerank,ribosome binding (GO:0043022),0.4534532375144996,1.0636954806006582,0.38757062146892657,0.9601159803076038,1.0,10/46,13.16%,EIF6;SBDS;EIF3C;PYM1;ETF1;YTHDF1;SEC61A1;NAA16;EIF2S1;NAA15
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.4671174362420987,1.0620820161767772,0.4070904645476773,0.9613020576938488,1.0,11/28,17.70%,LRRK2;PRKACA;MAP2K6;MAP3K9;MAP2K5;MAPK14;MAP2K2;RPS6KA2;MAP2K1;MAP2K4;RPS6KB1
prerank,RNA polymerase binding (GO:0070063),0.5024777973433097,1.059649463366034,0.4331983805668016,0.9653661609325757,1.0,5/18,10.50%,BRCA1;STOM;NEDD4;PKN2;YTHDC2
prerank,serine-type endopeptidase activity (GO:0004252),0.4348886112626395,1.0590340337701496,0.4,0.9631868673543497,1.0,11/80,17.12%,TYSND1;CD5L;PROC;F3;FURIN;PARL;PCSK6;HTRA2;RHBDD1;KLK2;PCSK5
prerank,microtubule minus-end binding (GO:0051011),0.5387992669544257,1.0589213521149023,0.42263610315186245,0.9593311482795437,1.0,5/13,16.42%,TUBGCP6;CAMSAP3;TUBGCP2;MACF1;CEP290
prerank,histone methyltransferase activity (GO:0042054),0.46674197234067816,1.058920428024591,0.4213615023474178,0.9551644496315878,1.0,7/32,8.54%,EHMT1;SUV39H1;EHMT2;KMT2E;SETD2;KMT5B;EZH2
prerank,RNA polymerase II complex binding (GO:0000993),0.4733792970533576,1.0583309609657952,0.41824644549763035,0.9530404710102317,1.0,10/32,14.60%,URI1;RPRD1B;CTR9;RPRD2;RPRD1A;AGO2;NCOA3;GTF2B;UVSSA;RECQL5
prerank,cadherin binding (GO:0045296),0.4183441097593416,1.0570249001452308,0.371,0.9533127585928091,1.0,91/315,17.06%,NUDC;DNAJB1;VCL;BAG3;ATXN2L;CLIC1;EHD4;CHMP5;EIF3E;ITGA6;SNX5;EHD1;HCFC1;UBFD1;MAPRE1;FLNA;YWHAE;TMOD3;CEMIP2;ALDOA;CTNNA1;FNBP1L;CAPZB;PTPRJ;MRTFB;ABI1;PACSIN2;ACVR1;MB21D2;EZR;GIPC1;PI4KA;MRE11;DLG1;EPS8L1;PKN2;PAK2;SPTBN1;PTPN1;PTPRT;NCK1;TWF2;ARHGAP1;ADD1;TXNDC9;APC;PDXDC1;ENO1;CDH11;ANXA2;CD2AP;DBNL;SNX1;CBL;PFKP;NOP56;CDH20;TBC1D10A;SH3GLB1;RTN4;WASF2;PTPRO;DOCK9;LIMA1;CDH18;FLNB;NDRG1;IST1;EPS15;CLINT1;PKP4;PPME1;HNRNPK;MACF1;STK24;CAPZA1;IQGAP1;SERBP1;VAPB;EPN2;TRIM25;YWHAB;RDX;TMPO;SPTAN1;MYO1B;PPFIBP1;CTNNA2;SNX9;GCN1;HSPA5
prerank,FMN binding (GO:0010181),-0.4495970661632723,-1.056216999824246,0.4161849710982659,0.7286517083537682,1.0,6/11,49.62%,POR;DUS2;MTRR;NDOR1;PNPO;NOS1
prerank,tubulin binding (GO:0015631),0.42284937096177483,1.0561223262888237,0.344,0.952269181440128,1.0,67/295,16.45%,TOGARAM2;PLK1;BRCA1;MID1;VASH2;LRRK2;SBDS;EML3;TBCA;ALMS1;NDEL1;MDM1;BBS4;MAP1A;STMN2;CCDC61;KIF13A;ALDOA;MTUS1;REEP2;TUBGCP6;KIF20B;DIXDC1;POLB;BRCA2;EZR;DCTN1;CCDC66;SETD2;RGS14;MAPT;TUBGCP2;MAST2;ARL4C;KIF26B;PHF6;KIF16B;APC;DIP2B;CDK5;TAOK1;TTLL4;PRNP;KIF3A;EML4;EML1;STARD9;EML2;RABGAP1;TERF1;FYN;NDRG1;MAP6;RMDN1;KIF21A;DAG1;CLASP1;ARL8A;PEX14;MAP4K4;KIF1B;CLIP1;PAK1;VAPB;LRPPRC;DNM1L;CEP295
prerank,protein phosphorylated amino acid binding (GO:0045309),0.45113301581416243,1.0558910781833823,0.4066666666666667,0.948876892117513,1.0,14/42,16.50%,FBXW7;LDLRAP1;GRB2;IRS1;YWHAE;YES1;NEDD4;PTPN3;ABL1;VAV2;SYK;VAV1;PIK3R1;YWHAB
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",-0.40609964141239707,-1.055767629499871,0.3761755485893417,0.7208958908957092,1.0,4/14,7.61%,NCF2;NCF1;CYBA;CYBB
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",-0.4235626053242724,-1.0521886974012706,0.4107744107744108,0.7204000313666697,1.0,6/13,42.69%,SREBF2;ECI1;EBP;IDI1;MIF;ECH1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",0.5533702668296253,1.051882799856341,0.4290171606864275,0.9573989843384438,1.0,3/10,11.13%,LACC1;APOBEC1;GDA
prerank,protein phosphatase 2A binding (GO:0051721),0.4851564753905973,1.0505759397492975,0.42857142857142855,0.95739218006556,1.0,9/23,17.95%,ADCY8;IGBP1;BOD1L1;MAPT;TP53;ENSA;PPME1;MFHAS1;SMG7
prerank,mRNA binding (GO:0003729),0.4198489277231002,1.0500334081975973,0.395,0.9551370489244054,1.0,65/249,16.59%,ELAVL4;DENR;SECISBP2L;EIF4A3;ELAVL2;ZC3H12D;HNRNPM;RPL41;EIF4ENIF1;CARHSP1;SYNCRIP;CSTF3;TARDBP;CSTF2;RBMS3;RNPS1;RBM15;DCP1B;ETF1;PUM2;RC3H2;RBM5;METTL3;PPP1R8;G3BP2;LUC7L;HNRNPA2B1;PTBP3;THOC5;NUP98;LARP4B;PABPC4;SRSF5;AGO2;YTHDF1;SNRNP70;FXR2;PUM1;RBFOX3;ZC3H12B;DCP1A;SF1;QKI;LSM14A;EIF3A;ZFP36L1;SAMD4A;TP53;RNF20;FUBP3;SRRM2;DDX5;MYEF2;PCBP3;UNK;RBMS1;G3BP1;HNRNPC;HNRNPK;SERBP1;HNRNPL;NSRP1;CELF2;CPEB2;YTHDF3
prerank,carbohydrate kinase activity (GO:0019200),-0.45341280364713143,-1.0495572814764,0.4327485380116959,0.7178329141315959,1.0,9/11,45.03%,NAGK;HK3;HK1;GNE;FGGY;POMK;XYLB;GALK1;KHK
prerank,ubiquitin-protein transferase activity (GO:0004842),0.4171062345993123,1.0469861402171683,0.357,0.9606039780077621,1.0,87/346,16.71%,TRIM55;NEURL1B;BRCA1;KLHL42;FBXO17;UBE2Z;RNF182;RNF31;RLIM;SH3RF3;FBXO21;FBXO3;PELI1;GID4;CDC23;AKTIP;TRAF7;RNF145;RC3H2;NHLRC1;UBE2A;RNF166;BIRC3;UBE2J2;CBLL1;FBXO9;RNF115;RNF34;PPIL2;MEX3C;NEDD4;BFAR;HECW1;RNF146;BIRC6;RCHY1;AREL1;RNF38;RNF216;FBXO11;UBE2Q2;RNF11;RFWD3;TRIM3;TRIM5;RNF157;CDC42;MYLIP;ASB2;TRAF2;FBXW11;RNF150;CBL;TRIM44;RNF144B;CUL4A;UBE3A;UBE2W;UBE3C;MIB1;VPS11;UBR5;RNF138;NHLRC3;HECTD1;RNF20;NFX1;TRIM56;UBE2H;TRIM59;RNF24;RNF135;RSPRY1;UBE2D3;DTX3;MSL2;TRIP12;TRIM26;RNF214;KCMF1;ZNRF3;UBE2G1;UBE2E3;TRIM25;UBR3;CNOT4;HACE1
prerank,protein homodimerization activity (GO:0042803),0.41499980568069605,1.0467108637239846,0.328,0.9575420203034419,1.0,122/589,15.90%,ANG;CBS;MID1;BANF1;NQO2;LRRK2;BLM;PDXK;TSG101;RELA;UBA5;SP1;EIF2AK1;TPD52L1;ADCY8;TFAP4;TMEM266;TPD52;SSBP1;TGFB2;ZNF318;BMPR1A;MTMR1;EEA1;PIP4K2A;FLNA;IRF3;PADI2;S100A6;RABEP1;MAP3K11;TPM1;WRN;SMAD3;TERF2;PDGFB;PANK1;FECH;HARS1;TARS2;NFS1;ABCB7;KIF20B;SPPL3;ACVR1;NUDT5;ABCD2;GLCE;HSP90AA1;IKBKB;CCDC66;TAP1;TENM4;BNIP3L;CAMK2D;MAP3K9;PTPRT;ADD1;RCHY1;IRAK2;CHEK2;FXR2;PIP4K2B;EXD2;CNOT9;ABCG1;NR6A1;ENO1;SMCHD1;NADK2;CANT1;DGKD;ACTN4;SRR;TKT;CACYBP;TRIM5;ST6GAL1;HPS4;BNIP3;ABCD3;PRKRA;SNX1;ZBTB38;VPS4B;ERN1;XPNPEP1;MFSD1;ERP29;SOX6;ADAM10;SH3GLB1;MYO9B;ABCD1;HSD17B4;NRBP1;BCL2;LRP6;RPE;PDCD6IP;CAMK2G;S100B;TERF1;PTPRO;PKD2;MIGA1;TBC1D22A;FZD9;LDB1;TIMM9;SCARB2;ARNT;ATG7;SMAD4;NPM1;HIP1;ABCG2;EXT1;GOLGA5;TPST2;INPP5F;PDGFC
prerank,acyl-CoA hydrolase activity (GO:0047617),0.5067231879486006,1.0459111168104938,0.451831750339213,0.95586746038163,1.0,4/17,12.94%,PLA2G6;ACOT9;ACOT13;ABCD1
prerank,steroid hydroxylase activity (GO:0008395),-0.4000922032699745,-1.0440965598171448,0.3970037453183521,0.7219335393685565,1.0,9/16,54.40%,CYP27A1;CYP7B1;CH25H;CYP2R1;CYP39A1;CYP2A6;CYP2U1;CYP1A1;CYP46A1
prerank,androgen receptor binding (GO:0050681),0.4790979606516899,1.043677172703022,0.41890166028097064,0.9585261859007047,1.0,8/25,13.71%,SMARCA4;ZBTB7A;PRKCB;EP300;KDM3A;PRPF6;KDM4C;DDX5
prerank,UDP-galactosyltransferase activity (GO:0035250),0.5526925667050921,1.0436123296828337,0.4353312302839117,0.9547208605518908,1.0,4/10,18.89%,B4GALT5;B4GALT1;B3GALT1;B3GALT5
prerank,ubiquitin protein ligase binding (GO:0031625),0.4173197057770462,1.0434574576267055,0.388,0.9512117924126514,1.0,48/254,13.32%,CBS;BRCA1;MID1;WFS1;VCL;TSG101;RELA;FBXW7;SMAD6;GLMN;UBXN1;UQCRC1;RNF31;TCP1;PRKAR2A;POLR2A;RAD18;JUN;YWHAE;SMAD3;PRKACA;SQSTM1;AMBRA1;ARRB2;UBE2A;UBE2J2;UBXN7;CKB;HSP90AA1;RNF34;SUMO2;HSPA9;SLF1;SYT11;CHEK2;FAF1;APC;TANK;TRAF2;DERL1;CUL4A;CAMLG;UBE2W;TP53;RNF20;BCL2;ACVR1B;RTN4
prerank,N-methyltransferase activity (GO:0008170),0.4948570548811249,1.0432327766419485,0.4452054794520548,0.9479993982355311,1.0,3/20,7.97%,TRMO;TFB2M;SETD3
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),0.45890533860038846,1.0422694972956805,0.44350961538461536,0.9470771345407504,1.0,11/32,16.47%,P4HTM;FTO;EGLN3;EGLN2;EGLN1;KDM4B;KDM4C;TET2;ALKBH5;ALKBH1;TET3
prerank,Lys48-specific deubiquitinase activity (GO:1990380),0.5128860103213341,1.0409318306202109,0.43304843304843305,0.9472414058309405,1.0,5/14,13.77%,DESI2;MINDY3;MINDY4;MINDY2;ATXN3
prerank,poly(A) binding (GO:0008143),0.49627240500724695,1.0400210803962453,0.45118733509234826,0.9462254197851581,1.0,4/21,7.94%,ELAVL4;EIF4A3;RBMS3;PABPC4
prerank,voltage-gated sodium channel activity (GO:0005248),0.4765285662274954,1.0387858612757581,0.4282018111254851,0.9461561671900429,1.0,1/22,0.39%,HCN3
prerank,NAD+ binding (GO:0070403),0.5271878921853774,1.0386428336225566,0.4513677811550152,0.942781962260426,1.0,2/12,3.29%,PARP9;HPGD
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.5448849685898121,1.0383961053317377,0.44510385756676557,0.939716041397154,1.0,1/11,0.90%,SLC25A24
prerank,cell-cell adhesion mediator activity (GO:0098632),-0.2977984492152524,-1.0380993480378142,0.36936936936936937,0.7268634182461606,1.0,12/42,17.91%,CNTN6;RAB10;STXBP6;DSCAML1;NTNG1;JAM3;LRRC4C;BAIAP2;SIRPA;CNTN2;EMB;BSG
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.4324979436285617,1.037224527729647,0.44114411441144114,0.9392749989691943,1.0,10/53,15.51%,SLC66A1;SLC7A2;SLC38A2;SLC7A11;SLC7A7;SLC7A8;SLC25A2;SLC38A9;SLC15A4;SLC38A6
prerank,ubiquitin protein ligase activity (GO:0061630),0.41231132800802595,1.0347791044315235,0.4144144144144144,0.9426460085166021,1.0,55/228,15.66%,TRIM55;NEURL1B;FBXO17;RLIM;SH3RF3;PELI1;GID4;RNF145;RC3H2;NHLRC1;RNF166;BIRC3;CBLL1;RNF115;RNF34;PPIL2;MEX3C;NEDD4;BFAR;HECW1;RCHY1;AREL1;RNF38;RNF216;RNF11;RFWD3;TRIM3;TRIM5;RNF157;CDC42;MYLIP;ASB2;RNF150;CBL;TRIM44;RNF144B;UBE3A;UBE3C;VPS11;UBR5;RNF138;NHLRC3;HECTD1;NFX1;TRIM56;TRIM59;RNF24;RNF135;UBE2D3;DTX3;MSL2;TRIP12;TRIM26;KCMF1;ZNRF3
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",0.45793297058842475,1.0344876343847365,0.4437799043062201,0.939800978171387,1.0,10/34,16.91%,DAPP1;IQGAP2;BTK;MAPKAP1;MYO1G;KIF16B;PLEKHB2;IQGAP1;ADAP2;MYO1B
prerank,neuropeptide binding (GO:0042923),0.4936218812714993,1.0340015949574677,0.444141689373297,0.9374384842519685,1.0,2/18,12.31%,GPR149;SORL1
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.5300680930487373,1.0337578725881813,0.4423631123919308,0.9344652867615352,1.0,1/12,0.90%,SLC25A24
prerank,GTP binding (GO:0005525),0.41289321536439444,1.0328927416146036,0.43561368209255535,0.9332911798593143,1.0,24/172,10.95%,TUBB4B;LRRK2;ARL5A;NRAS;RHOF;ARL4A;ADSS1;SEPHS1;ARL6;ARF3;NOA1;RERG;RAP1A;MTG2;TUBA1A;RAP1B;RAB6A;ARL4C;KRAS;PIP4K2B;RAB2A;CDC42;RIT2;ARF1
prerank,sequence-specific DNA binding (GO:0043565),0.4114894248196427,1.0321378185816468,0.379,0.9318949743532953,1.0,72/590,15.19%,POU2F3;ISL1;GLIS1;RORA;ZIC4;SP8;SP1;HLX;TFAP4;SOX13;SMG6;TGIF1;CLOCK;ZEB2;BBX;MAX;NFATC1;JUN;ZBTB7A;ELK3;IRF3;BCL6;SMAD3;TERF2;TEAD1;ESR1;NR3C1;JUND;PRDM4;MEF2A;MAPT;MECP2;TFCP2;CUX1;DRGX;KDM5B;LIN28B;MAFG;PPARG;NR6A1;MBNL2;HMBOX1;HIVEP1;HOXC4;TCF12;ZSCAN29;NR5A1;ZNF711;NR2C2;ZBTB38;PRDM1;GMEB2;ABL1;BACH2;TCF7L2;ATF6;MAF;BCL2;NR1D2;KLF13;RXRA;TERF1;SP4;CREB1;RFX3;RBPJ;PPARD;CTCF;ARNT;CTC1;SMAD4;ZBTB18
prerank,regulatory RNA binding (GO:0061980),0.4482682579974609,1.030536297069391,0.44405997693194926,0.9328360196857105,1.0,8/38,10.19%,ZNF346;TUT4;TLR7;PUM2;HNRNPA2B1;AGO2;PUM1;ZC3H7A
prerank,microtubule plus-end binding (GO:0051010),0.4785905868065418,1.0289453006506128,0.4318181818181818,0.9340298416139295,1.0,8/20,18.36%,MAPRE1;DCTN1;APC;FBXW11;CLASP1;CLIP1;CLASP2;MAPRE2
prerank,intracellular ligand-gated ion channel activity (GO:0005217),-0.44553315942374366,-1.0285120838712487,0.4415204678362573,0.7416590946821224,1.0,2/11,4.64%,RYR2;ITPR1
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.410536463334743,1.0272553499227368,0.43587174348697394,0.9353325735147775,1.0,56/232,15.66%,TRIM55;NEURL1B;FBXO17;RLIM;SH3RF3;PELI1;GID4;RNF145;RC3H2;NHLRC1;RNF166;BIRC3;CBLL1;RNF115;RNF34;PPIL2;MEX3C;NEDD4;BFAR;HECW1;RCHY1;AREL1;RNF38;RNF216;RNF11;RFWD3;TRIM3;TRIM5;RNF157;CDC42;MYLIP;ASB2;RNF150;CBL;TRIM44;RNF144B;UBE3A;UBE3C;VPS11;UBR5;RNF138;NHLRC3;HECTD1;NFX1;TRIM56;TRIM59;RNF24;RNF135;UBE2D3;DTX3;MSL2;TRIP12;TRIM26;PIAS1;KCMF1;ZNRF3
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.45913544701105957,1.0265061751392905,0.4454865181711606,0.9338398933349195,1.0,11/31,16.37%,UBE2Z;AKTIP;UBE2A;UBE2J2;BIRC6;UBE2Q2;UBE2W;UBE2H;UBE2D3;UBE2G1;UBE2E3
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),-0.442616505273391,-1.0246890871900698,0.46070460704607047,0.7422383571442441,1.0,8/11,21.97%,UBE4B;UBE4A;AMFR;UBE2K;RBX1;STUB1;ANAPC11;UBOX5
prerank,Hsp90 protein binding (GO:0051879),0.4504725662284746,1.023779975134837,0.465311004784689,0.9381841714150282,1.0,7/33,14.87%,PPID;USP19;CHORDC1;NR3C1;MAPT;ERN1;TSC1
prerank,sialyltransferase activity (GO:0008373),0.4737513085234907,1.0227074139242096,0.4496732026143791,0.9377389491586284,1.0,2/20,1.79%,ST8SIA5;ST8SIA4
prerank,miRNA binding (GO:0035198),0.45542741335394493,1.020592567832292,0.4551971326164875,0.9403697745158571,1.0,7/30,10.19%,ZNF346;TUT4;PUM2;HNRNPA2B1;AGO2;PUM1;ZC3H7A
prerank,guanyl ribonucleotide binding (GO:0032561),0.40863519090056927,1.0199138718200011,0.46184738955823296,0.9387311137689472,1.0,27/196,10.95%,TUBB4B;LRRK2;ARL5A;NRAS;RHOF;ARL4A;ADSS1;SEPHS1;ARL6;ARF3;NOA1;RAB8B;RAB12;RERG;RAP1A;MTG2;RAB5B;TUBA1A;RAP1B;RAB6A;ARL4C;KRAS;PIP4K2B;RAB2A;CDC42;RIT2;ARF1
prerank,Tat protein binding (GO:0030957),0.5290464936108946,1.0189586564422912,0.47058823529411764,0.9377228799278274,1.0,4/10,17.34%,SMARCA4;CTDP1;NPM1;MDFIC
prerank,alanine transmembrane transporter activity (GO:0022858),-0.420620463797837,-1.0184542213977186,0.4490358126721763,0.7479106910200584,1.0,4/12,14.58%,SLC36A1;SLC38A7;SLC36A4;SLC3A2
prerank,ligand-gated cation channel activity (GO:0099094),-0.2524968021953422,-1.0178886682807924,0.4230769230769231,0.7407635992037908,1.0,6/75,2.51%,P2RX7;GRIK1;GRIN2B;KCNN2;PTK2B;GRIN3A
prerank,poly-purine tract binding (GO:0070717),0.4718416083988929,1.017500530868753,0.4720101781170484,0.9383210296233848,1.0,5/27,7.94%,ELAVL4;EIF4A3;RBMS3;ATXN1;PABPC4
prerank,calcium:sodium antiporter activity (GO:0005432),0.5408753117193457,1.0173177394278157,0.47577092511013214,0.9352707124548667,1.0,1/10,1.09%,SLC24A5
prerank,phosphatidylinositol phosphate binding (GO:1901981),0.40981421863694534,1.0166595854721998,0.4624871531346352,0.9334102696970717,1.0,27/100,17.07%,WDR45;OSBP;DAPP1;IQGAP2;WDR45B;BTK;RNF34;GOLPH3;GSDMD;MAPT;PLA2G4A;MAPKAP1;SNX3;MYO1G;KIF16B;SNX20;GAP43;ANKFY1;NCF4;SNX24;PLEKHB2;HIP1;SNX13;IQGAP1;ADAP2;MYO1B;PLEKHA5
prerank,epidermal growth factor receptor binding (GO:0005154),0.4658766170708421,1.0165533034686656,0.47215189873417723,0.9302613375017968,1.0,7/25,15.24%,GRB2;AREG;CNOT9;ATXN2;SNX1;TGFA;HIP1
prerank,CARD domain binding (GO:0050700),-0.4074472866119741,-1.013833434036395,0.4584717607973422,0.7417016329718635,1.0,8/14,23.47%,CASP4;CARD11;IRGM;CARD16;NOD1;CARD9;BCL10;CASP1
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.44782863655927196,1.0137268936091066,0.4675642594859241,0.9347705869927393,1.0,5/30,8.86%,UBE2Z;GAS6;TNFAIP8;BIRC3;BIRC6
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",-0.4510163977238717,-1.012994410795149,0.47875354107648727,0.7357014409491113,1.0,4/10,33.64%,DPYSL3;DPYSL5;OPLAH;CRMP1
prerank,signaling receptor complex adaptor activity (GO:0030159),0.4372188378042179,1.0129735591965268,0.4689655172413793,0.933391318202572,1.0,10/38,15.70%,LRRK2;LDLRAP1;IRS1;G3BP2;RGS14;NCK1;FRS2;SH2B3;SH2B2;PIK3R1
prerank,protein phosphatase activator activity (GO:0072542),0.5059397612991986,1.0099572626872124,0.46448863636363635,0.9383277150296879,1.0,3/13,14.29%,IGFBP3;PPP2R5C;CALM1
prerank,flavin adenine dinucleotide binding (GO:0050660),0.42711616159048255,1.0098600257660932,0.4747252747252747,0.935177887248468,1.0,11/53,15.32%,NQO2;KDM1B;QSOX1;MTHFR;MICAL2;SDHA;ACADL;AIFM1;ETFA;ACOX3;MICAL3
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",-0.38484180502505194,-1.0082453505616433,0.4323308270676692,0.7297882451104303,1.0,6/16,15.79%,ATP6V0A1;ATP6V1A;ATP6V1D;ATP6V0C;ATP6V0B;ATP6V1C1
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",-0.38484180502505194,-1.0082453505616433,0.4323308270676692,0.7297882451104303,1.0,6/16,15.79%,ATP6V0A1;ATP6V1A;ATP6V1D;ATP6V0C;ATP6V0B;ATP6V1C1
prerank,protein tyrosine kinase binding (GO:1990782),0.4126780005844151,1.0067291595828078,0.4823906083244397,0.9404500617429142,1.0,14/71,12.92%,DUSP3;GAS6;SQSTM1;ACVR1;HSP90AA1;PITPNM1;NRG3;PTPN1;NCK1;SOCS5;CBL;BANK1;SH2B3;TP53
prerank,AMP binding (GO:0016208),-0.43235284843160304,-1.0064254011810152,0.4599406528189911,0.7260778878071459,1.0,8/11,36.92%,MPPED2;PRKAG1;ACSS2;PFKL;PYGL;PRKAG2;APRT;PFKM
prerank,protein kinase activator activity (GO:0030295),0.41833105412950977,1.0062791405844504,0.48004314994606256,0.9384098983819861,1.0,16/60,18.52%,RGCC;GAS6;ABI1;STK11;PAK2;TAOK1;MAP2K2;CALM1;STK3;IQGAP1;MAP2K1;NCKAP1L;DDX3X;STK4;ALS2;CAB39
prerank,potassium ion transmembrane transporter activity (GO:0015079),0.438185463946368,1.0034419446439518,0.4817073170731707,0.9430924132850118,1.0,7/31,16.61%,TMEM175;TMEM38B;SLC12A6;KCNK10;PKD2;HCN1;KCNA1
prerank,GTPase regulator activity (GO:0030695),0.4011934349668979,1.0034219964149271,0.49599198396793587,0.9397463109719211,1.0,65/212,17.29%,LRRK2;LLGL2;ITGB1BP1;RAB3GAP1;LLGL1;SIPA1L3;GDI1;NF1;TBC1D15;JUN;NRP1;IQGAP2;DOCK1;TAGAP;EVI5;VAV3;IPO7;ALDH1A1;TBC1D17;ARFGEF1;ARHGAP22;RGS14;RGS3;RIC8B;TBC1D14;ADGRB3;ARHGAP1;TBC1D10B;RAP1GDS1;IPO5;GNAQ;STXBP5;ARHGAP35;SIPA1L2;ARHGAP39;TBC1D4;STXBP5L;OCRL;TBC1D12;TBC1D5;TBC1D10A;TBC1D13;RABGAP1;ARHGAP15;ARHGAP32;MYO9B;ARHGAP45;TBC1D22A;TBC1D8;LARS1;ARHGAP31;WASL;TBC1D1;PDE6D;IQGAP1;DNM1L;RP2;CPEB2;ARHGAP17;PREX1;RIN2;TBCK;RALBP1;RAPGEF2;NCKAP1L
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),-0.35529004644856554,-1.001239456643765,0.4251968503937008,0.7292681597733093,1.0,3/21,25.70%,GRM1;CHRFAM7A;CHRNA7
prerank,potassium channel activity (GO:0005267),0.40205560552176006,0.9992084754228174,0.49896907216494846,0.947919202404633,1.0,17/89,17.25%,HCN3;TMEM175;KCNH8;KCNH7;KCNK2;TMEM38B;KCNK13;KCNK10;PKD2;KCNMB2;KCNMB3;KCNQ5;HCN1;KCND2;KCNA1;KCNA5;KCNB2
prerank,proton transmembrane transporter activity (GO:0015078),0.4334516189323225,0.9964328876984786,0.5022935779816514,0.952047117561449,1.0,5/39,9.23%,UQCRH;UQCRC1;SLC9A1;SLC33A1;CLCN5
prerank,metal ion binding (GO:0046872),0.3929213102219498,0.9927653765840818,0.532,0.9583310074673247,1.0,67/477,13.95%,PLK1;SCUBE1;CETN2;SNN;SLC25A24;MAN1B1;LRRK2;IGFBP3;PDXK;EYA2;MICU1;TDP2;DYRK2;TPD52;BRAF;ITSN1;LETM1;THBS1;PADI2;S100A6;CEMIP2;WRN;NT5C3A;ACER3;MAP3K20;NUDT5;GLCE;STK11;HPRT1;PITPNM1;GALNT3;CDC42BPB;SYT12;SYT11;PLA2G4A;TRPM4;MAST2;PI4K2A;EXD2;CDH11;CANT1;ANXA2;SRR;TKT;MT1G;MT1X;MT1B;MT1F;MT1E;MT1M;MT1H;MT1A;IDH2;PRNP;EML1;ABL1;ERN1;CDH20;SRPK2;RPE;S100B;COLEC11;CAMKK2;CDH18;PKD2;SPARCL1;ANXA5
prerank,cation channel activity (GO:0005261),0.40172090407973626,0.9917273733004061,0.5202072538860104,0.9578057048388428,1.0,15/94,13.91%,SLC24A5;TRPC5;TMEM175;CACNA1D;HVCN1;TMEM63B;TMEM38B;PIEZO2;TRPM4;ANXA2;SEC61A1;MCOLN1;TRPV2;KCNK10;PKD2
prerank,endoribonuclease activity (GO:0004521),0.4403731516772106,0.9915428875412549,0.5023866348448688,0.9548167161122512,1.0,6/32,12.18%,ZC3H12D;SMG6;AGO2;ZC3H12B;CPSF3;ERN1
prerank,ATPase regulator activity (GO:0060590),0.42653021631221943,0.9915068912330195,0.4925028835063437,0.9515976742570559,1.0,9/38,14.87%,DNAJB1;DNAJC15;BAG3;HSPH1;SIL1;FNIP1;DNAJC1;DNAJB4;TSC1
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",0.5276199605630731,0.9895496938994104,0.5031847133757962,0.9537184244570028,1.0,3/10,13.26%,DSE;GLCE;RPE
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),0.5255267099695793,0.9885581654113149,0.5269645608628659,0.9529914922561268,1.0,3/10,10.29%,PRKAR2A;PKIB;PKIA
prerank,voltage-gated potassium channel activity (GO:0005249),0.4038512903768453,0.9882220414808974,0.5141065830721003,0.950530282712271,1.0,5/80,6.34%,HCN3;KCNJ6;KCNH8;KCNH7;KCNK2
prerank,vinculin binding (GO:0017166),0.5177092548513056,0.9881130572332398,0.4941348973607038,0.947539348857266,1.0,5/11,17.49%,CTNNA1;PXN;DAG1;UTRN;RTCB
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.4650257481200941,0.9865360289815086,0.49612403100775193,0.9482944740753009,1.0,4/22,13.21%,DUSP3;DUSP16;DUSP10;DUSP12
prerank,muscle alpha-actinin binding (GO:0051371),0.4888068173028862,0.9864741537511712,0.4992764109985528,0.9452055080965337,1.0,3/15,13.91%,PDLIM2;PALLD;PKD2
prerank,L-glutamate transmembrane transporter activity (GO:0005313),-0.3913863715080718,-0.9838084224167081,0.4707792207792208,0.7604439131382487,1.0,5/14,16.91%,SLC1A2;SLC25A13;SLC38A7;SLC17A6;SLC1A1
prerank,secondary active transmembrane transporter activity (GO:0015291),0.41326549061815865,0.9811585873716426,0.5059978189749182,0.9557863686578377,1.0,10/51,14.89%,SLCO4C1;SLC35D1;SLCO1B1;SLC35E2B;SLC35E2A;SLC7A8;SLC25A16;SLCO2B1;SLC20A2;SLC25A3
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),0.41974008287166753,0.9808850106216459,0.5240274599542334,0.953211876318028,1.0,9/38,15.30%,WDR45;WDR45B;PLA2G4A;SNX3;KIF16B;SNX20;NCF4;HIP1;SNX13
prerank,NAD binding (GO:0051287),0.43440050718910056,0.9802725881864848,0.5094339622641509,0.9515575259725637,1.0,4/26,9.64%,PARP9;HPGD;ALDH1A1;CTBP1
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),-0.3375360368949755,-0.979019857704572,0.4927536231884058,0.7637478111533009,1.0,7/22,15.79%,ATP6V0A1;ATP6V1A;ATP6V1D;ATP6V0C;ATP2C1;ATP6V0B;ATP6V1C1
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.5105181424214781,0.9781453151523113,0.5293233082706766,0.9536438119879259,1.0,1/11,4.27%,AKR1B1
prerank,histone demethylase activity (GO:0032452),0.44842234874489323,0.9750895049177439,0.533249686323714,0.9582475003837131,1.0,6/27,11.95%,KDM5A;KDM3A;KDM5B;JMJD1C;KDM4B;KDM4C
prerank,3'-5' DNA helicase activity (GO:0043138),0.4883454252467547,0.9750162912814625,0.5199449793672627,0.9551741389068564,1.0,2/16,4.94%,BLM;WRN
prerank,cation transmembrane transporter activity (GO:0008324),0.41375308742715416,0.9750024618458714,0.5276836158192091,0.9519847434021108,1.0,8/48,15.51%,SLC66A1;SLC7A2;SLC38A2;SLC7A8;SLC25A2;SLC38A9;SLC15A4;SLC38A6
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.38790424632695547,0.9747956375925925,0.582,0.949328601304948,1.0,70/431,13.18%,TUBB4B;PLK1;ATP5F1A;LRRK2;BLM;PDXK;EIF4A3;ARL5A;NRAS;MINK1;RHOF;ARL4A;TARS1;ADSS1;SEPHS1;ARL6;ARF3;NOA1;VPS4A;DYRK2;BMPR1A;RERG;RAP1A;MTG2;ATP7A;BTK;HARS1;MAP3K20;CDK6;ACVR1;ABCD2;STK11;HSP90AA1;CLPX;TUBA1A;HSPA9;RAP1B;CDC42BPB;TAP1;SYN3;RAB6A;RPS6KA5;AARS1;TWF2;MAST2;ARL4C;PI4K2A;KRAS;DAPK1;PIP4K2B;RAB2A;ABCG1;TAOK1;SRR;CDC42;ABCD3;RIT2;ARF1;CHD8;GCK;PFKP;ABL1;ERN1;CDKL5;SRPK2;MYO9B;ABCA1;ABCD1;TGFBR1;ACVR1B
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.4315722357346717,0.9733802796521815,0.5264394829612221,0.9499100467491899,1.0,7/33,10.81%,REXO2;EXOSC5;EXOSC7;ERI3;XRN1;EXD2;XRN2
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.5046997206371956,0.9732885379761316,0.5092592592592593,0.946997897800776,1.0,2/10,9.23%,DCLRE1A;EXD2
prerank,core promoter sequence-specific DNA binding (GO:0001046),0.41568506078840034,0.9677862958234154,0.5076201641266119,0.9573792269623034,1.0,11/35,16.33%,RELA;SMARCA4;NR3C1;AGO2;UBTF;TAF4;GTF2B;TP53;SNAPC3;NPM1;TAF1B
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",0.4194596647625358,0.967093904118159,0.5224242424242425,0.9559735575893353,1.0,8/35,16.43%,NT5C3A;FTO;TARS2;DUS4L;AARS1;GATB;ALKBH1;TRIT1
prerank,phospholipase activity (GO:0004620),0.3983420928661765,0.9637418162429441,0.5509554140127388,0.9613011753956767,1.0,10/67,11.79%,SMPDL3A;SMPD3;SMPD1;PLA2G6;ABHD6;PLA2G4A;ABHD16A;PNPLA6;PLD4;PLCB4
prerank,ATP binding (GO:0005524),0.3835912133157568,0.9637081857035968,0.59,0.9582269688968137,1.0,61/266,17.06%,PLK1;ATP5F1A;BLM;PDXK;EIF4A3;MINK1;TARS1;VPS4A;DYRK2;BMPR1A;ATP7A;BTK;HARS1;MAP3K20;CDK6;ACVR1;ABCD2;STK11;HSP90AA1;CLPX;HSPA9;CDC42BPB;TAP1;SYN3;RPS6KA5;AARS1;TWF2;MAST2;PI4K2A;DAPK1;PIP4K2B;ABCG1;TAOK1;SRR;ABCD3;CHD8;GCK;PFKP;ABL1;ERN1;CDKL5;SRPK2;MYO9B;ABCA1;ABCD1;TGFBR1;ACVR1B;INSR;NVL;MTREX;MKNK1;NEK6;STK3;MAP4K4;UBA2;ABCE1;PPIP5K2;PRKACB;TBCK;MYO1B;HSPA5
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),0.497249293682939,0.9636788841361316,0.5279770444763271,0.9551696737217145,1.0,4/12,11.95%,KDM3A;JMJD1C;KDM4B;KDM4C
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.4325192213151695,0.9629800122021865,0.5381773399014779,0.9538057838486839,1.0,6/29,13.57%,PRKAR2A;SPRED2;PKIB;PKIA;KAT2B;SPRED1
prerank,pre-mRNA binding (GO:0036002),-0.31167821058018563,-0.9626058792697862,0.5025641025641026,0.7926465665553454,1.0,14/28,24.37%,HNRNPU;CELF4;TRA2B;ZRSR2;RNPC3;RBM41;HNRNPA1;PRPF8;ERI1;SLU7;SLBP;PTBP1;RBM4;RBM22
prerank,CCR chemokine receptor binding (GO:0048020),0.4401845973302868,0.9623612565847048,0.5181598062953995,0.9522184891345112,1.0,2/28,7.28%,CX3CL1;CCL25
prerank,metalloendopeptidase activity (GO:0004222),0.3964928553313942,0.9611611811766186,0.5736677115987461,0.9518699282606139,1.0,6/76,9.26%,ADAMTS12;NLN;ADAMTS2;ADAMTSL3;NRDC;ADAMTS10
prerank,transforming growth factor beta receptor binding (GO:0005160),0.46152862686751983,0.9591033585267552,0.5215633423180593,0.9538731594636122,1.0,5/18,12.97%,SMAD6;TGFB2;SMAD3;TGFBR2;TGFBR1
prerank,methyltransferase activity (GO:0008168),0.4053618451084849,0.9586564251730448,0.5363128491620112,0.9519687252222176,1.0,6/46,9.78%,EHMT1;SUV39H1;METTL3;NSUN3;AS3MT;NDUFAF7
prerank,manganese ion binding (GO:0030145),0.4021737703544283,0.954615923600522,0.5341545352743561,0.9586721957504691,1.0,9/48,12.37%,TDP2;DYRK2;GALNT1;WRN;GALNT3;EXD2;B4GALT1;ABL1;XPNPEP1
prerank,GTPase activator activity (GO:0005096),0.3790821971803145,0.9535453270454669,0.637,0.9583010695508675,1.0,89/313,17.29%,LRRK2;LLGL2;FGD6;RAPGEF1;FGD3;DOCK8;FGD1;RAB3GAP1;LLGL1;CYTH4;RIN3;ITSN1;SIPA1L3;NF1;TBC1D15;JUN;RAP1A;NRP1;IQGAP2;FARP2;DOCK1;TAGAP;EVI5;DENND6A;VAV3;FARP1;SBF2;ALDH1A1;TBC1D17;ARFGEF1;ARHGAP22;RGS14;EPS8L1;RAPGEF5;RGS3;RIC8B;TBC1D14;RAPGEF4;ADGRB3;ARHGAP1;FNIP1;KALRN;TBC1D10B;RAP1GDS1;GNAQ;STXBP5;ARHGAP35;AKAP13;HPS4;SIPA1L2;ARHGAP39;ARHGEF17;TBC1D4;CYTH1;STXBP5L;OCRL;TBC1D12;VAV2;TBC1D5;TBC1D10A;TBC1D13;RABGAP1;ARHGAP15;ARHGAP32;MYO9B;ARHGAP45;DOCK9;ELMO1;DOCK11;TBC1D22A;TBC1D8;LARS1;ARHGAP31;TBC1D1;VAV1;IQSEC2;IQGAP1;DENND2C;RALGPS1;DNM1L;RP2;ARHGAP17;DOCK10;PREX1;RIN2;TBCK;RALBP1;RAPGEF2;NCKAP1L
prerank,protein kinase binding (GO:0019901),0.380382354472923,0.9529813723508053,0.656,0.9566602233321899,1.0,87/479,13.90%,PLK1;RGCC;ROR2;WDR45;CDK5RAP3;DUSP3;RELA;IRAK4;DVL1;RHOF;PGAM1;GRB2;PRKAR2A;LLGL1;SASH1;MAPRE1;MSN;CEP250;IRS1;NELL1;CADPS;MAP3K11;HDAC9;POLA1;PRKCB;SMAD3;PRKACA;SQSTM1;SPRED2;PTPRJ;ESR1;HDAC5;AP2A1;NR3C1;ACVR1;PDE3B;HSP90AA1;EZR;KIF11;IKBKB;DCTN1;DLG1;MAP2K6;MAPT;DCTN2;PAK2;DUSP16;MAPKAP1;DUSP10;TBC1D14;PTPN1;TWF2;LIMS1;GRK5;CHEK2;FAF1;MAVS;TOM1L2;CEP152;APC;PTPN23;PKIA;TRIM5;MVP;CDC42;TRAF2;IFNAR2;KAT2B;ABL1;NBEAL1;RB1CC1;RPS6;PRKCSH;TCF7L2;BANK1;ADAM10;CYLD;RNF138;SH2B3;MAPKAPK2;TP53;SPRED1;USP37;ADIPOR1;BICD1;NELL2;PRKD2
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),0.45859425018484823,0.947959269059029,0.5558510638297872,0.9659185714521138,1.0,3/18,10.11%,SOCS4;SOCS7;SOCS5
prerank,iron ion binding (GO:0005506),0.40283478282489726,0.9464921399462841,0.5652173913043478,0.9664429711082363,1.0,8/48,8.47%,FECH;FTO;NFU1;EGLN3;EGLN2;KDM3A;EGLN1;ALOX5
prerank,phosphatidylinositol binding (GO:0035091),0.38491766421200674,0.9463469026104677,0.5904365904365905,0.9638014777825995,1.0,24/91,15.54%,WDR45;ZFYVE9;SNX5;EEA1;RNF34;PITPNM1;SNX10;EPB41;MAPT;WDFY1;TULP3;SNX1;GAP43;AIDA;SNX8;PIGU;ANKFY1;PITPNA;SNX24;MYO1E;HIP1;SNX13;PITPNB;MTM1
prerank,nucleotidyltransferase activity (GO:0016779),-0.34723436249407696,-0.9455097575505714,0.5232067510548524,0.8226662021005653,1.0,7/19,14.18%,TENT2;TENT4B;PAPSS1;MTPAP;PNPT1;TENT4A;CGAS
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),-0.394756576311992,-0.9448634130355685,0.5454545454545454,0.8159615279821263,1.0,4/12,9.29%,PIK3CG;PIK3CA;PIK3C3;PIK3C2B
prerank,SUMO binding (GO:0032183),0.48458414324680005,0.9421773779649925,0.5574712643678161,0.9705782017091017,1.0,1/13,0.61%,HABP4
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.4396903334970938,0.9411188034561979,0.5508365508365508,0.9670390800204391,1.0,6/21,13.30%,CDK7;CDK2;CDK6;CDK9;CDK5;CDK8
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.4396903334970938,0.9411188034561979,0.5508365508365508,0.9670390800204391,1.0,6/21,13.30%,CDK7;CDK2;CDK6;CDK9;CDK5;CDK8
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.374823961807454,0.9407517269790783,0.62058526740666,0.964933257701326,1.0,38/147,16.78%,FGD6;RAPGEF1;FGD3;DOCK8;FGD1;RAB3GAP1;CYTH4;RIN3;ITSN1;RAP1A;FARP2;DOCK1;DENND6A;VAV3;FARP1;SBF2;ARFGEF1;EPS8L1;RAPGEF5;RIC8B;RAPGEF4;FNIP1;KALRN;AKAP13;HPS4;ARHGEF17;CYTH1;VAV2;DOCK9;ELMO1;DOCK11;VAV1;IQSEC2;DENND2C;RALGPS1;DOCK10;PREX1;RIN2
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),0.4582574155061022,0.9404302991430702,0.5421195652173914,0.9626831930859662,1.0,5/18,13.18%,BMPR1A;ACVR1;TGFBR2;TGFBR1;ACVR1B
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),0.4638618655602786,0.9387709070377833,0.5642458100558659,0.9636122672816244,1.0,1/15,8.02%,PLA2G4A
prerank,kinase activity (GO:0016301),0.3777657704281304,0.936308567178961,0.6156186612576064,0.9662527935869657,1.0,26/109,15.83%,LRRK2;PDXK;SEPHS1;FCSK;PANK1;CHKB;CKB;PI4KA;DGKI;PKN2;LYN;CDK5;NADK2;DGKD;TAOK1;IPMK;GK;MTOR;ABL1;CDKL5;PIK3C2A;CHKA;ETNK1;TRRAP;MAP4K4;DGKZ
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.4441547529820985,0.9350649203435819,0.5495118549511855,0.9661288016266588,1.0,3/18,6.42%,GAS6;TNFAIP8;BIRC3
prerank,antiporter activity (GO:0015297),0.44340896167810767,0.9345133306425164,0.5522193211488251,0.9645518832719675,1.0,4/20,11.12%,SLC35D1;SLC35E2B;SLC35E2A;SLC25A16
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),0.4852579317807611,0.9334735407604228,0.5823699421965318,0.9639295252343273,1.0,5/12,15.70%,IRS1;FRS2;SH2B3;SH2B2;PIK3R1
prerank,cysteine-type endopeptidase activity (GO:0004197),0.37381176230419766,0.9325301321138183,0.6019007391763463,0.962935386674104,1.0,13/78,10.53%,USP11;CTSC;USP24;USP34;USP29;USP33;USP1;USP48;USP20;USP5;USP46;CTSZ;CAPN2
prerank,hexosyltransferase activity (GO:0016758),0.37399527308721325,0.9320674971459917,0.6157024793388429,0.9610474414697252,1.0,19/101,17.14%,POGLUT3;B4GALT3;GBA2;MTAP;CHSY1;POMT2;GBE1;B4GALT5;B4GALT1;B3GALNT1;B3GNT2;MGAT4B;B3GALNT2;DPY19L1;EXT1;MGAT4A;LARGE1;B3GALT1;EXT2
prerank,enoyl-CoA hydratase activity (GO:0004300),0.49167594325555186,0.9315271137860079,0.5768645357686454,0.9593124673144148,1.0,4/10,18.99%,ECHS1;HSD17B4;HADHA;AUH
prerank,ATPase binding (GO:0051117),0.3811022475708954,0.9292171243430426,0.5980810234541578,0.9612857226861107,1.0,14/71,14.20%,WFS1;DNAJB1;UBXN1;AR;ESR1;EZR;SNX10;PTPN3;ATP6V1E1;DERL1;ABCA1;ATXN3;PKD2;ATP6V0A2
prerank,G protein-coupled receptor activity (GO:0004930),0.36974450654950386,0.9292089172156527,0.6626626626626627,0.9584054748048759,1.0,17/239,14.62%,RXFP1;S1PR1;ADGRE1;C5AR1;P2RY14;TAPT1;GPR149;GPR65;CMKLR1;ADGRB3;ADGRE5;MTNR1A;XPR1;CYSLTR1;CALCRL;LPAR6;P2RY12
prerank,Toll-like receptor binding (GO:0035325),0.48252083457561,0.9288083622115203,0.5754437869822485,0.9564495043563647,1.0,1/11,1.63%,CD36
prerank,nucleotide diphosphatase activity (GO:0004551),0.4518635958043953,0.9279149049308417,0.5333333333333333,0.9555790225866228,1.0,2/14,4.93%,ENPP5;ENPP4
prerank,chloride channel activity (GO:0005254),-0.24708712572945435,-0.9272054178826509,0.6,0.8479851908682776,1.0,11/59,12.68%,GABRB1;ANO6;GABRA2;TTYH2;ANO3;GABRA3;PACC1;TTYH3;CLCN4;GLRA1;CLCN6
prerank,protein serine/threonine kinase activator activity (GO:0043539),-0.2727647386941946,-0.9270303939349561,0.5963855421686747,0.8401080883554992,1.0,4/34,3.24%,CCNT2;CALM2;CAB39L;CCNT1
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",-0.38618048283067175,-0.9256193249554815,0.5548172757475083,0.8353895160867929,1.0,5/12,8.38%,PDE4D;PDE8A;PDE4B;PDE8B;PDE1B
prerank,peptide N-acetyltransferase activity (GO:0034212),0.47960115863691954,0.9228353254929783,0.5648148148148148,0.9636753336793424,1.0,4/10,17.23%,NAA25;NAA16;NAA15;NAA20
prerank,extracellular ligand-gated ion channel activity (GO:0005230),-0.41779375829669924,-0.9227234422681565,0.5714285714285714,0.8340370258589973,1.0,6/10,29.90%,GABRA2;GABRA3;GABRA5;GABRA4;GABRG1;GABRA1
prerank,glutamate receptor activity (GO:0008066),-0.3366463353970842,-0.921358470623819,0.5746268656716418,0.8288646525036912,1.0,5/19,13.22%,GRIK1;GRM1;GRIK4;GRM3;GRIK2
prerank,sequence-specific mRNA binding (GO:1990825),-0.4084511389908603,-0.921209428132192,0.597667638483965,0.8214163435646404,1.0,3/10,6.16%,DHX9;SSB;FMR1
prerank,phosphatidic acid binding (GO:0070300),0.4384230020912539,0.921094020347803,0.5682704811443433,0.96463635091039,1.0,5/19,8.13%,SMPD3;PACSIN2;PITPNM1;GSDMD;MAPKAP1
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.48622444119977076,0.9198538907335294,0.5811437403400309,0.9644066340556274,1.0,5/10,16.82%,SETD2;SETD3;ASH1L;NSD2;SETD5
prerank,P-type ion transporter activity (GO:0015662),0.4680948346621173,0.9169380417490594,0.6014705882352941,0.9676875040786792,1.0,2/12,9.21%,ATP7A;ATP6V1E1
prerank,amyloid-beta binding (GO:0001540),0.37639691880251686,0.9168818324160507,0.6287799791449427,0.9649475981153884,1.0,15/79,14.85%,CD36;PFDN1;LDLRAP1;TGFB2;EPHB2;APBA1;GRIA4;ITM2B;CACNA1A;CLSTN1;PRNP;SORL1;INSR;GRIN2A;TLR4
prerank,glucuronosyltransferase activity (GO:0015020),0.44034573147256334,0.916622648712346,0.5826666666666667,0.962638739424607,1.0,4/19,17.14%,CHSY1;EXT1;LARGE1;EXT2
prerank,ADP binding (GO:0043531),0.4106360863082292,0.9163280775087445,0.5776699029126213,0.9604308557187429,1.0,6/25,12.94%,ATP5F1A;TAP1;ABCG1;ERN1;MYO9B;ABCD1
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),0.41443339336934626,0.9151632630724689,0.5849297573435505,0.9600309473316818,1.0,5/25,10.02%,PARP9;PARP8;PARP2;TNKS2;PARP4
prerank,high voltage-gated calcium channel activity (GO:0008331),0.48825763546090784,0.9131939324861036,0.5892575039494471,0.9614665960259641,1.0,3/10,14.78%,CACNA1D;CACNA1A;CACNA1C
prerank,nucleosomal DNA binding (GO:0031492),-0.3171901272766866,-0.9122254497501825,0.5874439461883408,0.833469565691243,1.0,7/21,9.33%,SMARCC1;RBBP4;H3-3A;HDAC1;CHD4;SMARCE1;SMARCB1
prerank,adenylate cyclase binding (GO:0008179),-0.39617597512287467,-0.9120316632628374,0.6023391812865497,0.8261548972000718,1.0,4/10,7.19%,CALM2;CAP1;AKAP6;ADCY2
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),-0.2943748609242358,-0.9111505407687681,0.5958549222797928,0.8205607373845087,1.0,9/28,21.53%,MADD;RIPK1;FEM1B;TRAP1;TRAF3;TRAF6;EDA;TMBIM1;BID
prerank,symporter activity (GO:0015293),0.4834923424554355,0.9108109370977445,0.6012558869701727,0.963742838661985,1.0,10/10,51.68%,SLC28A3;SLC5A8;SLC5A12;SLC5A5;SLC4A4;SLC28A1;MFSD2A;SLC46A2;SLC28A2;SLC5A6
prerank,ligand-gated calcium channel activity (GO:0099604),-0.3313450946041073,-0.9066757727310396,0.5517241379310345,0.8232665051693986,1.0,3/19,4.64%,RYR2;GRIN2B;ITPR1
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.3617395612379438,0.9065172325670262,0.846,0.9699475296338638,1.0,88/732,15.19%,POU2F3;ISL1;GLIS1;RORA;ZIC4;SP8;RELA;IRF1;SP1;TFAP4;POU5F2;SOX13;KLF9;ZBTB5;TGIF1;CLOCK;ZEB2;RUNX1;NFATC1;JUN;AR;ZBTB7A;ZNF569;ELK3;WBP2;IRF3;BCL6;SMAD3;TEAD1;ZNF467;ESR1;HDAC5;NR3C1;IKZF1;JUND;PRDM4;MEF2A;WIZ;TFCP2;ZBTB11;NACC1;MAFG;PPARG;NR6A1;TAL1;HBP1;HIVEP1;HOXC4;TCF12;ZNF568;FOXN3;ZSCAN29;NR5A1;NR2C2;SOX11;ZBTB38;BCL11A;ZNF182;PRDM1;HIVEP2;DNMT3A;GMEB2;BACH2;TCF7L2;ZBTB34;ATF6;SOX6;TP53;MAF;NR1D2;KLF13;MYT1L;RXRA;SP4;KCNIP3;RREB1;CARF;CREB1;RFX3;RBPJ;PPARD;DACH2;HIVEP3;CTCF;ARNT;SNAPC3;SMAD4;ZBTB18
prerank,single-stranded DNA binding (GO:0003697),0.3686586121261988,0.9062572644323281,0.6386292834890965,0.9677246212760373,1.0,16/93,15.15%,POLR2D;BLM;TDP2;SSBP1;POLA1;BRCA2;RBBP8;MAPT;ERCC4;RAD51B;HMGB1;RNF138;FUBP3;RBMS1;RAD23B;CTC1
prerank,SH3 domain binding (GO:0017124),0.377071981251923,0.905512637266191,0.6370449678800857,0.9663991051866089,1.0,16/62,15.36%,GRB2;ADAM15;SOCS7;ADAM12;WIPF1;ABI1;MAPT;REPS1;CD2AP;CBL;ABL1;WASF2;ELMO1;ZNF106;EVL;SYNJ2
prerank,cysteine-type peptidase activity (GO:0008234),0.3630428719333688,0.902429803740096,0.6524064171122995,0.9701248643892764,1.0,17/73,15.49%,USP11;CTSC;USP24;USP34;USP29;USP33;USP1;USP48;USP20;USP5;USP46;CTSZ;CAPN2;ATG4C;USP37;OTULINL;PDIA3
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),0.4743433830370295,0.9003418467445649,0.6060606060606061,0.9714270628875405,1.0,4/12,12.97%,BMPR1A;ACVR1;TGFBR2;TGFBR1
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",-0.3259859331826174,-0.9000810974638286,0.5783582089552238,0.8298970868858069,1.0,14/18,67.42%,HSD17B8;HSD17B7;DHRS11;HSD17B10;HSD17B2;HSD17B1;HSD11B1;HSD3B7;DHRS9;SRD5A2;HSD3B2;HSD17B14;AKR1C1;HSD17B3
prerank,alpha-tubulin binding (GO:0043014),0.3907392648430747,0.8990827652253642,0.6019184652278178,0.9714106465710568,1.0,8/31,15.14%,BBS4;SETD2;ARL4C;DIP2B;TAOK1;EML4;FYN;ARL8A
prerank,ligand-gated anion channel activity (GO:0099095),-0.32652045595783996,-0.8955606081791897,0.5894039735099338,0.8326375752197234,1.0,10/17,29.90%,GABRB1;GABRA2;GABRA3;GLRA1;GABRA5;GLRA2;GABRA4;GABRB3;GABRG1;GABRA1
prerank,poly(U) RNA binding (GO:0008266),0.42578888847304547,0.8946082544088637,0.6140808344198174,0.977801180465718,1.0,7/20,16.15%,RBMS3;ATXN1;PABPC4;HNRNPH1;RBMS1;HNRNPC;PATL1
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.36450784229229777,0.8909243927035307,0.6610703043022036,0.9824847828971373,1.0,4/73,13.85%,RXFP1;SORCS3;CYSLTR1;CALCRL
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.3550642441739316,0.8900309307398163,0.901,0.9814832127263907,1.0,104/831,15.19%,POU2F3;GLIS1;RORA;ZIC4;SP8;ZBTB8A;RELA;IRF1;SP1;ZFP90;CASZ1;TFAP4;POU5F2;SOX13;KLF9;ZBTB5;TGIF1;CLOCK;ZEB2;BBX;RUNX1;MAX;NFATC1;JUN;AR;ZBTB7A;ZNF569;ELK3;WBP2;IRF3;BCL6;TRPS1;SMAD3;TEAD1;RBAK;ZNF467;ESR1;HDAC5;NR3C1;IKZF1;JUND;PRDM4;MEF2A;WIZ;TFCP2;CUX1;DRGX;ZBTB11;NACC1;MAFG;PPARG;NR6A1;TAL1;ENO1;CDC5L;DEAF1;HBP1;HIVEP1;ACTN4;HOXC4;ZBTB46;TCF12;ZNF568;GTF2B;ZSCAN29;NR5A1;NR2C2;SOX11;ZBTB38;BCL11A;ZNF182;PRDM1;HIVEP2;DNMT3A;GMEB2;ZFP69;BACH2;TCF7L2;ZBTB34;ATF6;SOX6;TP53;MAF;NR1D2;KLF13;MYT1L;RXRA;NFX1;SP4;KCNIP3;RREB1;CARF;CREB1;RFX3;RBPJ;PPARD;DACH2;HIVEP3;CTCF;ARNT;SNAPC3;NPAS3;SMAD4;ZBTB18
prerank,kinase binding (GO:0019900),0.3558052806130303,0.8892097660956892,0.827,0.9803245788272028,1.0,79/434,15.55%,PLK1;RGCC;WDR45;CDK5RAP3;DUSP3;RELA;IRAK4;DVL1;RHOF;EIF4ENIF1;PGAM1;GRB2;LLGL1;SASH1;MAPRE1;MSN;POLR2A;CEP250;UBQLN1;FLNA;CADPS;POLA1;SMAD3;PRKACA;SQSTM1;SPRED2;PTPRJ;ESR1;AP2A1;NR3C1;KIF11;IKBKB;DCTN1;DLG1;MAP2K6;MAPT;DCTN2;PAK2;MAPKAP1;TBC1D14;PTPN1;LIMS1;CHEK2;FAF1;CNOT9;MAVS;TOM1L2;CEP152;APC;PTPN23;DGKD;TRIM5;MVP;CDC42;TRAF2;IFNAR2;KAT2B;NBEAL1;RB1CC1;RPS6;TCF7L2;ADAM10;CYLD;RNF138;TP53;SPRED1;TTC28;USP37;ADIPOR1;BICD1;CALM1;TPCN2;CLTC;DNAJC3;BECN1;NPM1;LRBA;NEK6;NBEA
prerank,methyl-CpG binding (GO:0008327),-0.3007453562456944,-0.8885139389291987,0.6009615384615384,0.8398833368777858,1.0,14/22,34.12%,ZBTB4;CHTOP;MBD1;TET1;CXXC4;ERH;ZCWPW1;MBD2;ZBTB21;PRMT1;WDR77;PRMT5;MBD3;LRWD1
prerank,adenyl ribonucleotide binding (GO:0032559),0.35352245523085213,0.8878095249526171,0.772,0.980322430858567,1.0,64/291,17.17%,PLK1;ATP5F1A;BLM;PDXK;EIF4A3;MINK1;TARS1;VPS4A;DYRK2;BMPR1A;ATP7A;BTK;HARS1;MAP3K20;CDK6;ACVR1;ABCD2;STK11;HSP90AA1;CLPX;HSPA9;CDC42BPB;TAP1;SYN3;RPS6KA5;AARS1;RAPGEF4;TWF2;MAST2;PI4K2A;DAPK1;PIP4K2B;ABCG1;TAOK1;SRR;ABCD3;CHD8;GCK;PFKP;ABL1;ERN1;CDKL5;SRPK2;MYO9B;ABCA1;ABCD1;TGFBR1;ACVR1B;INSR;NVL;MTREX;MKNK1;HCN1;NEK6;STK3;MAP4K4;UBA2;ABCE1;PPIP5K2;PRKACB;TBCK;MYO1B;HSPA5;RAPGEF2
prerank,neuropeptide receptor binding (GO:0071855),-0.35361404135747787,-0.8872627415515607,0.6116207951070336,0.8352769149728444,1.0,4/14,35.72%,AGRP;PPY;SHANK1;NMU
prerank,exoribonuclease activity (GO:0004532),0.4515182141164177,0.8864556570731943,0.6048850574712644,0.9801277831933384,1.0,2/12,6.57%,EXOSC5;EXOSC7
prerank,voltage-gated cation channel activity (GO:0022843),0.3577381376401522,0.8860859852277172,0.6932642487046632,0.9780729446778202,1.0,17/97,17.25%,HCN3;CACNG7;CACNA1D;KCNH8;KCNH7;HVCN1;CACNA1A;PKD2;GRIN2A;TPCN2;CACNA1C;KCNQ5;HCN1;KCND2;KCNA1;KCNA5;KCNB2
prerank,ATPase activator activity (GO:0001671),0.41020600134970586,0.8845523582292748,0.5986842105263158,0.9783379150495903,1.0,2/20,2.29%,DNAJB1;DNAJC15
prerank,ubiquitin-specific protease binding (GO:1990381),-0.3161010262063512,-0.8844083106263988,0.6169354838709677,0.83377567387632,1.0,6/19,11.85%,PRKN;VCP;CHMP3;AMFR;SUMO1;DERL2
prerank,C-C chemokine binding (GO:0019957),-0.30093965064897965,-0.8834736222462155,0.6210045662100456,0.8284355451831057,1.0,15/22,66.54%,CCR2;CXCR4;ZFP36;CCR1;CCR6;CCR9;CCRL2;ACKR3;ACKR1;CXCR5;CXCR6;XCR1;CXCR3;CXCR2;CCR7
prerank,platelet-derived growth factor receptor binding (GO:0005161),0.4421552830508731,0.882399190518602,0.6381766381766382,0.9797467965627643,1.0,4/13,15.90%,PDGFB;PTPRJ;ERN1;PDGFC
prerank,GDP binding (GO:0019003),0.3652323812325795,0.8808713328497434,0.6695095948827292,0.979809743538001,1.0,12/63,12.49%,NRAS;RAB8B;RAB12;RERG;RAP1A;RAB5B;RAP1B;KRAS;RAB2A;RIT2;RAB18;GNAI3
prerank,acetylcholine receptor activity (GO:0015464),-0.302670897875961,-0.8783789325440028,0.679324894514768,0.8318766950449148,1.0,3/22,25.70%,CHRM3;CHRFAM7A;CHRNA7
prerank,calcium-dependent phospholipid binding (GO:0005544),0.3745733611534069,0.8773833803351514,0.6659316427783903,0.9838616905634614,1.0,5/49,10.14%,CPNE5;SYT12;SYT11;PLA2G4A;ANXA2
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),-0.309643652818768,-0.8773048074712614,0.6239669421487604,0.8268976243847609,1.0,3/21,17.48%,P2RX7;GRIK2;P2RX4
prerank,C-C chemokine receptor activity (GO:0016493),-0.29649326768360795,-0.8766012226952273,0.6170212765957447,0.8212887901604977,1.0,14/21,66.54%,CCR2;CXCR4;CCR1;CCR6;GPR75;CCR9;CCRL2;ACKR3;CXCR5;CXCR6;XCR1;CXCR3;CXCR2;CCR7
prerank,mRNA methyltransferase activity (GO:0008174),0.4460705682415358,0.875693001939959,0.6118518518518519,0.9843847987658257,1.0,2/12,6.37%,METTL8;METTL3
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.3687862349076901,0.8756077674308581,0.6425438596491229,0.9818214600323057,1.0,11/54,16.00%,SIRT7;HDAC9;ACER3;HDAC11;HDAC5;ASRGL1;ASAH1;MIER3;HDAC2;GLS;GLS2
prerank,neuropeptide hormone activity (GO:0005184),-0.3062185929648242,-0.8738604824380356,0.5852534562211982,0.8195956623617242,1.0,18/22,69.40%,AGRP;PPY;ADCYAP1;PENK;CCK;PNOC;GRP;NPFF;NPY;CRH;GAL;NMB;VIP;SPX;CORT;NPPA;GHRH;CALCB
prerank,channel activity (GO:0015267),0.3736806103924162,0.8728937155880814,0.6682080924855491,0.984099027883207,1.0,4/41,13.03%,TMEM266;TMEM120B;TRPV2;BCL2
prerank,pentosyltransferase activity (GO:0016763),0.37838884912810655,0.8721239409545569,0.6599286563614745,0.9828457744551696,1.0,6/36,10.02%,PARP9;PARP8;LACC1;PARP2;TNKS2;PARP4
prerank,calcium-release channel activity (GO:0015278),-0.3134081440469416,-0.8707728026532188,0.6176470588235294,0.8187262972585547,1.0,3/17,4.64%,RYR2;ITPR2;ITPR1
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.34719283044690125,0.8700795191456435,0.919,0.9841040289567421,1.0,88/731,15.19%,POU2F3;GLIS1;RORA;ZIC4;SP8;RELA;IRF1;SP1;TFAP4;POU5F2;SOX13;KLF9;ZBTB5;TGIF1;CLOCK;ZEB2;RUNX1;MAX;NFATC1;JUN;AR;ZBTB7A;ZNF569;ELK3;WBP2;IRF3;BCL6;SMAD3;TEAD1;ZNF467;ESR1;HDAC5;NR3C1;IKZF1;JUND;PRDM4;MEF2A;WIZ;TFCP2;ZBTB11;NACC1;MAFG;PPARG;NR6A1;TAL1;HBP1;HIVEP1;HOXC4;TCF12;ZNF568;ZSCAN29;NR5A1;CREB3L2;NR2C2;SOX11;ZBTB38;BCL11A;ZNF182;PRDM1;HIVEP2;DNMT3A;GMEB2;BACH2;TCF7L2;ZBTB34;ATF6;SOX6;TP53;MAF;NR1D2;KLF13;MYT1L;RXRA;SP4;KCNIP3;RREB1;CARF;CREB1;RFX3;RBPJ;PPARD;DACH2;HIVEP3;CTCF;ARNT;SNAPC3;SMAD4;ZBTB18
prerank,metalloaminopeptidase activity (GO:0070006),-0.32902972708095624,-0.8687912557957552,0.6372881355932203,0.8160550503791725,1.0,7/16,21.06%,MMP16;TRHDE;XPNPEP3;LTA4H;RNPEPL1;MMP14;ANPEP
prerank,poly-pyrimidine tract binding (GO:0008187),0.4026771030767271,0.8686743092918967,0.6474278544542033,0.9840293830721271,1.0,8/23,16.15%,RBMS3;ATXN1;PABPC4;U2AF2;HNRNPH1;RBMS1;HNRNPC;PATL1
prerank,lipid phosphatase activity (GO:0042577),0.4387611984891943,0.8684311094455323,0.6275862068965518,0.9818015023388124,1.0,2/14,5.74%,SGPP1;SGPP2
prerank,protease binding (GO:0002020),0.3499537699861046,0.8671137279810837,0.6995884773662552,0.981590871340486,1.0,18/99,14.92%,POLG;TYSND1;RIOK3;BRCA2;RHBDD2;BFAR;F3;ANXA2;FURIN;PRNP;DERL1;TP53;BCL2;LCOR;FN1;CLTC;PTEN;NFRKB
prerank,CoA hydrolase activity (GO:0016289),0.42827738225971046,0.8656390138661778,0.6508795669824087,0.9815290114010453,1.0,3/16,12.94%,ACOT9;ACOT13;ABCD1
prerank,lipase activator activity (GO:0060229),0.456868613772117,0.8644724677769686,0.6498470948012233,0.9809106871263242,1.0,2/10,13.79%,BTK;FYN
prerank,lysophospholipase activity (GO:0004622),0.4052023087014707,0.8636357141273427,0.6343381389252949,0.9797804437501525,1.0,4/20,10.21%,PLA2G6;PLA2G4A;ABHD16A;PNPLA6
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.36694914367759013,0.8620930427154363,0.6692913385826772,0.9799768892841741,1.0,15/49,16.68%,UBXN1;RAD18;UBQLN1;SQSTM1;BABAM2;ZFAND6;TAB3;RNF169;MINDY2;EPS15;OPTN;RAD23B;OTUD7A;UIMC1;ZBTB1
prerank,lipoprotein particle receptor binding (GO:0070325),0.3800576108042241,0.8593560680116165,0.656934306569343,0.9821930307912142,1.0,4/27,14.68%,LDLRAP1;AP2A1;RELN;CLTC
prerank,CoA-ligase activity (GO:0016405),0.4253238882436736,0.8580178136411359,0.6332378223495702,0.9819476560175994,1.0,1/14,2.58%,ACSBG1
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),-0.37760525043182436,-0.8574794987456652,0.6731301939058172,0.8316092740786816,1.0,5/10,33.55%,SIRPA;JUP;CD200;CXADR;PKP2
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.37547364694861596,0.8572030801076786,0.6774941995359629,0.9808134971970677,1.0,7/40,13.56%,SUV39H1;METTL8;TARBP1;SETD3;AS3MT;DNMT3A;DPH5
prerank,nuclear localization sequence binding (GO:0008139),0.41142556048508766,0.8550116928537426,0.6680053547523427,0.9820008330523521,1.0,4/18,9.84%,KPNB1;RANBP6;KPNA6;IPO5
prerank,phosphatidylinositol kinase activity (GO:0052742),-0.32993528657375015,-0.854450222137148,0.6387832699619772,0.8301463750766856,1.0,5/15,9.29%,PIK3CG;PI4KB;PIK3CA;PIK3C3;PIK3C2B
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.38816343960430494,0.8539143320830096,0.649810366624526,0.9814163829991662,1.0,5/26,16.81%,CHSY1;B3GALNT1;B3GNT2;B3GALNT2;B3GALT1
prerank,RNA 7-methylguanosine cap binding (GO:0000340),0.43949884772794334,0.8538577080715563,0.6495726495726496,0.9789169930765176,1.0,6/12,17.22%,AGO2;CYFIP2;DCPS;EIF4E2;CYFIP1;EIF4E
prerank,ATP hydrolysis activity (GO:0140603),0.366970516127104,0.8527808493429994,0.6816091954022988,0.9781582161984114,1.0,9/41,13.62%,KIF20B;ABCD2;HSP90AA1;CLPX;VWA8;SMCHD1;VPS4B;ABCD1;MYO1E
prerank,aspartic-type peptidase activity (GO:0070001),-0.38312530248566035,-0.8506216566909922,0.6567164179104478,0.830454580131873,1.0,3/10,22.26%,CTSD;CTSE;BACE1
prerank,MAP kinase kinase kinase activity (GO:0004709),-0.366254003823997,-0.8503015918135435,0.6708860759493671,0.824447091244541,1.0,5/11,22.56%,MAP3K4;MAP3K13;TAOK2;MAP3K1;EGFR
prerank,DNA replication origin binding (GO:0003688),0.3947758075439327,0.8480572353961601,0.6480099502487562,0.9835833773064615,1.0,3/23,9.38%,ORC4;POLA1;ORC2
prerank,calcium ion binding (GO:0005509),0.3365532544647683,0.8472031423060763,0.851,0.9823354041247755,1.0,38/323,14.65%,SCUBE1;CETN2;SLC25A24;MAN1B1;MICU1;TPD52;BRAF;ITSN1;LETM1;THBS1;PADI2;S100A6;CEMIP2;ACER3;GLCE;PITPNM1;GALNT3;SYT12;SYT11;PLA2G4A;TRPM4;CDH11;CANT1;ANXA2;SRR;TKT;PRNP;EML1;CDH20;S100B;COLEC11;CAMKK2;CDH18;PKD2;SPARCL1;ANXA5;CALM1;AIF1
prerank,gamma-tubulin binding (GO:0043015),0.396980599928407,0.8467131826666191,0.677336747759283,0.9806065136850375,1.0,8/21,18.25%,TUBGCP6;DIXDC1;BRCA2;TUBGCP2;NDRG1;PAK1;CDK5RAP2;DDX3X
prerank,organic cation transmembrane transporter activity (GO:0015101),0.4145249602957219,0.8455017313979766,0.6732954545454546,0.980148646469116,1.0,3/16,15.17%,SLC7A8;SLC25A26;SLC44A1
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.3735373372627074,0.8445023957282383,0.6757090012330457,0.9792056723163272,1.0,3/28,8.04%,RNASEH2A;POP1;AGO2
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.348412794694976,0.8430407805143644,0.7200424178154825,0.9792194666588262,1.0,14/74,14.61%,PDXK;FCSK;PANK1;NT5C3A;CHKB;PI4KA;DGKI;NADK2;DGKD;IPMK;GK;PIK3C2A;CHKA;ETNK1
prerank,sodium channel activity (GO:0005272),0.3640313449604341,0.841914142252937,0.6938300349243306,0.978589134420098,1.0,1/37,0.39%,HCN3
prerank,hormone receptor binding (GO:0051427),-0.3303987622613439,-0.8393427878297881,0.658273381294964,0.8377985365855751,1.0,4/14,34.84%,JAK2;JAK1;SOCS2;ADCYAP1
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.34909057961006057,0.839274586004922,0.7224043715846995,0.9804266908684912,1.0,17/60,18.10%,LRRK2;LRRK1;CTDSPL2;CTDNEP1;PHLPP1;SSU72;PPM1A;RPAP2;PPP4C;CTDP1;CAMK2G;PTEN;ILKAP;PPP1CB;PPP3CA;PPP6C;PHLPP2
prerank,protein kinase regulator activity (GO:0019887),0.34125842516503246,0.8391665913409811,0.7443298969072165,0.9780836145156774,1.0,9/95,9.63%,RGCC;GMFB;PRKAR2A;ANKRD54;ELP3;STK11;NCK1;FAF1;APC
prerank,histone acetyltransferase binding (GO:0035035),0.39630037798001105,0.8391406165110924,0.6821705426356589,0.975599814763699,1.0,5/21,12.92%,ZBTB7A;KANSL1L;MEF2A;ECD;TP53
prerank,MAP-kinase scaffold activity (GO:0005078),-0.3631411155955758,-0.8384499274833893,0.6882716049382716,0.8328305507874231,1.0,3/11,6.02%,SPAG9;MAPK8IP3;KSR1
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.38579021292010035,0.8365237538376383,0.6861219195849546,0.9773013794904967,1.0,2/22,6.32%,LDLRAP1;AP2A1
prerank,phosphotyrosine residue binding (GO:0001784),0.3615241207751187,0.8336387604045282,0.6903669724770642,0.9798099128846656,1.0,10/37,15.70%,LDLRAP1;GRB2;IRS1;YES1;PTPN3;ABL1;VAV2;SYK;VAV1;PIK3R1
prerank,5'-nucleotidase activity (GO:0008253),0.4167455984465717,0.8331110347441585,0.6832116788321168,0.9782326366429495,1.0,1/13,5.29%,NT5C3A
prerank,purinergic nucleotide receptor activity (GO:0001614),0.4109143744464207,0.8313736012680023,0.6609686609686609,0.9787148728229133,1.0,1/15,2.01%,P2RY14
prerank,chemokine receptor activity (GO:0004950),0.37743329554956645,0.8312554228825488,0.7027707808564232,0.9764294195434755,1.0,1/24,5.58%,CMKLR1
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),-0.36046619964635884,-0.8310431591135502,0.7371601208459214,0.8394249262549958,1.0,1/11,8.31%,KCND3
prerank,store-operated calcium channel activity (GO:0015279),0.43451007459182467,0.8288778655067748,0.6931297709923664,0.9779293132952331,1.0,1/10,2.08%,TRPC5
prerank,signal sequence binding (GO:0005048),0.36322498149864524,0.8276103147190595,0.7129411764705882,0.9775132469585897,1.0,7/35,10.34%,KPNB1;RANBP6;KDELR2;KPNA6;BABAM2;IPO5;SEC61A1
prerank,single-stranded DNA helicase activity (GO:0017116),0.39095493635669437,0.8257598342190925,0.7064935064935065,0.977974972383432,1.0,1/19,1.53%,RFC2
prerank,WW domain binding (GO:0050699),0.3723237110445683,0.8249986326802752,0.7096774193548387,0.9766475691848635,1.0,2/26,6.00%,PMEPA1;KIF20B
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",0.40291598440180765,0.8245053688664437,0.7117726657645467,0.9749296429949388,1.0,1/16,1.94%,CD38
prerank,phosphatidylcholine transporter activity (GO:0008525),0.3922530416199616,0.823335968345199,0.6975138121546961,0.9743667630174644,1.0,6/17,15.46%,PITPNM1;ABCA7;ABCG1;PITPNA;ABCA1;PITPNB
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.3269327168684074,0.8207843856784145,0.8460764587525151,0.9759234574462938,1.0,26/173,15.19%,RELA;ZFP90;SOX13;ZBTB5;TGIF1;ZEB2;MAX;JUN;ELK3;BCL6;TRPS1;NR3C1;NACC1;PPARG;ENO1;DEAF1;BCL11A;PRDM1;ZFP69;ZBTB34;MYT1L;NFX1;KCNIP3;PPARD;CTCF;ZBTB18
prerank,protein tyrosine phosphatase activity (GO:0004725),0.33778987438000385,0.8188280904101584,0.7555555555555555,0.9765460074305059,1.0,15/71,14.87%,EYA2;DUSP3;PTPRJ;PTPN1;PTPRT;PTPN3;PTP4A3;PTPN23;PTPDC1;PALD1;PTPRU;PTPRO;PTEN;PTPN9;PTPN18
prerank,adenylyltransferase activity (GO:0070566),-0.29308230973044774,-0.8179326379813304,0.753731343283582,0.8558971843915443,1.0,7/21,14.64%,TENT2;TENT4B;MTPAP;NMNAT2;TENT4A;PAPOLG;GPHN
prerank,phosphatase activity (GO:0016791),0.33398659847386436,0.8157850404740573,0.7551240560949298,0.9788342564979985,1.0,9/73,13.55%,MDP1;DUSP3;PTPRJ;DUSP16;DUSP10;MINPP1;OCRL;DUSP12;PTPRO
prerank,Lys63-specific deubiquitinase activity (GO:0061578),0.4325776715109767,0.8155770659365853,0.6859375,0.9767644344075418,1.0,3/10,13.77%,DESI2;CYLD;ATXN3
prerank,mRNA 5'-UTR binding (GO:0048027),0.37585857463088657,0.8144367028961207,0.6939281288723668,0.9761746262756935,1.0,2/24,3.31%,RPL41;SYNCRIP
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.41418854910915953,0.8134040921362501,0.7091988130563798,0.9753144934647812,1.0,4/11,17.23%,NAA25;NAA16;NAA15;NAA20
prerank,UDP-glycosyltransferase activity (GO:0008194),0.3325508319547471,0.8132176200728202,0.7481243301178992,0.97319070216871,1.0,12/70,17.14%,POGLUT3;CHSY1;B4GALT1;B3GALNT1;B3GNT2;MGAT4B;B3GALNT2;EXT1;MGAT4A;LARGE1;B3GALT1;EXT2
prerank,protein kinase A catalytic subunit binding (GO:0034236),0.40175305080143026,0.8124839188528189,0.7074626865671642,0.9719099871109506,1.0,3/13,10.29%,PRKAR2A;EZR;PKIA
prerank,palmitoyltransferase activity (GO:0016409),0.3663501171072261,0.8108636789688203,0.7114914425427873,0.9719843997602456,1.0,5/28,14.15%,ZDHHC24;ZDHHC5;ZDHHC1;ZDHHC6;ZDHHC20
prerank,chemorepellent activity (GO:0045499),0.37050149742873745,0.8094700508690251,0.7060975609756097,0.9716695129839396,1.0,4/25,10.93%,SEMA6D;NRG3;SEMA3D;SEMA6A
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.40840513948872803,0.8081478965286794,0.7230113636363636,0.9712790424547455,1.0,1/14,10.20%,DHRS3
prerank,calcium activated cation channel activity (GO:0005227),-0.2910996142346118,-0.8029092524685586,0.7799227799227799,0.8745522531168093,1.0,5/17,14.79%,ANO6;KCNN2;TMEM63A;ANO10;KCNMA1
prerank,microtubule motor activity (GO:0003777),0.3398453512439136,0.7990497635547859,0.755826859045505,0.9824225863958351,1.0,12/51,16.87%,KIF13A;KIF20B;KIF11;KIF26B;KIF16B;KIF3A;STARD9;APPBP2;KIF21A;DYNC1I2;KIF1B;KIF2A
prerank,beta-tubulin binding (GO:0048487),-0.24795262286660769,-0.7976356061450425,0.8469945355191257,0.8764294076947338,1.0,5/31,5.75%,BCAS3;TBCD;ARL8B;APPL1;SMC3
prerank,methylated histone binding (GO:0035064),0.33498034942447263,0.7956524454157606,0.7783783783783784,0.9850345067643124,1.0,11/62,12.96%,THAP7;ZMYND8;KDM5A;DPF2;KMT2E;NCAPD3;ING3;GLYR1;CHD8;ZMYND11;ATRX
prerank,heparan sulfate sulfotransferase activity (GO:0034483),0.39639499093815506,0.7948649100297178,0.7124824684431977,0.9837796307753843,1.0,3/15,11.40%,NDST3;HS6ST2;HS3ST4
prerank,protein-arginine N-methyltransferase activity (GO:0016274),0.40836546555646014,0.794781690530426,0.7057949479940565,0.981542729780701,1.0,3/11,9.78%,FBXO11;PRMT9;NDUFAF7
prerank,phosphatase binding (GO:0019902),0.32067925302420913,0.7891844075526183,0.8174358974358974,0.987449777341029,1.0,27/105,17.61%,CTSC;CARHSP1;SYTL2;SMAD3;MAPK1;DLG1;SNX3;PTPRT;MAST2;STX17;TRPC4AP;MVP;TRAF2;PXN;RCAN3;KIF3A;MAPK14;TP53;SPRED1;SHOC2;PPME1;PIK3R1;IQGAP1;TBK1;STAT6;CHCHD3;CTNNB1
prerank,calcium channel activity (GO:0005262),0.32060179270077405,0.7848151220277073,0.7991587802313355,0.991304821601968,1.0,13/84,14.78%,SLC24A5;TRPC5;CACNG7;CACNA1D;TRPM4;CACNA1A;ANXA2;SEC61A1;MCOLN1;TRPV2;PKD2;TPCN2;CACNA1C
prerank,MHC class II protein complex binding (GO:0023026),0.4046530174377843,0.783459041318403,0.7514705882352941,0.990814677636995,1.0,2/11,6.93%,YWHAE;HSP90AA1
prerank,G protein-coupled photoreceptor activity (GO:0008020),-0.3267419962335217,-0.780450968320243,0.7516556291390728,0.8970083374203041,1.0,9/12,67.34%,ELOVL4;OPN3;GPR88;RRH;GPR52;OPN1MW3;OPN1MW;OPN5;OPN4
prerank,methylation-dependent protein binding (GO:0140034),0.3284570602648613,0.7787253002354994,0.7950108459869848,0.9948276713792155,1.0,10/57,12.96%,THAP7;ZMYND8;KDM5A;KMT2E;NCAPD3;ING3;GLYR1;CHD8;ZMYND11;ATRX
prerank,GTPase inhibitor activity (GO:0005095),0.3928671946827948,0.7761055184093202,0.7655367231638418,0.9959633732212161,1.0,5/13,16.53%,IQGAP2;IPO5;PDE6D;IQGAP1;CPEB2
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",0.40769194467284114,0.7736501700793472,0.7588757396449705,0.996832537342556,1.0,1/11,1.88%,PTDSS2
prerank,U6 snRNA binding (GO:0017070),0.38417767838418687,0.7733718748181874,0.7580645161290323,0.9948858045222957,1.0,1/14,2.30%,LSM7
prerank,semaphorin receptor binding (GO:0030215),0.361089604125849,0.7707472262889822,0.7563775510204082,0.9960812181363329,1.0,4/23,10.93%,SEMA6D;SEMA3D;RIT2;SEMA6A
prerank,vascular endothelial growth factor receptor binding (GO:0005172),0.3885815851601456,0.7701877729909743,0.7606461086637298,0.9944421105744589,1.0,1/12,3.19%,VEGFC
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.34184718202489556,0.7678903270146391,0.7962308598351001,0.9952460809679629,1.0,6/34,10.81%,REXO2;EXOSC5;EXOSC7;ERI3;EXD2;XRN2
prerank,SUMO transferase activity (GO:0019789),-0.29367125718026593,-0.767655113167148,0.8125,0.910233449395169,1.0,7/16,29.61%,PIAS2;PIAS4;TOPORS;RANBP2;CBX4;TRIM28;HDAC4
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),-0.32508944824555897,-0.7674199920393293,0.7978142076502732,0.9038207626186483,1.0,7/11,67.49%,CHRNA7;CHRNA4;CHRNB2;CHRNA5;CHRNA3;CHRNA9;CHRNB4
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),0.35370803946642515,0.7673447191077247,0.7816813048933501,0.9936259292494944,1.0,4/24,14.15%,ZDHHC24;ZDHHC1;ZDHHC6;ZDHHC20
prerank,peptidase activator activity (GO:0016504),-0.26482533290558624,-0.7666851628296396,0.7931034482758621,0.8981342577900868,1.0,4/22,7.01%,PSMD14;VCP;MAL;VSIR
prerank,tau protein binding (GO:0048156),0.3263967291579274,0.7647082890746482,0.7854671280276817,0.9947504665662842,1.0,9/40,14.30%,MAP1A;EP300;HSP90AA1;DCTN1;CDK5;TAOK1;S100B;FYN;ROCK2
prerank,glutamate receptor binding (GO:0035254),0.3698297769376532,0.7628205427630115,0.7532467532467533,0.994981112699641,1.0,2/17,5.53%,HOMER2;SQSTM1
prerank,I-SMAD binding (GO:0070411),0.38163661345937,0.7598831928453491,0.7510668563300142,0.9965682360976669,1.0,4/13,15.19%,SMAD6;SMAD3;TGFBR1;SMAD4
prerank,fibroblast growth factor binding (GO:0017134),0.3612547768232822,0.75737100731321,0.747051114023591,0.9975698257318211,1.0,2/21,7.11%,THBS1;API5
prerank,myosin binding (GO:0017022),0.3162727247581702,0.7567690371113865,0.8165938864628821,0.9960481055819524,1.0,8/55,13.05%,LLGL2;LLGL1;ARFGEF1;GIPC1;RAB6A;STXBP5;STXBP5L;RAB3C
prerank,snoRNA binding (GO:0030515),0.3338858179871364,0.7567159881253535,0.7940119760479042,0.9937997569144986,1.0,5/30,12.08%,PRKDC;NUDT5;UTP6;HEATR1;NOP56
prerank,ankyrin binding (GO:0030506),0.36225607769458634,0.7544822503488705,0.7782258064516129,0.9943158646764801,1.0,2/19,8.18%,CACNA1D;SPTBN1
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),0.31196812569599663,0.7470972988391078,0.8215451577801959,1.0,1.0,5/57,8.91%,UQCRH;UQCRC1;NDUFS1;NDUFA9;NDUFV2
prerank,phospholipid transfer activity (GO:0120014),-0.2566049758699366,-0.7467323075839847,0.8468468468468469,0.9208408460009538,1.0,7/21,15.34%,CERT1;ABCA3;PITPNC1;PLEKHA8;PLEKHA3;GLTP;PLTP
prerank,outward rectifier potassium channel activity (GO:0015271),0.38472299069208965,0.7403850657050043,0.7927927927927928,1.0,1.0,4/11,16.88%,KCNK2;PKD2;KCND2;KCNA5
prerank,mannosyltransferase activity (GO:0000030),0.3452561902551093,0.7383300660374404,0.7810026385224275,1.0,1.0,2/21,4.72%,ALG3;POMT2
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),0.36566478134061997,0.7358276398849041,0.7835616438356164,1.0,1.0,2/15,8.17%,PLA2G4A;SNX3
prerank,sulfotransferase activity (GO:0008146),0.31907830531591946,0.734447392236816,0.7990487514863258,1.0,1.0,1/33,1.12%,UST
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.38529764600632155,0.7326977070070776,0.7910216718266254,1.0,1.0,1/11,7.44%,SLC25A20
prerank,aspartic-type endopeptidase activity (GO:0004190),0.3803988803911267,0.7311710261967985,0.7737752161383286,1.0,1.0,5/12,19.42%,SPPL3;NAPSA;PSEN1;SPPL2A;DDI2
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",0.38202749608675657,0.7302046211689524,0.8104477611940298,1.0,1.0,1/11,2.08%,TRPC5
prerank,cholesterol binding (GO:0015485),0.30900812335775035,0.7288190857883257,0.8425821064552661,1.0,1.0,11/47,16.25%,SOAT1;SIDT1;STARD5;ABCG1;ABCA1;OSBPL1A;SCARB2;GRAMD1B;ERLIN1;CD81;OSBPL2
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.3377646154398494,0.7285909092285954,0.7966751918158568,1.0,1.0,4/25,9.53%,DAPP1;MAPKAP1;MYO1G;KIF16B
prerank,sulfate transmembrane transporter activity (GO:0015116),0.3602417814569173,0.7282766723259521,0.7810734463276836,1.0,1.0,1/14,6.52%,SLC26A11
prerank,translation initiation factor activity (GO:0003743),0.3149694944974616,0.7278895769249599,0.8089622641509434,1.0,1.0,10/36,18.07%,EIF3C;EIF3E;AGO2;EIF1;EIF3A;EIF2S1;EIF4E2;EIF4E;EIF3H;EIF2S2
prerank,transaminase activity (GO:0008483),-0.3068061862636511,-0.7271889146640608,0.817910447761194,0.9391819266651344,1.0,4/11,18.54%,GOT1;ABAT;GOT2;BCAT1
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.30472986559314796,0.7258942051095564,0.8381057268722467,1.0,1.0,7/55,13.91%,SLC24A5;TRPC5;CACNA1D;ANXA2;SEC61A1;TRPV2;PKD2
prerank,Notch binding (GO:0005112),-0.24759987336621542,-0.7232388322734568,0.8584905660377359,0.9371700285676313,1.0,13/22,46.91%,MEGF10;CUL3;SNW1;SNED1;HIF1AN;JAG1;KCTD10;AAK1;TCIM;JAG2;ADAM17;DLK2;NOTCH4
prerank,phospholipase activator activity (GO:0016004),0.3861587363694069,0.7230332192677746,0.7978395061728395,1.0,1.0,2/10,13.79%,BTK;FYN
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),0.3666661948349023,0.7217703303363833,0.7973372781065089,1.0,1.0,2/11,11.97%,NUDT5;DCPS
prerank,Wnt-activated receptor activity (GO:0042813),0.35467844380668107,0.716701383552873,0.7899159663865546,1.0,1.0,3/15,14.51%,LRP5;FZD9;FZD3
prerank,titin binding (GO:0031432),-0.29141179646474913,-0.714031307378098,0.8445121951219512,0.9413399036253377,1.0,2/13,7.55%,CALM2;CAPN3
prerank,motor activity (GO:0003774),0.2999157005365194,0.7136213569768466,0.8610206297502715,1.0,1.0,13/60,16.87%,KIF13A;KIF20B;KIF11;KIF26B;KIF16B;KIF3A;STARD9;APPBP2;MYO1E;KIF21A;DYNC1I2;KIF1B;KIF2A
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),0.3321084340683488,0.7133237009199436,0.8261997405966277,1.0,1.0,8/22,16.68%,SQSTM1;TAB3;RNF169;MINDY2;OPTN;OTUD7A;UIMC1;ZBTB1
prerank,nuclear export signal receptor activity (GO:0005049),0.37928106448861226,0.7122524825432772,0.8273716951788491,1.0,1.0,2/11,8.27%,EIF4ENIF1;CSE1L
prerank,platelet-derived growth factor binding (GO:0048407),0.36879840543479586,0.7037454323798269,0.8212209302325582,1.0,1.0,1/11,5.17%,PDGFB
prerank,tumor necrosis factor receptor binding (GO:0005164),0.36403371883141994,0.7029935424986558,0.8043478260869565,1.0,1.0,2/12,10.87%,BABAM2;TRAF2
prerank,amino acid binding (GO:0016597),0.3091276781542287,0.7017788407456901,0.8243080625752106,1.0,1.0,5/31,12.33%,AARS1;GLRB;SRR;GRM7;GLRA3
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),0.2942439312578209,0.700010951223366,0.8677777777777778,1.0,1.0,7/55,15.51%,SLC7A2;SLC38A2;SLC7A8;SLC25A32;SLC38A9;SLC16A6;SLC38A6
prerank,ribonuclease P RNA binding (GO:0033204),0.36157288994596903,0.6937987183292432,0.8364197530864198,1.0,1.0,1/10,7.51%,POP1
prerank,MAP kinase activity (GO:0004707),0.3419710953983785,0.6917450386998687,0.8330871491875923,1.0,1.0,4/14,16.31%,MAPK1;MAPK8;MAPK14;MAPK6
prerank,insulin-like growth factor receptor binding (GO:0005159),0.3527894931899008,0.6881042377710788,0.8276877761413843,1.0,1.0,3/12,15.70%,IRS1;INSR;PIK3R1
prerank,telomerase RNA binding (GO:0070034),0.32250890507267727,0.6871374097424966,0.8525641025641025,1.0,1.0,3/22,9.48%,SMG6;XRN1;SNRPD3
prerank,voltage-gated calcium channel activity (GO:0005245),0.29908807786710667,0.6866941540406668,0.8672875436554133,1.0,1.0,6/37,14.78%,CACNG7;CACNA1D;CACNA1A;PKD2;TPCN2;CACNA1C
prerank,H4 histone acetyltransferase activity (GO:0010485),0.3592730635054612,0.6865028156435211,0.8215384615384616,1.0,1.0,2/10,6.78%,EP300;BRCA2
prerank,N-acetyltransferase activity (GO:0008080),0.3200337319194162,0.6850373650831947,0.8451268357810414,1.0,1.0,3/19,11.99%,EP300;KAT2B;ESCO1
prerank,monocarboxylate:sodium symporter activity (GO:0140161),-0.3065528496108461,-0.6838428574613635,0.8635097493036211,0.9665618160604229,1.0,8/10,69.36%,SLC6A1;SLC6A11;SLC10A1;SLC10A6;SLC10A3;SLC6A12;SLC6A13;SLC10A2
prerank,protein heterodimerization activity (GO:0046982),0.27080634390033215,0.6830686197317396,0.9596774193548387,1.0,1.0,35/178,17.25%,ADCY8;MICU1;PEF1;YWHAE;TPM1;PDGFB;SDCBP;METTL3;MEF2A;IKBKB;TENM4;ADD1;IRAK2;FXR2;ABCG1;DGKD;SNX1;ATF6;TP53;BCL2;MIGA1;FZD9;TLR4;ARNT;NPAS3;HIP1;EXT1;UBA2;MEF2C;VAPB;ZBTB1;TOP2B;SAE1;EXT2;KCNB2
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",-0.22102830723819894,-0.6805748668914184,0.9322033898305084,0.9630725884378254,1.0,7/25,29.45%,CYP27A1;POR;MSMO1;MICAL1;CH25H;FMO5;MTRR
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),0.3405826633244604,0.6785207030670792,0.842031029619182,1.0,1.0,3/13,13.10%,PIP4K2A;PIP4K2B;PIK3C2A
prerank,chloride channel inhibitor activity (GO:0019869),0.35088814607422425,0.6778725889274855,0.8562300319488818,1.0,1.0,1/10,4.75%,STX7
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",0.32891782040283957,0.677547629973335,0.8486486486486486,1.0,1.0,3/17,11.28%,DECR1;TECR;PTGR2
prerank,tRNA binding (GO:0000049),0.28650040880658334,0.6774976206145616,0.8762769580022701,1.0,1.0,4/43,8.31%,NSUN6;PTCD1;TRNAU1AP;AARS1
prerank,ionotropic glutamate receptor binding (GO:0035255),-0.2981956812952442,-0.6774051966646475,0.8885448916408669,0.9594004709257284,1.0,7/10,32.28%,NSF;IGSF11;DLG4;SHANK2;GNAS;SHANK1;SHANK3
prerank,phospholipase inhibitor activity (GO:0004859),0.3578095192116456,0.6768096161790993,0.8549141965678627,1.0,1.0,2/10,13.95%,ANXA2;ANXA5
prerank,nucleotidase activity (GO:0008252),0.33294677767069614,0.6758201959030071,0.8555399719495091,1.0,1.0,1/15,5.29%,NT5C3A
prerank,transition metal ion transmembrane transporter activity (GO:0046915),0.29738601191020764,0.6656404320155759,0.8954326923076923,1.0,1.0,4/30,12.50%,SLC39A11;ATP7A;SLC31A1;SLC39A10
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),0.34117334776033936,0.6646374694608744,0.8656716417910447,1.0,1.0,2/12,10.90%,RELA;GTF2B
prerank,diacylglycerol kinase activity (GO:0004143),0.3434365263964869,0.6627654462701157,0.8427299703264095,1.0,1.0,4/11,17.83%,DGKI;DGKD;DGKZ;DGKH
prerank,inward rectifier potassium channel activity (GO:0005242),0.3030699898364742,0.6605284341139214,0.8862793572311496,1.0,1.0,1/24,3.02%,KCNJ6
prerank,TBP-class protein binding (GO:0017025),0.3080587459510543,0.6563522642567876,0.8654353562005277,1.0,1.0,4/21,12.00%,ESR1;PSMC5;GTF2B;YEATS2
prerank,pyrophosphatase activity (GO:0016462),0.27489070070579225,0.6531446102391664,0.9161147902869757,1.0,1.0,6/50,11.97%,PRUNE2;NUDT5;NUDT9;ENTPD1;RNGTT;DCPS
prerank,cytokine receptor activity (GO:0004896),0.26619346276083583,0.6531238556796538,0.9184100418410042,1.0,1.0,8/83,11.87%,LIFR;IL10RB;CMKLR1;IL1RAP;CD44;F3;IFNAR2;IL17RA
prerank,hexosaminidase activity (GO:0015929),0.334465922232262,0.6526772572314051,0.8717557251908397,1.0,1.0,1/12,4.89%,CEMIP2
prerank,kinase inhibitor activity (GO:0019210),0.2879097420961618,0.6513817486959842,0.8862837045720985,1.0,1.0,6/33,16.50%,GMFB;NCK1;LRP6;DNAJC3;NPM1;YWHAB
prerank,cAMP response element binding (GO:0035497),0.3468570678418108,0.650929178280884,0.8540706605222734,1.0,1.0,3/10,14.01%,JUN;CREB3L2;CREB1
prerank,amino acid:sodium symporter activity (GO:0005283),0.333323501545961,0.6501226705888307,0.8824383164005806,1.0,1.0,1/11,5.63%,SLC38A2
prerank,RNA stem-loop binding (GO:0035613),0.3409789747406107,0.649965433165889,0.8807069219440353,1.0,1.0,2/12,6.03%,CSDE1;RC3H2
prerank,RNA cap binding (GO:0000339),0.3180490880949695,0.6476312545658116,0.8612945838837517,1.0,1.0,6/16,17.22%,AGO2;CYFIP2;DCPS;EIF4E2;CYFIP1;EIF4E
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.31929629768964174,0.6468404273837537,0.8796033994334278,1.0,1.0,2/15,7.97%,SETD1A;SETD3
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),0.34259329088176343,0.6444616217018881,0.8687315634218289,1.0,1.0,1/11,6.53%,PPP1R8
prerank,nuclear receptor coactivator activity (GO:0030374),0.2733563179655082,0.6444139464493713,0.9003285870755751,0.9987538363971273,1.0,7/52,10.26%,BRD8;PRKCB;BUD31;NCOA1;NCOA3;CNOT9;ACTN4
prerank,phosphatidylglycerol binding (GO:1901611),-0.2553023373560734,-0.6439052926971368,0.8970099667774086,0.9811889603351922,1.0,7/13,32.75%,OPA1;PITPNC1;PLTP;PLEKHN1;MME;GSDME;STOML2
prerank,ribosomal small subunit binding (GO:0043024),0.31787917442231967,0.6425245163765806,0.8602739726027397,0.9983544505128158,1.0,6/17,18.25%,EIF4B;EIF1;NPM1;ABCE1;CPEB2;DDX3X
prerank,ephrin receptor activity (GO:0005003),0.3134720921473062,0.6398640345179193,0.8944444444444445,0.9966430371801892,1.0,2/17,10.08%,EPHB2;EPHA5
prerank,transmembrane-ephrin receptor activity (GO:0005005),0.3134720921473062,0.6398640345179193,0.8944444444444445,0.9966430371801892,1.0,2/17,10.08%,EPHB2;EPHA5
prerank,protein phosphatase binding (GO:0019903),0.25886552188760414,0.6396903035939246,0.9519427402862985,0.9947728007761967,1.0,26/117,17.95%,ADCY8;SLC9A1;IGBP1;BOD1L1;MAPT;SNX3;PTPRT;STX17;MVP;TRAF2;PXN;KIF3A;MAPK14;TP53;PPP1R16B;SHOC2;ENSA;PPME1;PIK3R1;PPP1R9B;IQGAP1;TBK1;STAT6;MFHAS1;CTNNB1;SMG7
prerank,aminopeptidase activity (GO:0004177),0.28772454484170146,0.6366894525455246,0.8957286432160804,0.995320770637319,1.0,4/26,12.65%,METAP1;LNPEP;XPNPEP1;ERAP1
prerank,chloride transmembrane transporter activity (GO:0015108),0.30804893048625365,0.6348571303261492,0.9002849002849003,0.9948156598723167,1.0,1/16,6.35%,CLCN7
prerank,glycine binding (GO:0016594),0.33170074297406016,0.6344918748067434,0.897239263803681,0.9930609631214756,1.0,3/11,12.33%,GLRB;SRR;GLRA3
prerank,retinoic acid binding (GO:0001972),0.32498430634023845,0.6338118738522301,0.8775510204081632,0.9916121121635565,1.0,12/12,67.53%,RXRA;CYP26A1;UGT1A10;UGT1A1;UGT1A4;UGT1A8;UGT1A7;UGT1A6;CYP26C1;CYP26B1;NR2F2;RARA
prerank,phospholipase binding (GO:0043274),0.32140148190360407,0.6335279102143432,0.8938053097345132,0.9898529685601161,1.0,3/13,13.79%,BTK;SYK;FYN
prerank,cation:chloride symporter activity (GO:0015377),-0.28178532267760514,-0.6332580841754623,0.9164265129682997,0.9819410386354966,1.0,6/10,37.86%,SLC12A9;SLC12A2;SLC6A1;SLC12A7;SLC12A5;SLC12A4
prerank,anion channel activity (GO:0005253),0.26191815937172236,0.6331125491294544,0.9359391965255157,0.9881728064490046,1.0,7/61,12.33%,CLIC1;LRRC8B;CLCN7;CLCN5;GLRB;GABRG2;GLRA3
prerank,NADPH binding (GO:0070402),-0.255915221002026,-0.6301394501506582,0.9256756756756757,0.9773074215656197,1.0,7/13,30.73%,KCNAB1;QDPR;HMGCR;LBR;DUS2;MTRR;CBR4
prerank,ion channel inhibitor activity (GO:0008200),0.2705194811856548,0.627005555645976,0.9202813599062134,0.9911846564509957,1.0,7/35,15.78%,STX7;NEDD4;CAMK2D;CALM1;KCNMB2;ENSA;STX8
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),0.26793447453995817,0.6160375551648558,0.9352941176470588,0.9960348008436017,1.0,4/34,12.65%,NDUFS1;NDUFA9;NDUFV2;NDUFA10
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),0.26793447453995817,0.6160375551648558,0.9352941176470588,0.9960348008436017,1.0,4/34,12.65%,NDUFS1;NDUFA9;NDUFV2;NDUFA10
prerank,protein kinase inhibitor activity (GO:0004860),0.2610652381643947,0.6082387958856073,0.9367231638418079,0.9998963454075033,1.0,7/42,16.50%,GMFB;SPRED2;NCK1;SPRED1;DNAJC3;NPM1;YWHAB
prerank,zinc ion transmembrane transporter activity (GO:0005385),0.28595125639752045,0.6068138340266652,0.9178617992177314,0.9989424046473676,1.0,2/20,12.50%,SLC39A11;SLC39A10
prerank,ion channel activity (GO:0005216),0.24503137698868244,0.6050169707560764,0.9644723092998955,0.9982822993279148,1.0,11/80,15.72%,TMC7;TMEM63B;PIEZO2;TRPM4;GRIA4;MCOLN1;TMEM120B;TRPV2;PKD2;GRIN2A;GRID2
prerank,inorganic cation transmembrane transporter activity (GO:0022890),0.25408671045081066,0.6045836314908405,0.9360986547085202,0.9965831627312451,1.0,6/48,13.91%,PIEZO2;TRPM4;MCOLN1;SLC12A6;TRPV2;PKD2
prerank,transferrin receptor binding (GO:1990459),0.3128724770489759,0.6012176021229882,0.89792663476874,0.9969601211010494,1.0,3/10,16.20%,IKBKB;SNX1;CD81
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),0.29905921498878213,0.5977006041257747,0.9137426900584795,0.9974532648931129,1.0,3/13,13.00%,LCLAT1;AGPAT4;AGPAT5
prerank,nucleoside-triphosphatase activity (GO:0017111),0.23913305026023937,0.5972010438573028,0.993993993993994,0.9957834575009331,1.0,36/248,15.26%,LRRK2;NRAS;RHOF;GPN1;RAB8B;RERG;RAP1A;MTG2;KIF20B;ABCD2;HSP90AA1;RAB5B;CLPX;RAP1B;RAB6A;VWA8;KRAS;RAB2A;GNAQ;SMCHD1;CDC42;RIT2;VPS4B;RAB18;GNAI3;SRPRA;ABCD1;RAB3C;TBC1D24;MYO1E;SAR1B;GNB1;RAB7A;ARHGDIB;ARL8A;ATL2
prerank,GTPase activity (GO:0003924),0.23959275712077974,0.5966219625652909,0.9919678714859438,0.9941749370392768,1.0,27/192,15.26%,LRRK2;NRAS;RHOF;GPN1;RAB8B;RERG;RAP1A;MTG2;RAB5B;RAP1B;RAB6A;KRAS;RAB2A;GNAQ;CDC42;RIT2;RAB18;GNAI3;SRPRA;RAB3C;TBC1D24;SAR1B;GNB1;RAB7A;ARHGDIB;ARL8A;ATL2
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),-0.23975292686655514,-0.5963809225909965,0.9471947194719472,0.9908310989373136,1.0,7/14,26.51%,MAL;PYCARD;BCL2L13;RACK1;NOD1;CASP1;EBAG9
prerank,snRNA binding (GO:0017069),0.25371648802190616,0.595077054778284,0.9524361948955916,0.9932044595654521,1.0,5/42,11.15%,LSM7;CDK9;SNRNP70;SNRPD3;RBM7
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),0.2975080682923203,0.5943329054135391,0.9121037463976945,0.9917201879747978,1.0,3/13,15.87%,TARBP1;TRMT1L;THUMPD3
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),0.3014208899352228,0.5904804771317084,0.9097633136094675,0.9923333539431297,1.0,2/12,14.31%,APAF1;CASP8AP2
prerank,calcium-activated potassium channel activity (GO:0015269),-0.25140141233875646,-0.589834758911809,0.9283489096573209,0.9872214048280747,1.0,1/11,1.70%,KCNN2
prerank,ribonuclease P activity (GO:0004526),0.29932529701664784,0.5822091734786768,0.9259818731117825,0.9958534729483067,1.0,1/11,7.51%,POP1
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),0.28960792564541266,0.5803781857230361,0.924219910846954,0.995131044770274,1.0,3/13,12.33%,GLRB;GABRG2;GLRA3
prerank,actin monomer binding (GO:0003785),0.2710531288633372,0.5762706998891557,0.9449311639549437,0.9955891721451825,1.0,5/22,16.13%,TWF2;TMSB4X;ABL1;LIMA1;MRTFA
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),0.2769709249954607,0.5748376090076841,0.9328859060402684,0.9944519180916234,1.0,2/18,10.14%,TMOD3;ANXA2
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),-0.18708216489196872,-0.5679524837403235,0.9798994974874372,0.9905950300241488,1.0,7/26,31.14%,MPC1;MPC2;SLC6A1;SLC16A2;SLC16A1;SLC16A3;SLC6A11
prerank,receptor antagonist activity (GO:0048019),0.2711102879951003,0.5666916263841834,0.9280774550484094,0.9971866796870094,1.0,1/17,11.03%,PXDN
prerank,chemokine binding (GO:0019956),0.24935267422677326,0.5641110498766636,0.957983193277311,0.9966054716096553,1.0,2/30,12.01%,ITGA4;HMGB1
prerank,PDZ domain binding (GO:0030165),0.23313968216975678,0.5627942738281234,0.978401727861771,0.9953808934143394,1.0,10/61,15.72%,LLGL2;CRIM1;SRR;SDC2;TBC1D10A;MAP2K2;FZD3;PTEN;SYNJ2;GRID2
prerank,carboxy-lyase activity (GO:0016831),0.2579950954228671,0.5605918851412921,0.9571428571428572,0.9946218554421175,1.0,1/23,2.88%,GGCX
prerank,dipeptidyl-peptidase activity (GO:0008239),-0.24763426382514447,-0.5586748661979014,0.9775280898876404,0.9874422828910323,1.0,7/10,36.28%,DPP8;NAALAD2;DPP7;DPP9;DPP10;PRCP;DPP4
prerank,neuropeptide receptor activity (GO:0008188),0.24596728533533374,0.5550201539593717,0.9529702970297029,0.9957741417967182,1.0,1/29,6.75%,SORCS3
prerank,"DNA binding, bending (GO:0008301)",0.2746107483676544,0.5512049026666124,0.9552669552669553,0.9958096343541646,1.0,14/14,72.56%,HMGB1;TERF1;FOXL1;HMGB4;FOXD1;HMGB3;LEF1;FOXC1;TOP2A;HMGA2;SAP30L;TFAM;HMGB2;HHEX
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.26365632095357194,0.5491089508531636,0.9584487534626038,0.9948792453685196,1.0,1/16,8.47%,ALOX5
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),0.26822474493654863,0.54589286312231,0.9417613636363636,0.9945690863332888,1.0,3/15,13.00%,LCLAT1;AGPAT4;AGPAT5
prerank,thioesterase binding (GO:0031996),0.2836782045702247,0.5415863404849908,0.9412628487518355,0.9946464492961543,1.0,2/11,10.87%,CDC42;TRAF2
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.22008458005138837,0.5338127093508133,0.9851380042462845,0.9960825631647294,1.0,6/75,12.98%,HPGD;UGDH;GLYR1;DHRS3;HSD17B11;HSD17B4
prerank,cardiolipin binding (GO:1901612),0.280540556377476,0.5332617361114655,0.9371165644171779,0.9944154269081501,1.0,1/10,7.46%,GSDMD
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),0.2315928146710892,0.5226246773171342,0.978021978021978,0.9966110184383592,1.0,4/32,15.51%,SLC38A2;SLC7A8;SLC38A9;SLC38A6
prerank,phosphatase activator activity (GO:0019211),0.25506788852123485,0.5175007191221908,0.9498607242339833,0.9966876784307179,1.0,3/14,14.29%,FRS2;PPP2R5C;CALM1
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),0.2706762144124091,0.5104038717667078,0.9609984399375975,0.9971992498358423,1.0,2/10,11.95%,KDM4B;KDM4C
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.2640763291695435,0.5068715713842163,0.9646539027982327,0.9965274508641118,1.0,11/11,73.61%,HCN1;CNGA4;CNGA1;KCNA10;CNGA2;CNGA3;CNGB1;AQP1;CNGB3;HCN4;HCN2
prerank,solute:sodium symporter activity (GO:0015370),-0.16522490260436684,-0.5046401378854348,1.0,0.9949180819494471,1.0,3/27,17.30%,SLC5A3;SLC20A1;SLC4A7
prerank,sulfuric ester hydrolase activity (GO:0008484),0.2577718632147842,0.5023011998579457,0.9542097488921714,0.9961459808025579,1.0,3/12,16.08%,ARSB;ARSK;GNS
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.25895517212219554,0.4935941296377518,0.9719626168224299,0.9968347481989851,1.0,1/10,11.25%,KAT2B
prerank,inorganic anion transmembrane transporter activity (GO:0015103),0.22043470851877447,0.48383013731744406,0.9805589307411907,0.9976549733607952,1.0,2/27,11.18%,SLC26A11;XPR1
prerank,tRNA methyltransferase activity (GO:0008175),0.22870242575570937,0.47742554811438714,0.9830747531734838,0.9972958342536207,1.0,1/16,5.02%,TARBP1
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),-0.1989180360063913,-0.47066211175274403,0.9911504424778761,0.9938967903656476,1.0,7/11,41.64%,RPS3;HMCES;APLF;NEIL2;HMGA2;NEIL1;NEIL3
prerank,tRNA-specific ribonuclease activity (GO:0004549),0.2147422692074712,0.4296332306843603,0.9885222381635581,1.0,1.0,1/14,7.51%,POP1
prerank,monocarboxylic acid binding (GO:0033293),0.20497362471740782,0.4275213528628644,0.9919028340080972,1.0,1.0,18/18,79.53%,RXRA;PLA2G1B;CYP26A1;UGT1A10;PSAP;AKR1C1;UGT1A1;UGT1A4;UGT1A8;UGT1A7;UGT1A6;NR1H4;CYP26C1;CYP26B1;NR2F2;RARA;NAPEPLD;PYGL
prerank,delayed rectifier potassium channel activity (GO:0005251),0.16379635449402874,0.37350800073944923,1.0,1.0,1.0,32/32,83.65%,KCNQ5;KCNA1;KCNA5;KCNB2;KCNC2;KCNQ3;KCNA7;KCNE1;KCNE5;KCNA10;KCNE2;KCNA3;KCNG3;KCNE4;KCNS1;KCNG4;KCNE3;KCNG1;KCNQ1;KCNQ4;KCNH2;KCNC4;KCNS3;KCNG2;KCNA4;KCNB1;KCNC3;KCNA2;KCNC1;KCNQ2;KCNA6;KCNH1
prerank,protein phosphatase 1 binding (GO:0008157),0.17353629618718705,0.36289799058833233,0.9974160206718347,1.0,1.0,4/21,18.30%,PPP1R16B;SHOC2;PPP1R9B;PHACTR4
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.17869515961902818,0.35942522462030974,1.0,1.0,1.0,1/14,10.53%,CAPN2
prerank,hormone activity (GO:0005179),0.1262325637930251,0.2979752457869886,1.0,0.999922821357168,1.0,1/54,7.28%,CCL25
